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SUMMARY
The development of gingival inf lamination is not well 
understood, despite many years of investigation. 
Accordingly, the main aims of this thesis were, to study 
the immune and inflammatory cellular infiltrate during the 
development of gingival inflammation and to examine the 
effect of proinflammatory cytokines on adhesion molecule 
expression using gingival organ culture.
Two studies were performed which utilised the experimental 
gingivitis model. In the model, experimental gingival 
inflammation was induced in two groups of healthy 
volunteers by withdrawing oral hygiene procedures and 
allowing plaque to accumulate undisturbed for 21-days and 
10-days. Tissue for analysis was obtained from the 
experimental gingivitis studies and from patients 
undergoing routine periodontal treatment. Immunohistology 
and computerised image planimetry were employed for 
assessing changes within periodontal cellular infiltrate 
and adhesion molecules; and a bioassay was used to assess 
changes in the levels of interleukin-1. Initial studies 
showed that a single staining avidin-biotin-complex method 
utilising peroxidase as the substrate, gave the optimal 
immunohistological staining procedure.
Clinical parameters during the experimental gingivitis 
studies changed as expected, with the 10-day study 
demonstrating minimal changes and the 21-day study showing 
large increases as expected. The 10-day study was aimed at 
analysing changes during very early 'histological'
xxviii
inflammation and the 21-day study during 'clinically 
detectable' inflammation.
The cytokine, interleukin-1 was demonstrated in crevicular 
fluid during the 21-day study in healthy human volunteers. 
A sensitive and specific bioassay allowed detection of 
biologically active interleukin-1 in inflamed gingiva. 
Interleukin-1 levels increased rapidly with plaque 
accumulation and in advance of the subsequent gingival 
inf lammation, peaking within 7 days of the start of 
gingivitis.
Monoclonal antibodies to CDla (specific for Langerhans 
cells and thymocytes) and HLA-DR (class II major 
histocompatibility antigens - (MHC)) were used to identify 
Langerhans cells within gingival biopsies taken every 7 
days of the 21-day study and every 3 days of the 10-day 
study. HLA-DR antibody stained dendritic cells within the 
oral epithelium which were morphologically identical to the 
CDla+ Langerhans cells. During the 10-day study the number 
of CDla+ Langerhans cells and HLA-DR+ Langerhans cells did 
not change with time. However, within the 21-day study, 
Class II MHC Langerhans cell numbers rose and plateaued 
between day 7 and 14, then decreased to baseline by day 21. 
As plaque accumulated and inflammation developed there was 
an initial increase, followed by a decrease in CDla+ 
Langerhans cells. It was hypothesised that this may 
reflect the antigen presenting and migrating role of 
Langerhans cells to lymph nodes.
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The cellular infiltrate of gingival tissue was also 
analysed and it was found that all of the cell types 
studied (neutrophils; T-cells and T-cell subsets i.e. 
helper, suppressor, naive and memory) were present in 
varying quantities. Periodontal cellular infiltrate was 
seen within healthy tissue and within experimentally 
inflamed gingival tissue; and demonstrated preferential 
accumulation in the connective tissue subjacent to the 
junctional epithelium. Higher numbers of memory-T cells 
than naive-T cells were found within healthy gingival 
tissue; with subsequent inflammation development their was 
no change in memory-T cells numbers, with a simultaneous 
decrease in the number of naive-T cells. This suggests 
that the naive-T cells were maturing into memory-T cells, 
and in turn are maintaining the numbers of memory-T cells 
within the gingival tissue.
Vascular endothelium expressed ELAM-1 (endothelial cell 
leukocyte adhesion molecule-1), VCAM-1 (vascular cell 
adhesion molecule-1) and ICAM-1 (intercellular adhesion 
molecule-1) both in clinically 'healthy' tissue (day 0) and 
in experimentally inflamed tissue (day 3 to 10 and day 7 to 
21). Positive vessels were found mainly in the connective 
tissue subjacent to the junctional epithelium where the 
highest numbers of T cells (CDlla+) and neutrophils were 
also seen. Although T cells were found in all tissue areas 
studied, neutrophils were largely concentrated in the 
junctional epithelium and the subjacent connective tissue 
but were absent from the oral epithelial region. As the 
experimental gingivitis lesion developed the number of T 
cells or neutrophils in the different tissue regions did
XXX
not change significantly. The most intense vascular ELAM-1 
staining redistributed to the connective tissue subjacent 
to the junctional epithelium, ICAM-1 demonstrated no bias 
in its distribution and VCAM-1 showed no difference in 
staining intensity between junctional epithelium and oral 
epithelium connective tissue areas. A prominent feature 
was the intense ICAM-1 positive staining of the junctional 
epithelium and its absence in the closely adjacent oral 
epithelium, in both clinically 'healthy' and inflamed 
tissue. Similar patterns of adhesion molecule expression 
were seen within diseased periodontal tissue, with adhesion 
molecules located within the most infiltrated areas.
Gingival vascular adhesion molecules did not exhibit the 
typical modulation seen in other tissue types, they were 
present throughout the 10 and 21 days of experimental 
gingivitis. This suggests one of two possibilities, either 
the blood vessels in gingiva are functionally specialised 
and constitutively express ELAM-1 and VCAM-1, plus high 
levels of ICAM-1 to facilitate leucocyte traffic into the 
gingival crevice; or that the gingival vessels are 
permanently activated even in 'health' due perhaps to the 
constant ingress of bacterial products such as 
lipopolysaccharide across the junctional epithelium which 
is a loosely packed highly permeable epithelial barrier.
As changes in interleukin-1 were detected before 
recognisable gingival changes, interleukin-1 may have 
potential as an early marker of gingival inflammatory 
changes. Also, the migration of Langerhans cells within 
the gingival epithelium may represent an important early
xxxi
event in the gingival immune response to plaque. 
Generally, greater numbers of cells were seen in the same 
areas as the adhesion molecules. The gradient of ICAM-1 in 
junctional epithelium, with the strongest staining on the 
crevicular aspect plus the vascular expression of ELAM-1, 
VCAM-1 and ICAM-1 in both clinically 'healthy' and inflamed 
tissue may be crucial processes which direct leucocyte 
migration towards the gingival crevice.
The importance of these adhesion mechanisms in protecting 
against periodontal disease is highlighted by the rapid and 
severe periodontitis that characterises leucocyte adhesion 
deficiency (LAD). The studies presented in this thesis have 
highlighted the importance of understanding the initiation 
of gingival inflammation and the kinetics of adhesion 
molecule expression and their control of leucocyte 
trafficking. Further studies are required to ascertain if 
defects in adhesion molecule expression may play a part in 
determining an individuals susceptibility to periodontal 
disease.
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Chapter 1 
Introduction
1.1 Introduction
Periodontal disease, a general term for destructive 
inflammatory reactions affecting the supporting tissues of 
the teeth, is one of the most prevalent examples of a 
chronic inflammatory process afflicting man. The primary 
aetiological agent in periodontal disease is now known to 
be the accumulation of bacterial plaque in the periodontal 
crevice and at the gingival margin (Listgarten, 1988). 
However, the nature of the organisms present and the 
virulent factors they produce are likely to be more 
important than the actual quantity of plaque that has 
collected (Maiden et al., 1990). It is probably the action 
of these bacterial products on the underlying connective 
tissues that elicits the inflammatory response within 
periodontal disease.
The term periodontal disease, is used to denote any disease 
involving the periodontium, this includes osseous 
dysplasias, dermatoses and other generalized disorders 
producing changes in the epithelial and connective tissues. 
However, for the purposes of this thesis the term 
periodontal disease will be confined to gingivitis and 
chronic periodontitis.
1.2 The oral mucosa
The oral mucosa can be divided into three zones;
(1) the masticatory mucosa i.e. the gingiva and the 
covering of the hard palate,
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(2) the specialised mucosa i.e. the mucosa covering the 
dorsum of the tongue and
(3) the oral mucous membrane, lining the remaining of the 
oral cavity.
1.2.1 The gingiva - structure and function
The gingiva is the part of the oral mucosa that covers the 
alveolar processes of the jaws and the cervical portions of 
the teeth. It can be divided anatomically into marginal 
and attached gingival areas (Fig. 1.1). In about 50% of 
cases the marginal gingiva is demarcated from the adjacent 
attached gingiva by a shallow linear depression, the free 
gingival groove (Ainamo & Loe, 1966). In fully erupted 
teeth the gingival margin (groove) is located on the enamel 
approximately 0.5 to 2 mm coronal to the cervix (cemento- 
enamel junction).
In human teeth the gingival margin seldom forms a knife- 
edged termination against the tooth, but is rounded, this 
is the orifice of the gingival sulcus. The gingival sulcus 
is a shallow crevice around the tooth bound by the surface 
of the tooth on one side and the epithelium lining the free 
margin of the gingiva on the other. In fully developed 
teeth the gingival sulcus is lined coronally with sulcular 
epithelium, the nonkeratinised extension of the oral 
epithelium, and the bottom of the sulcus is formed by the 
coronal surface of the junctional epithelium. The 
junctional epithelium unites the gingival connective tissue
2
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Figure 1,1 Anatomic relationships of normal gingiva.
both with the enamel surface from the cervix of the tooth 
and with the bottom of the gingival sulcus. The length of 
the junctional epithelium rarely exceeds 2 to 3 mm.
The interdental gingiva occupies the interproximal space 
beneath the area of tooth contact. The interdental gingiva 
can be pyramidal i.e. one papilla's tip is immediately 
beneath the contact point, or have a 'col' shape i.e. a 
valley-like depression that connects a facial and a lingual 
papilla and conforms to the shape of the interproximal 
contact (Cohen, 1959) (Fig. 1.2).
1.2.2 Gingival epithelium
The marginal gingiva comprises three areas of epithelium, 
oral epithelium, the sulcular epithelium and the junctional 
epithelium (Fig. 1.3). The principal cell type of the oral 
and gingival epithelium is the keratinocyte. Other cell 
types found in the epithelium are clear cells or non- 
keratinocytes, which include Langerhans cells (LCs) 
(Difranco et al., 1985), Merkel cells (Ness, Morton & Dale, 
1987) and melanocytes (Squier & Waterhouse, 1967; 
Schroeder, 1969).
The keratinocytes constitute about >90% of gingival 
epithelium and synthesis keratin. The process of 
keratinisation involves a sequence of biochemical and 
morphologic events that occur in the cell as it migrates 
from the basal layer towards the surface (Schroeder, 1981).
3
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Three types of surface differentiation occurs within the 
gingival epithelium;
(1) keratinisation i.e. the surface cells form scales of 
keratin and lose their nuclei,
(2) parakeratinisation i.e. the cells of the superficial 
layers retain their nuclei and the granular layer is 
absent f
(3) nonkeratinisation i.e. the cells of the surface layers 
are nucleated and no signs of keratinisation are present.
1.2.2.1 The oral epithelium
The oral epithelium of the gingiva is keratinised and 
covers the crest and outer surface of the marginal gingiva, 
the surface of the attached gingiva and is joined to the 
underlying connective tissue by a basal lamina (Stern, 
1965). The border between the oral epithelium and the 
underlying lamina propria of the connective tissue is 
uneven and characterised by deep epithelial ridges that 
surround finger-like connective tissue papillae (rete pegs) 
(Fig. 1.3). These ridges and papillae as they appear in 
histologic preparations represent interdigitating pegs or 
folds that tend to run horizontally and parallel to the 
surface of the gingiva (Loe & Karring, 1971).
The oral epithelium of the gingiva is, like epidermis, 
subdivided into several layer of cells. In the basal layer 
(stratum basale, stratum germinativum) all cells are 
adjacent to the connective tissue, from which they are
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separated by basement membrane (basal lamina). The cells 
are small and more or less cuboidal or columnar in shape. 
The next several layers of cells constitute the prickle 
cell layer {stratum spinosum) composed of relatively large 
polyhedral shaped cells. Superficial to the stratum 
spinosum are several layers of flattened cells that form 
the granular layer {stratum granulosum) and the cytoplasm 
of these cells characteristically display keratohyalin 
granules. The most superficial layer is the cornified 
layer {stratum corneum), which consists of flattened cells 
that have lost their nuclei and most other organelles as 
they become keratinised (Schroeder & Theilade, 1966) (Fig. 
1.4).
1.2.2.2 The sulcular epithelium
The sulcular epithelium lines the gingival sulcus. It is 
a thin, nonkeratinised stratified squamous epithelium 
without rete pegs and extends from the coronal limit of the 
junctional epithelium to the crest of the gingival margin 
(Fig. 1.3). The sulcular epithelium has the potential to 
keratinise if (1) it is reflected and exposed to the oral 
cavity (Bral & Stahl, 1977; Caffesse, Karring & Nasjleti, 
1977) or (2) the bacterial flora of the sulcus is totally 
eliminated (Caffesse, Kornman & Nasjleti, 1980), suggesting 
that local irritation of the sulcus prevents sulcular 
keratinisation.
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1.2.2.3 The junctional epithelium
The junctional epithelium consists of a collar-like band of 
stratified squamous nonkeratinising epithelium (Fig. 1.3). 
It is three to four cell layers thick in early life, but 
the number of layers increases with age to 10 or even 20; 
its length ranges from 0.25 to 1.35 mm. The junctional 
epithelium is attached to the tooth surface (epithelial 
attachment) by means of a basal lamina (basement membrane) 
that is comparable with that which attaches epithelium to 
connective tissue elsewhere in the body (Listgarten, 1986). 
The basal lamina consists of a lamina densa (adjacent to 
the enamel) and a lamina lucida to which hemidesmosomes are 
attached. Polymorphonuclear leucocytes (PMNs or
neutrophils) are found routinely in the junctional 
epithelium of both conventional and germ-free rats 
(Yamasaki et al., 1979).
1.2.3 The gingival connective tissue
The connective tissue (lamina propria) of the gingiva 
consists primarily of cells, fibres, nerve processes and 
blood vessels embedded in dense collagenous connective 
tissue. The connective tissue of the gingiva is densely 
collagenous, containing a prominent system of collagen 
fibre bundles called the gingival fibres which are arranged 
in three groups/ gingivodental, circular and transseptal 
(Arnim & Hagerman, 1953). The main cell is the fibroblast, 
which synthesises the basic elements of the connective 
tissue. Other cells found include undifferentiated
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mesenchymal cells, mast cells (Shelton & Hall, 1968) and 
macrophages.
Leucocytes have been found in 'clinically' healthy gingival 
sulci in humans and experimental animals. The predominant 
leucocyte found is the PMN, they appear in small numbers 
extravascularly in the connective tissue adjacent to the 
bottom of the sulcus; from there they travel across the 
epithelium (Cattoni, 1951; Grant & Orban, 1960; Thurre et 
al., 1984) to the gingival sulcus where they accumulate and 
are eventually lost to the oral cavity (Fig. 1.5). 
Leucocytes are present in the sulcus, even when 
histological sections of adjacent tissue are free of 
inflammatory infiltrate (Attstrom, 1970).
1.2.4 Vessels within the gingiva
The vessels in the gingival connective tissue are of two 
main types, blood or lymphatic vessels.
1.2.4.1 The blood supply of the gingiva
The blood vessels in the gingival connective tissue are 
arterioles, capillaries, and small veins. Capillaries 
terminating immediately below the basement membrane provide 
the nutritional supply for the gingival epithelium. 
Microscopic studies of the gingival surface in vivo have 
shown that there are approximately 50 capillaries per 
square millimetre, each of which terminates in a loop in 
the peripheral part of the connective tissue papillae
7
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adjacent to the epithelial border. Wide variation in 
numbers exist as well as between individuals. However, 
longitudinal studies have shown that within a particular 
gingival region the same vascular pattern persists over a 
long period of time. Indicating that under normal 
circumstances the blood supply is quite consistent with 
respect to the number, distribution, and size of the blood 
vessels (Karring & Loe, 1967).
The blood supply of the gingival tissues is derived mainly 
from supraperiosteal vessels originating from the lingual, 
mental, buccinator, and palatine arteries. These vessels 
give off branches along the facial and oral surfaces of the 
alveolar bone (Karring & Loe, 1967). Next to the 
junctional epithelium and sulcular epithelium the terminal 
blood vessels form a plexus that extends under the 
epithelial surface from the gingival margin to the apical 
extension of the junctional epithelium (Egelberg, 1966).
1.2.4.2 The lymphatic drainage of the gingiva
The lymphatic drainage of the gingiva involves the 
lymphatics of the connective tissue papillae. The lymph 
progresses into the collecting network external to the 
periosteum of the alveolar processes and then to the 
regional lymph nodes (particularly the submaxillary group). 
In addition, lymphatics just beneath the junctional 
epithelium extend into the periodontal ligament and 
accompany the blood vessels.
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1.2.5 Sulcular fluid
In I960, Brill & Bronnestam carried out a series of 
experiments. These studies initiated interest in studying 
the composition of sulcular fluid and they showed that 
after performing immunoelectrophoretic analyses that at 
least seven different plasma proteins could be shown to be 
present within the fluid. These results indicated that 
small molecules were passing from the subepithelial 
connective tissues into the gingival crevice and out into 
the oral cavity. Also, Brill, (1959) confirmed the 
presence of sulcular fluid (gingival crevicular fluid - 
GCF) in humans and considered it a transudate. Later, 
other workers confirmed that the sulcular fluid was an 
inflammatory exudate and not a continuous transudate (Loe 
& Holm-Pedersen, 1965? Weinstein et al., 1967).
Fluid and plasma proteins leak from the microvasculature 
percolating through the connective tissue and junctional 
epithelium into the gingival sulcus to give rise to the 
gingival fluid (Egelberg, 1967); and in crevices which have 
no gingival inflammation, there is no exudation or fluid 
according to Oliver, Holm-Pedersen & Loe, (1969).
The flow of GCF has been shown to have a close relationship 
with capillary permeability, with fluid passing from the 
subepithelial connective tissues between or through the 
cells of the junctional epithelium into the crevice (Brill 
& Bronnestam, 1960). With Schroeder, Rossinsky & 
Listgarten, (1989) confirming recently that the junctional
epithelium of human gingiva is the pathway for inflammatory 
exudation.
Analysis of constituents of GCF provides information about 
the nature of the host response in the periodontium 
(Offenbacher et al., 1984; Smith et al., 1985) and offers 
to provide a means of monitoring the progression of chronic 
inflammatory periodontal disease (Fine & Mandel, 1986). 
Two techniques are most commonly employed for collection of 
GCF; they are (a) pre-cut methyl cellulose filter paper 
strips and (b) microcapillary tubes (Cimasoni, 1983). 
Collection of GCF is frequently accomplished with the 
intra-crevicular placement of strips (Cimasoni, 1983). 
Problems with sampling GCF can be encountered as repeated 
sampling of the same site results in changes in GCF flow 
rate (Mann, 1963; Cimasoni, 1983) and also that repeated 
placement of filter strips results in changes in the 
subjacent microvasculature (Egelberg, 1966).
1.2.6 Clinical indices
Clinical indices have been used to study the extent and 
severity of gingivitis for many years. Two types of Index 
systems are commonly used when clinical assessment of 
gingiva is required, one measures the presence of plaque 
and the other gingival involvement. Pocket depth 
assessment on the other hand, is used more in assessing 
periodontal destruction and is an indicator of disease 
experience rather than the current situation.
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1.2.6.1 Plaque index
Plaque Indexes (PI) generally estimate the soft 
accumulations on teeth either in terms of tooth area 
covered or in thickness of the material in the area 
measured (reviewed by Fischman, 1986). The indices are 
generally quantified non-linearly and the scores assigned 
on an arbitrary scale. This plaque scoring system can be 
used on a whole mouth or on a selected tooth or site basis.
1.2.6.2 Gingival index
Gingival indexes (GI) measuring gingival involvement have 
relied on one or more of the following criteria; gingival 
colour, bleeding, gingival crevicular fluid flow, contour, 
bleeding-upon-probing etc. Indices using bleeding-upon- 
probing (L5e & Silness, 1963) are widely used, with 
bleeding being used as an indicator of the extent of 
gingival inflammation. Indices using bleeding-upon-probing 
are invasive and prevent histological assessment of 
untraumatised gingival tissue. The modified gingival 
index (MGI) of Lobene et al. (1986) is a modification of 
this GI (Loe & Silness, 1963). It omits the bleeding-upon- 
probing component of the index and makes it more sensitive 
to early changes in gingiva, increasing the sensitivity of 
the lower scores. The MGI does not disturb plaque 
accumulation, causes minimal irritation and injury to the 
soft tissues and is therefore ideally suited for use in 
longitudinal studies (i.e. experimental gingivitis studies)
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where gingival biopsies are taken for histological 
assessment.
1.2.6.3 Pocket depth
Probing pocket depth, recession and loss of attachment are 
parameters used to evaluate the amount of tissue lost in 
periodontal disease and permit quantification of the apical 
extension of the inflammatory lesion.
1.3 Periodontal health and disease
1.3.1 Introduction
Prior to the decade of the 1960's, very little research was 
performed on gingivitis. However following the development 
of the Periodontal Index of Russell, (1959), the 
Periodontal Disease Index of Ramfjord & Arbor, (1959), and 
other similar indices, many epidemiologic studies assessing 
the prevalence and severity of gingivitis and periodontitis 
have been carried out. Many features of periodontitis have 
been elucidated but some mechanisms still remain 
unresolved. The following sections will outline what is 
known about periodontitis and will also highlight the 
deficient areas which require further research.
1.3.2 Bacterial plaque
It has now generally been accepted that substances in 
bacterial plaque are the prime aetiological agents 
responsible for gingivitis and periodontitis (Listgarten, 
1988; Christersson, Zambon & Genco, 1991); and theories
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exist which propose that different forms of, and the 
severity of, periodontal disease can be related to shifts 
in the proportions of bacterial species within plaque 
(Newman, 1990). A classical demonstration of the 
importance of microbial plaque in gingivitis was made by 
Loe, Theilade & Jensen, (1965) using their experimental 
gingivitis model. They demonstrated that gingival 
inflammation in healthy gingiva could be induced by the 
accumulation of microbial plaque and that removal of the 
plaque resulted in resolution of the lesion. With the 
microbiological aetiology of the disease now confirmed in 
studies using human and experimental animal models (Payne 
et al., 1975; Lindhe & Rylander, 1975; Page & Schroeder, 
1976; Moore et al., 1982, 1984; Ohta et al., 1991), plaque 
has been accepted as the causative agent in gingival 
inflammation.
Even though it has been demonstrated that good oral hygiene 
can prevent the development of gingival inflammation and 
periodontal disease (Saxe et al., 1967; Suomi et al., 1969, 
1971a; Suomi, Leatherwood & Chang, 1973), not all the 
characteristics of the disease can be accounted for by 
dental plaque. For example periodontal lesions can occur 
in the absence of plaque (Van der Waal, 1991), variation in 
susceptibility between animal species and between humans 
can not be explained by plaque alone (Fish, 1935; Page, 
Simpson & Ammons, 1975; Ammons, Schectman & Page, 1972) and 
prevalence from tooth to tooth (site specificity) as
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exemplified by the distributions of lesions in juvenile 
periodontitis is not explained. This suggests that host 
defense mechanisms may play an important role in the 
pathogenesis of periodontal disease.
1.3.3 Defence mechanisms operating in the gingiva
Various defence mechanisms are in operation around the 
gingival sulcus, and elucidation of their role has been 
greatly helped by studies on germ-free rats and dogs and on 
animals whose teeth have been kept meticulously clean 
(Attstrom & Egelberg, 1970, 1971; Attstrom, 1971;
Listgarten & Heneghan, 1971, 1973; Attstrom, Graf-De Beer 
& Schroeder, 1975; Schroeder, Graf-De Beer & Attstrom, 
1975; Garant, 1976a, 1976b).
The intact epithelial barrier is one of the host defence 
mechanisms which prevents bacteria entering the connective 
tissue, however large molecules can enter via the 
junctional epithelium (Steinberg, Joseph & Evans, 1981). 
Any noxious substances which manage to penetrate the 
epithelial barrier are dealt with by phagocytosis and other 
defense mechanisms operative within the connective tissue.
One of the earliest events in gingivitis is 'ulceration' 
(Schroeder & Attstrom, 1979) of the wall of the gingival 
sulcus resulting in an influx of microbial substances into 
the underlying connective tissue. Saliva, another of the 
host defence mechanisms, contains secretory IgA antibody,
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peripheral blood leucocytes capable of phagocytosis and 
killing? agglutinins which can cause clumping and clearance 
via nonspecific interactions and its flushing action helps 
clear bacteria from the oral cavity. Once inflammation 
begins, gingival fluid exudes from the gingival sulcus (Loe 
& Holm Pedersen, 1965), this can be protective as it has 
uni-directional flow resulting in a flushing action and 
contains all the substances present in blood serum but in 
lower concentrations. Complement proteins are present 
within the gingival exudate and complement is activated 
during gingival inflammation (Schenkein & Genco, 1977a, 
1977b; Okada & Silverman, 1979). Activation of complement 
leads to enhancement of phagocytosis and killing of 
bacteria as well as initiation and perpetuation of the 
inflammatory response. Complement components can play a 
role in tissue damage such as bone resorption (Raisz et 
al., 1974 )f as well as in healing and connective tissue 
regeneration (Bordin, Page & Narayana, 1984).
GCF contains nonspecific opsonins and antibody specific for 
determinants of pocket bacteria, these may participate in 
host defence by enhancing microbial killing and clearance. 
Antibody specific for periodontal pocket bacteria comes 
from two sources, peripheral blood or it is locally 
produced by plasma cells present within the soft tissues of 
the pocket wall (Lally, Baehni & McArthur, 1980; Mouton et 
al., 1981; Schonfeld & Kagan, 1982; Daly, Cripps & Clancy, 
1983b). Gingival plasma cells produce two types of
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antibodies, antibodies that react specifically with 
periodontal pocket bacteria, as well as non-specific 
antibody resulting from polyclonal activation (Page & 
Schroeder, 1981).
Another host mechanism which can be protective is the high 
turnover rate of sulcus tissue, junctional epithelium, 
matrix components of the gingival connective tissue and 
periodontal ligament. These tissue components have a high 
regeneration potential and thus the periodontium can 
accommodate considerable amounts of damage without long 
term deleterious consequences.
1.3.4 Neutrophil traffic into the gingival crevice 
Neutrophils are important in the prevention of the 
development of gingivitis and formation of gingival and 
periodontal pockets. It has been suggested that in normal 
conditions a constant stream of neutrophils (PMNs) migrate 
from the vessels of the gingival plexus through the 
junctional epithelium to the gingival margin into the 
gingival sulcus and oral cavity (Ryder, 1980a, 1980b,
1980c). Most bacteria produce substances that
chemotactically attract neutrophils (Lareau, Herzberg & 
Nelson, 1984) and chemotactic substances are also present 
within the saliva. A chemical gradient of chemotactic 
agents seems to exist across normal, intact junctional 
epithelium and connective tissue. Neutrophils on leaving 
the blood vessels are guided by this gradient towards the
16
gingival margin or into the gingival sulcus where they 
become functional (Kowolik & Raeburn, 1980; Kowashi, 
Jaccard & Cimasoni, 1980; Charon et al., 1982b; Thurre et 
al., 1984) (Fig. 1.5). These neutrophils, together with 
the epithelial barrier could be considered as the first 
line of defence at the gingival tooth junction.
Local and systemic host defence mechanisms can usually 
control microbial challenge around the teeth and prevent 
breakdown of the periodontal apparatus. Tissue response 
may be seen as gingival inflammation and the damage caused 
is minimal, which is usually repaired by the high turnover 
rate of the tissue components. No pockets form and 
periodontal disease does not occur. It is easy to
understand how gingivitis and periodontal disease can occur 
in an individual who has an underlying or pre-existing 
defect in their primary front line defence system (ie 
neutrophil dysfunction) (Genco et al., 1986) but it is more 
difficult to explain why gingivitis/periodontitis occurs in 
apparently healthy individuals.
1.3.5 Clinical, morphologic and functional changes within 
gingiva as inflammation develops
Inf lammatory changes in the gingiva develop within a couple 
of days of undisturbed bacterial growth on the cervical 
portion of the tooth surface. Clinical inflammation is 
initially seen as discrete colour and texture changes of 
marginal tissues. After ten to twenty days of plaque
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accumulation overt gingivitis is established in most 
individuals and is characterised by gingival redness and 
swelling. The soft tissue have an increased tendency to 
bleed on gentle probing.
Morphologic and functional changes in the gingiva during 
plaque accumulation have been thoroughly investigated using 
both humans and experimental animal models, especially 
beagle dogs (Zachrisson, 1968; Schroeder, 1970a, 1970b;
Attstrom & Egelberg, 1971; Lindhe, Hamp & Loe, 1973; 
Schroeder, Mtinzel-Pedrazzoli & Page, 1973; Lindhe & 
Rylander, 1975; Payne et al., 1975; Schroeder et al., 1975; 
Schroeder & Lindhe, 1975; Schroeder & Attstrom, 1979). 
Based on qualitative as well as morphometric point-counting 
procedures used for stereologic analysis of the gingival 
and periodontal tissue (Schroeder & Graf-De Beer, 1976), 
and combined with previous observations (Schroeder, 1970b; 
Page & Schroeder, 1973; Lindhe et al., 1974; Page et al., 
1974; Attstrom et al., 1975; Page et al., 1975; Payne et 
al., 1975; Schroeder et al., 1975), 5 different states 
ranging from health to advanced disease of the periodontium 
have been proposed. This classification was initially 
proposed by Page & Schroeder, (1976), the stages were 
divided into health, the initial lesion, the early lesion, 
the established and the advanced lesion. Page & Schroeder, 
(1976) proposed that the 'initial' infiltrate of PMNs was 
rapidly replaced within 48 hours by a lymphocytic lesion, 
which persisted, unless further challenged by exogenous
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stimuli from plaque. With further plaque challenge, the 
composition of the cellular infiltrate, was then suggested 
to transform into a plasma cell dominated lesion. At which 
stage tissue destruction including bone resorption was 
suggested to occur. Recent ideas on periodontal disease 
activity (discussed in section 1.5) and the fact that not 
all postulated stages have been observed histologically 
(Zachrisson, 1968, Payne et al., 1975, Seymour, Powell & 
Aitken, 1983a; Seymour et al., 1983b; Brecx et al., 1987b); 
and the inability to test the models validity with true 
longitudinal studies, brings into question Page & 
Schroeder's, (1976) model.
The following sections will review the current thoughts on 
the histopathology of each stage from health to disease, 
making references to Page & Schroeder, (1976) model where 
appropriate.
1.3.5.1 Healthy gingiva
Normal gingiva is characterised clinically by its pink 
colour, firm consistency, scalloped outline of the gingival 
margin and firm interdental papillae (Orban, 1948; Ainamo 
& Loe, 1966), which does not bleed on gentle probing and 
occupies the entire space available below the contact area 
of the neighbouring tooth.
Normal gingiva is relatively free from inflammatory cell 
accumulation and the gingival sulcus is rarely evident at
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the microscopic level in these tissues. The oral surface 
is covered with keratinised oral epithelium which fuses 
with the junctional epithelium. The latter is firmly 
attached to the tooth surface via hemidesmosomes and the 
marginal portion of the junctional epithelium harbours few 
neutrophilic granulocytes and mononuclear cells. The space 
between the oral epithelium and junctional epithelium is 
normally occupied by collagenous structures, immediately 
below the junctional epithelium there is a microvascular 
plexus, containing numerous venules (Egelberg, 1967). 
Isolated inflammatory cells may be present in this area 
and/or around some vessels in more distant locations 
(Attstrom et al., 1975; Lindhe & Rylander, 1975).
About 40% of the normal gingiva volume is occupied by 
epithelial structures (oral epithelium - 30%; junctional 
epithelium - 10%) and the remaining 60% volume is occupied 
by connective tissue components such as collagen fibres, 
matrix cells, vessels and nerves.
1.3.5.2 Clinically 'healthy' gingiva
Under experimental conditions clinically 'healthy' gingiva 
can be established. The tissues are characterised by GI 
scores of 0 and only a trace of gingival exudate (Loe & 
Holm-Pedersen, 1965; Oliver et al., 1969), but this does 
not correspond with histologically 'normal' gingiva (Brecx 
et al., 1987a). Histologically normal gingival tissue is 
only found adjacent to relatively plaque-free teeth and
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therefore is relatively rare in humans, but can be found in 
germ-free animals (Listgarten & Heneghan, 1971); and also 
in animals whose gingiva have been kept meticulously clean 
(Lindhe & Rylander, 1975). Biopsies of clinically normal 
human gingiva exhibit inflammatory cell infiltration. 
These leucocytes appear to be important in the day-to-day 
host response to bacteria and other substances to which the 
gingiva are exposed. This small but definite infiltrate of 
inflammatory cells can be detected in the coronal portion 
of the connective tissue, and as well as containing
lymphocytes, predominantly T-cells with very few B-cells or 
plasma cells (Page & Schroeder, 1976; Seymour et al.,
1983a, 1983b), it also contains PMNs, monocytes and
macrophages. It occupies around 3-5% of the connective 
tissue volume and is in contact with the junctional
epithelium. Collagen is depleted in this infiltrated area 
and the tissue compartment is rich in vascular structures. 
Fluid and plasma proteins leak from the microvasculature 
percolating through the connective tissue and junctional 
epithelium into the gingival sulcus to give rise to the 
gingival fluid (Egelberg, 1967). In the vast majority of 
crevices which have no gingival inflammation, no exudation 
or fluid is seen. This phenomena was demonstrated by 
Oliver et al. (1969) when they grouped gingival areas 
according to their gingival index score (Loe & Silness, 
1963). Using filter paper strips to collect the GCF, it 
was shown that 65% of sites with a GI=0 demonstrated no 
gingival exudation, with the remaining sites (35%)
21
demonstrating only traces amounts of exudation; whereas all 
sites with a GI>1 demonstrated gingival exudation. They 
concluded that GCF could be collected from all sites with 
clinically detectable gingival inf lammation (i.e. GI scores 
>1), and sites with no gingival inflammation (i.e. GI=0) 
exhibited no exudation of GCF; but when present, it could 
only be collected in trace amounts.
One of the major problems in determining the pathogenesis 
of periodontal disease is the inability of investigators to 
distinguish clearly between normal and pathologically 
altered tissue. At what point disease actually commences 
has not been determined and in the absence of any 
definitive evidence two possibilities exist. Firstly, 
features seen in the initial lesion are merely reflecting 
enhanced levels of activity of host defence mechanisms 
normally seen within the gingival tissues (Attstrom et al., 
1975; Payne et al., 1975; Schroeder et al., 1975; Page & 
Schroeder, 1976), or that the 'initial' stage is reflecting 
a quiescent phase which follows the destructive disease; 
and thus may be a later or a constantly recurring stage in 
the progression of the disease (Gillett et al., 1990).
1.3.5.3 The initial lesion - gingivitis
Following plaque accumulation one of the earliest reactions 
seen is characteristically an acute exudative inflammatory 
response known as the initial lesion (Payne et al., 1975; 
Schroeder et al., 1975) as classified by Page & Schroeder,
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(1976). The initial lesion is localised around the 
gingival sulcus and usually emerges after 2-4 days of 
plague accumulation, but the changes can be seen within 24 
hours of plaque accumulation and these usually consist of 
vascular changes beneath the junctional epithelium. More 
blood is brought to the area due to dilation of the
arterioles, capillaries and venules of the dentogingival 
plexus. Simultaneously, intercellular gaps between 
capillary or venular endothelial cells appear due to
elevation of the hydrostatic pressure, resulting in
increased permeability of the microvascular bed to fluids 
and proteins which leak into the tissues. This results in 
an increase in gingival crevicular fluid flow seen both in 
animal models and human models (Payne et al., 1975;
Schroeder et al., 1975). This increase in fluid flow may 
function as a defence mechanism, removing bacterial 
products from the gingival tissues by diluting and flushing 
them out and by supplying antibacterial serum components 
such as antibodies and complement to the area. Usually 
non-inflamed gingiva has minute concentrations of gingival 
crevicular fluid, so the amount of fluid present and the 
concentration of specific plasma proteins in the gingival 
sulcus could be used to estimate the extent of inflammation 
(Fine & Mandel, 1986). As the vascular changes occur 
numerous neutrophils, monocytes/macrophages as well as 
lymphoid cells begin to migrate from the dentogingival 
microvascular plexus and the cellular response is well 
established by 2 to 4 days (Lindhe et al., 1973; Listgarten
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& Ellegaard, 1973; Payne et al., 1975; Schroeder et al., 
1975; Brecx et al., 1987b), and is reversible if the 
exogenous stimuli i.e. plaque is removed.
The nature of the initial lesion is relatively well 
understood. In vitro and in vivo studies have demonstrated 
that extracts of microbial plaque from humans, as well as 
sonic extracts of periodontal bacteria are chemotactic for 
leucocytes (Hellden & Lindhe, 1973; Wennstrom et al., 1980; 
Lareau et al., 1984) and the initial lesion can be induced 
by their application to the gingival sulcus region in 
otherwise normal animals• In human models the initial 
lesion contains no plasma cells in the connective tissue 
area subjacent to the junctional epithelium (Payne et al., 
1975; Brecx et al., 1988a); this is in contrast to the 
findings with animal models where plasma cells are found to 
predominate apically to the gingival sulcus (Listgarten & 
Ellegaard, 1973). It has been suggested that host defense 
mechanisms may not always have a beneficial role, they may 
be destructive and although neutrophils and macrophages are 
recruited to the area to defend the host against bacterial 
attack, their accumulation in the coronal part of the 
connective tissue and junctional epithelium probably 
accounts for much of the damage seen in this portion of the 
gingiva (Lehner, 1972; Page & Schroeder, 1973; Genco et 
al., 1974; Horton, Oppenheim & Mergenhagen, 1974). A 
feasible mechanism of this destruction of collagen in dogs, 
could be the activity of collagenase and other enzymes
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released by the infiltrating and transmigrating neutrophils 
during the initial stage of gingivitis (Attstrom & 
Schroeder, 1979; Schroeder & Attstrom, 1979). Such a loss 
of collagen however,is not seen in humans at this early 
stage (Brecx et al., 1987b). These discrepancies in the 
development of inflamination at this early stage, questions 
the role of animal models in studying the development of 
human gingival and periodontal inflammation.
1.3.5.4 The early lesion - gingivitis
The early lesion evolves from the initial lesion within 
about one week following the beginning of plaque 
accumulation (Schroeder et al., 1973; Payne et al., 1975). 
The vessels of the coronal portion of the dentogingival 
plexus remain dilated (Egelberg, 1967; Lindhe & Rylander, 
1975) and with additional plaque accumulation there is 
more pronounced infiltration of PMNs and 
monocyte/macrophages within the dentogingival epithelium, 
compared with the initial lesion. The junctional 
epithelium now contains increased numbers of transmigrating 
neutrophilic granulocytes and infiltration of mononuclear 
cells,especially lymphocytes (Listgarten & Ellegaard, 1973; 
Schroeder et al., 1973; Payne et al., 1975; Schroeder et 
al., 1975). The inflammatory cell infiltrate at this stage 
has increased to occupy approximately 10-15% of the 
connective tissue volume of the free gingiva (Schroeder et 
al., 1973) and it contains small and medium sized 
lymphocytes, many of which are T-cells (responsible for
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cell mediated immune reactions), while others represent B 
cells (which will probably develop into antibody producing 
plasma cells) (Seymour et al., 1983b). Lymphocytes
predominate in the early lesion and only a few plasma cells 
have been demonstrated (Listagarten & Ellegaard, 1973; 
Payne et al., 1975; Seymour et al., 1983b; Brecx et al., 
1987b). Clinically the early lesion may appear as 
gingivitis, the gingival fluid flow and the numbers of 
transmigrating leucocytes reach their maximum between 6 and 
12 days after the onset of clinical gingivitis (Lindhe et 
al., 1973).
Some fibroblasts within the inflammatory cell infiltrate 
appear to be altered (Page & Schroeder, 1973; Simpson & 
Avery, 1973, 1974; Page et al., 1975), whilst fibroblasts 
in adjacent noninflamed connective tissue have been shown 
to have normal ultrastructural features (Simpson & Avery, 
1973, 1974). The fibroblasts become pathologically altered 
as evidenced by electron-lucent nuclei, swollen 
mitochondria and vacuolization of the endoplasmic reticulum 
with rupture of the cell's membrane. The altered cells 
have been shown to be intimately associated with activated 
lymphocytes, suggesting a cell mediated killing mechanism 
(Schroeder & Page, 1972; Simpson & Avery, 1974). 
Presumably some of these fibroblasts have been injured by 
cytotoxic products such as lymphotoxin produced primarily 
by lymphoid cells (Granger & Williams, 1968; Schectman et 
al., 1972; Walker & Lucas, 1972).
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Furthermore the basal cells of the junctional/sulcus 
epithelium have proliferated and rete pegs have been seen 
piercing and entering the coronal part of the infiltrate 
(Schroeder, 1970a; Schroeder et al., 1973; Horton et al., 
1974; Simpson & Avery, 1974; Payne et al., 1975; Schroeder 
et al., 1975; Page & Schroeder, 1976). The character of 
the cellular infiltrate and the nature of the pathological 
alterations observed, has lead to the concept that cellular 
hypersensitivity may be an important component of the early 
lesion. Wilde, Cooper & Page, (1977) demonstrated that 
typical early lesions could be created in the gingival 
tissue of rats and monkeys sensitised to skin contact 
antigens followed by challenge at the gingival margin with 
the same antigen. A specific T-cell mediated mechanism was 
suggested, as sensitization can only be transferred to 
unsensitised animals by means of lymphocytes, but not by 
serum from the sensitised animals.
The duration of the early lesion has not been definitively 
determined, Seymour et al. (1983a, 1983b) studied biopsies 
from individuals undergoing a period of experimental 
gingivitis for 21 days, they found the initial infiltrate 
to consist mostly of lymphocytes, approximately 70% of 
which were T-cells. Although the size of the lymphoid cell 
infiltrate did increase during the 21 day course of the 
experiment, the composition did not change. Recently a 
six-month experimental gingivitis study carried out by 
Brecx et al. (1988a) reported that greater than six months
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of oral hygiene abstention is required, if plasma cells are 
to dominate the lesion. Thus, the early lesion may persist 
for longer time periods than previously suspected. Though 
some studies have been carried out in humans, where 
biopsies have been taken in a cross-sectional manner from 
children suffering from gingivitis (Schroeder et al., 
1973; Longhurst, Gillett & Johnson, 1980), and these studies 
have suggested that lesions are plasma cells dominated. It 
must be noted, however, that childhood gingivitis lesions 
(plasma cell dominated) are different from adult gingivitis 
lesions,which are lymphocyte dominated (Payne et al., 1975; 
Brecx et al., 1987b). The biopsies in the studies were 
taken in a cross-sectional manner and divided into groups 
according to gingival index scores; it is therefore 
impossible to determine for what length of time 
inflammation has been developing at these sites. Since 
clinical parameters have been shown to reach a maximum 
after 4 months of oral hygiene abstention (Brecx et ai., 
1988a), the sites in the aforementioned studies may have 
been exposed to plaque for an undeterminable period of time, 
and therefore may not represent an early lesion i.e. as 
suggested by Page & Schroeder model, (1976).
1.3.5.5 The established lesion
The established lesion as defined by Page & Schroeder, 
(1976) is hypothesised to be predominated by plasma cells. 
Many investigators have supported this hypothesis by 
stating that only 3-4 weeks of plaque accumulation is
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needed for a plasma cell dominated lesion to be formed 
(Zachrisson, 1968; Payne et al., 1975). This concept has 
been challenged by Brecx et al. (1988a), after carrying out 
a six-month experimental gingivitis study, where they 
concluded that greater than six months of plaque 
accumulation was needed before the lesion became plasma 
cell dominated. The exact period of time required for
lesions in humans to become plasma cell dominated is still 
unknown, though within 18 months periodontitis can be 
initiated in otherwise healthy dogs by withdrawing oral 
hygiene procedures. Therefore, with the passage of time, 
the established lesion characterised by a predominance of 
plasma cells and B-lymphocytes evolves from the early
lesion, probably in conjunction with the creation of a 
small gingival pocket lined with pocket epithelium 
(Schroeder & Lindhe, 1975). This phase of the lesion 
development is commonly referred to as 'chronic
gingivitis'• Continued exposure to plaque results in 
increased fluid exudation from the vasculature and
increased numbers of leucocytes migrating into the tissues 
and the gingival crevice and persistence of plaque sustains 
the inflammatory reaction within the coronal gingiva.
In the established lesion, features seen in the earlier 
stages of the lesion are still present but in an 
accentuated form (Mulvihill et al., 1967; Simpson & Avery,
1974). Large numbers of mature plasma cells are seen 
(Freedman, Listgarten & Taichman, 1968; Simpson & Avery,
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1974) and these are situated primarily in the coronal 
connective tissue as well as around vessels in more distant 
parts of the gingival connective tissue. Collagen loss 
continues in both apical and lateral directions as the 
inflammatory cell infiltrate expands, resulting in 
collagen-depleted areas radiating deeper into tissues (Page 
& Schroeder, 1973). As gingivitis develops the overall 
size of the connective tissue infiltrate increases, 
proliferation of the dentogingival epithelium is maintained 
and the rete pegs extend into the connective tissue 
infiltrate. The pocket epithelium is not attached to the 
tooth surface and forms the external boundary for the 
inflammatory cell infiltrate. It is also heavily 
infiltrated with PMNs, macrophages, lymphocytes and plasma 
cells. Most of the neutrophils, eventually migrate across 
the epithelium into the gingival pocket. The pocket 
epithelium may be extremely thin and may actually be 
ulcerated in some areas. It is also fragile and more 
permeable to the passage of substances than the junctional 
epithelium (Thilander, 1964). Removal of plaque at this 
stage only results in healing of the lesion by repair, and 
not resolution as seen in the earlier stages (Mackler et 
al., 1977; Okada, Kida & Yamagami, 1983).
Established lesions of 2 types appear to exist, some remain 
stable and do not progress for months or years (Lovdal, 
Arno & Waerhaug, 1958; Suomi, Smith & McClendon, 1971b; 
Lindhe, Hamp & Loe, 1975; Page et al., 1975), while others
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appear to become more active and convert to progressive 
destructive lesions. The nature of this conversion has 
been studied, but it is not understood (Schroeder & Lindhe,
1975). Conflicting views exist, Seymour, Powell & Davis, 
(1979) hypothesised that it is a change from T-cell 
dominance to B-cell dominance in this infiltrate, which 
converts such a lesion from a stable state to an active 
state with aggressive destruction. This view is not shared 
by Page, (1986) nor does it fit with the results of 
Gillet, Cruchley & Johnson, (1986) who find mainly B-cell 
infiltrate associated with the non-progressive lesions in 
childhood gingivitis. More recently however, Walsh et al. 
(1987a) suggest that lesions of chronic gingivitis in 
children are T-cell dominated. Further analysis of the 
techniques used within these studies sheds some light on 
the conflicting results. Gillet et al. (1986) in their 
study used a monoclonal antibody directed against HLA-DR to 
separate their lymphoid population into two large groups 
HLA—DR+ and HLA-DR' populations. They found that in 
childhood gingivitis two groups of cells of equal size were 
obtained, one positive for the marker and one negative for 
the marker. They proposed that the HLA-DR+ cells were B- 
lymphocytes and the HLA-DR' cells were unactivated T-helper 
cells. From their study they concluded that the lesions of 
childhood gingivitis were B-cell dominated; but on further 
analysis it can be demonstrated that many assumptions were 
made by the investigators. The major flaw in their study 
was pointed out by the investigators themselves, they
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highlight the point that the HLA-DR+ population contains 
untransformed B cells, as well as activated T-helper cells. 
Therefore, the T-helper cells can be present in either cell 
pool depending upon their activation status. Walsh et 
al.'s (1987a) study was better designed, a panel of eleven 
monoclonal antibodies were used to differentiate the 
population of cells present in childhood gingivitis 
lesions. They concluded from their study that the non­
progressive lesions were T-cell dominated (Seymour et al., 
1982). Supporting the view of Seymour et al. (1982) and 
the hypothesis proposed by the same group in 1979 (Seymour 
et al., 1979).
1.3.5.6 The advanced lesion - periodontitis
The last stage of the lesion is known as the advanced 
lesion. The histopathological and ultrastructural features 
of this lesion have been investigated thoroughly 
(Znamensky, 1902; James & Counsell, 1927; Fish, 1935; 
Freedman et al., 1968; Page et al., 1975), and it has been 
shown that with continued plaque growth along the crown and 
the cementum of the root surface there, is a deepening of 
the periodontal pocket which is accompanied by the 
proliferation of the dentogingival epithelium over the 
'detached root' surface. The advanced lesion has 
characteristic features, alveolar bone loss, fibrosis of 
the gingiva with widespread manifestations of inflammatory 
and immunopathological tissue damage (Freedman et al., 
1968; Garant & Mulvihill, 1972; Simpson & Avery, 1973).
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The lesion is no longer localised and the inflammatory cell 
infiltrate extends laterally and apically into the 
connective tissue.
Conflicting views existed about the type of cell that 
predominates in the advanced lesion. Schroeder & Lindhe, 
(1975) studied in dogs, the conversion of the stable 
established lesion into the advanced destructive lesion of 
chronic periodontitis. They observed that the lesion 
changed from a lymphocyte and plasma cell rich established 
lesion into an advanced lesion which was histologically a 
plasma cell dominated lesion. This view of the advanced 
lesion was questioned by Okada, Kassai & Kida, (1984) they 
found that the predominant cells in the lesion were T-cells 
and not plasma cells; but their study on humans suffering 
from adult periodontitis did not look for the presence of 
B cells or plasma cells, so the study had an inbuilt bias. 
It has now been generally accepted that plasma cells are 
the dominant cell type in the advanced lesion, with noted 
presence of macrophages, lymphocytes and PMNs (Freedman et 
a i m ,  1968; Garant & Mulvihill, 1972; Simpson & Avery, 
1973). The first indication of alveolar bone destruction 
can be histologically seen in the advanced lesion and is 
evidenced by bone loss and fibre attachment loss. 
Development of periodontitis can be initiated using 
experimental systems but only in experimental animal models 
(Lindhe et a i m ,  1973), not in human models (Brecx et a i m ,  
1988a), thus further questioning the validity of using
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animal models to study the development of gingivitis and 
periodontitis, and extrapolating to the human situation.
1.4 Classification of Periodontal diseases
Periodontal disease is broadly classified into two distinct 
entities depending upon the extent of the lesion. In 
gingivitis the inflammatory lesion is confined to the 
tissues of the marginal gingiva, and in periodontitis the 
deeper tissues (alveolar bone, periodontal ligament and 
cementum) are involved (Lyons, Bernier & Goldman, 1959, 
Socransky et al., 1984; Kornman, 1987).
1.4.1 Gingivitis
Plaque-associated gingivitis is the most common form of 
periodontal disease. It is characterised clinically by 
redness, gingival bleeding, oedema, gingival sensitivity 
and tenderness (Loe et al., 1965). Plaque development 
within the experimental gingivitis model is characterised 
by a gradual increase in mass and a thickening of bacterial 
plaque at the gingival margin. On analysing the 
composition of the bacterial plaque, it has been 
demonstrated that predominate bacteria are gram positive 
i.e. bacteria normally associated with health (Socransky, 
1977). In chronic or long-standing gingivitis, 25% of the 
bacteria may be gram negative (van Palenstein-Helderman,
1975). Most forms of gingivitis are plaque induced, 
however, secondary factors appear to modify the clinical
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characteristics of the disease and result in many 
subclassifications.
1.4.1.1 Acute necrotising ulcerative gingivitis
Acute necrotising ulcerative gingivitis is an acute, 
recurring, gingival infection of complex aetiology, 
characterised by necrosis of the tips of the gingival 
papillae, spontaneous bleeding pain and fetor oris 
(Goldhaber & Giddon, 1964; Glossary of Periodontic terms, 
1986). Recurrent episodes of acute necrotising ulcerative 
gingivitis can develop into a chronic condition which can 
lead to a periodontitis type lesion (Silver, Southcott & 
Wade, 1974), with resultant bone loss which is 
characterised by marked interproximal bony craters.
1.4.1.2 Hormonally-related gingivitis
Hormonally-related gingivitis can present as pregnancy 
gingivitis, puberty gingivitis, gingivitis associated with 
birth control medication and steroid therapy (Loe, 1965; 
Sutcliffe, 1972; Knight & Wade, 1974; Samant et al., 1976; 
Kalkwarf, 1978). These forms of gingivitis are 
characterised by an apparent exaggerated response to 
plague, reflected by intense inflamination, redness, oedema 
and enlargement.
1.4.1.3 Drug-induced gingival overgrowth
Individuals on drug therapy i.e. phenytoin for epilepsy, 
cyclosporin for immunosuppression, nifedipine and other
35
calcium ion channel blocking drugs can directly affect the 
periodontal tissues, resulting in drug-induced gingival 
overgrowth (gingival hyperplasia) (reviewed by Seymour & 
Heasman, 1988). Clinically, the lesion starts as beadlike 
enlargements of the gingival margin and papilla. 
Enlargement continues and the marginal and papillary 
growths unite and excessive growth results in the formation 
of pseudopockets.
1.4.1.4 Desquamative gingivitis
Desquamative gingivitis is characterised by sloughing of 
gingival epithelium which leaves an intensely red surface. 
Sloughing of the epithelium is due to vesiculation and is
considered a sign of disease. Lesions can be caused by
allergic reactions (Perry, Deffner & Sheridan, 1973), oral 
manifestations of oral dermatoses - erosive lichen planus, 
benign mucous membrane pemphigoid, bullous pemphigoid and 
pemphigus vulgaris (Shklar, Meyer & Zacarian, 1969;
McCarthy, & Shklar, 1980; Greenberg, 1984).
1.4.2 Periodontitis
There are four major types of periodontitis: adult, rapidly 
progressive, juvenile and prepubertal (Page & Schroeder, 
1982).
1.4.2.1 Adult periodontitis
Adult periodontitis may have its onset in adolescence and 
continues for life and is not usually clinically
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significant until the mid-thirties. Its severity increases 
with age, there is no sex bias and disease development is 
slow and continuous, as evaluated using pooled data 
(Marshall-Day, Stephens & Quigley, 1955; Russell, 1967; Loe 
et al., 1978, 1986; Listgarten, 1986). Although microbial 
plague is linked to the aetiology of periodontal disease, 
the overriding influence is probably individual host 
susceptibility. Fifteen to thirty percent of individuals 
are susceptible to severe periodontal destruction (Jenkins 
& Kinane, 1989) and the hosts inflammatory and immune 
processes are likely to be crucial factors in this 
individual predisposition.
1.4.2.2 Early-onset periodontitis
Early-onset periodontitis has been recognised for many 
years, but the definitions of apparently different forms of 
the disease are not yet clear. Subdivisions of juvenile 
periodontitis; into those with localised and those with 
generalised patterns of destruction are often made. 
Refractory forms of periodontitis are also recognised 
(McFall, 1982; Haffajee et al., 1988; Van Dyke et al., 
1988) .
The disorder is reported to include a form localised 
primarily to the first molars and incisors, often referred 
to as juvenile periodontitis; and, a more generalised form, 
often referred to as rapidly progressive or generalised 
periodontitis (Baer, 1971; Burmeister et al., 1984). While
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many authors refer to these disorders as distinct entities, 
it has been argued that they cannot be separated since both 
occur in the same family (Spektor, Vandesteen & Page, 
1985).
Rapidly progressive periodontitis (RPP) occurs in young 
adult populations from their early-twenties through to mid­
thirties, It is characterised by severe gingival 
inflammation and rapid loss of connective tissue attachment 
and alveolar bone support and is characterised by an acute 
florid inflammation of the gingival tissues. Although, the 
disease may not affect all the teeth, it is not confined 
specifically to the molar and incisor areas. Patients 
affected by RPP are not different from age matched 
population with a healthy periodontium when compared in 
terms of humoral immunoglobulin and complement levels 
(Ranney et al., 1981). Also, neither the blastogenic 
response of blood-derived lymphocytes, nor the production 
of lymphocytic inhibition factor, nor tests for phagocytic 
or killing capacity appears to differentiate between the 
two groups (Tew et al., 1981).
Juvenile periodontitis (JP) has its onset around puberty 
and is characterised by severe angular bony defects on the 
first permanent molars, and sometimes the incisors (Baer, 
1971). The rate and severity of destruction is not 
consistent with the relatively sparse plaque and the lack 
of severe clinical signs of inflammation (Baer, 1971). JP
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also appears to have a racial bias with more blacks 
affected than whites (Burmeister et al,, 1984). The onset 
of JP is rapid and when compared with periodontal disease 
in adults, the rate of attachment loss is 3 to 5 times 
faster and has been estimated at 4 to 5 pm per day 
(Waerhaug, 1977). Early stages of the disease may involve 
one or two sites around the first molars and incisors, and 
a definite diagnosis is made when at least three sites 
exhibit  ^5 mm loss of attachment. Family studies (Saxen, 
1980; Saxen & Nevanlinna, 1984), strongly suggest genetic 
control of clinical phenotypic expression (including 
juvenile periodontitis and generalised periodontitis 
cases), but these studies, which are complicated by 
diagnostic limitations and age effects, have not included 
laboratory measures on variables known to be of importance 
in these disorders, namely abnormal neutrophil chemotaxis 
and bacterial agents (Boughman et al,, 1988). While the 
exact aetiologic relationship between altered neutrophil 
function and early-onset periodontal disease remains 
unknown, reduced neutrophil chemotaxis response has been 
reported frequently (Cianciola et al,, 1977; Lavine et al,, 
1979; Van Dyke et al,, 1980; Ranney et al,, 1982; 
Ellegaard, Borregaard & Ellegaard, 1984; Page et al., 1984; 
Suzuki et al,, 1984). Schenkein, Best & Gunsolley, (1991) 
have shown that race can influence chemotactic 
responses and that blacks have an increased 
prevalence of defects in early-onset periodontitis. Kinane 
et al, (1989a) using leading front analysis suggested
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initially that a chemotactic defect existed in patients 
suffering from rapid onset periodontitis, but on further 
analysis by using a different technique, Kinane et al. 
(1989b) found no chemotactic abnormality. This suggests 
that the results of these conflicting studies, may not be 
due to intrinsic cell behaviour but may reflect the 
techniques used. Most studies have focused on JP, but PMN 
abnormalities have also been observed in generalised forms 
of early-onset disease (Katsuragi et al., 1988). In a 
study of 22 families of probands with localised JP and 
chemotaxis defects, Van Dyke, Levine & Genco, (1985) showed 
that a total of 40 siblings (100% of those with localised 
JP) also had a neutrophil abnormality. But it is not clear 
whether the neutrophil abnormality creates susceptibility 
or if it is secondary to the actions of periodontal 
pathogens•
1.4.2.3 Pre-pubertal periodontitis
Pre-pubertal periodontitis (Pre-PP) is a rare condition and 
occurs as a generalised or localised disease (Page et al., 
1983; Waldrop et al., 1987). Generalised Pre-PP begins with 
the eruption of the primary teeth and affects both primary 
and secondary teeth. It is characterised by severe 
gingival inflammation, rapid bone loss, mobility and tooth 
loss. PMN and mononuclear leucocyte defects are present 
(Page et al., 1985) and work by Page, Beatty & Waldrop, 
(1987) suggests that the functional abnormality in PMNs may 
have a molecular basis. Subjects also having increased
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susceptibility to skin and upper respiratory tract 
infection. Localised Pre-PP affects only some of the 
primary teeth, is less aggressive and may be related to 
either a PMN or mononuclear leucocyte defect, but not both.
1.4.2.4 Refractory periodontitis
Refractory periodontitis refers to disease in multiple 
sites in patients which continue to demonstrate attachment 
loss after appropriate therapy and appear to be more 
resistant to treatment (Lundstrom, Johannsson & Hamp, 1984; 
Haffajee et al., 1988; Van Dyke et al., 1988). These sites 
presumably continue to be infected with periodontal 
pathogens (Haffajee et al., 1988; Van Dyke et al., 1988).
1.5 Periodontal disease activity
Three models have been described to explain destruction of 
the periodontal supporting tissues; the continuous 
paradigm, the random burst theory and the asynchronous 
multiple burst hypothesis (Socransky et al., 1984).
The continuous paradigm implies slow, constant and 
progressive destruction and is supported by cross-sectional 
studies (Marshall-Day et al., 1955; Russell, 1967; Loe et 
al., 1978) and longitudinal monitoring of sites not 
responsive to treatment (Badersten, Nilveus & Egelberg, 
1985). Pooling data from groups, individuals and sites in 
cross-sectional studies can give the impression that 
destruction was slow and continuous (Loe et al., 1978).
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The random burst theory proposed short periods of 
destruction, separated by periods of no destruction, 
occurring randomly through time and at random sites within 
an individual (Socransky et al., 1984). Whereas the 
asynchronous multiple burst hypothesis proposed that 
destruction occurred within a defined period of time and 
then the disease went into remission (Socransky et al., 
1984). In the multiple burst hypothesis many sites would 
show bursts of activity over a limited period of time and 
the sites would become inactive for an indefinite period.
Existing data can not refute any of these three proposed 
patterns of periodontal destruction and any, all or none 
may be relevant in any individual (Haffajee et al., 1988).
1.6 Pathogenic mechanisms of periodontal disease
1.6.1 Introduction
Periodontal diseases (gingivitis and periodontitis) are 
bacterial infections, with plague well documented as the 
causative agent (Listgarten, 1988; Christersson et al., 
1991). Host responses triggered by bacterial infections 
are immunologic and the role of the immune response in the 
pathogenesis of periodontal disease is still unknown. A 
variety of different immune effector mechanisms may be 
involved, also a variety of immune cells may be interacting 
(i.e. T and B cells, macrophages and neutrophils) and their 
effects could be amplified by the production of numerous 
enzymes, monokines and lymphokines. All these processes
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may interact and cause periodontal injury, but the exact 
role of each cell type and mechanism within the 
pathogenesis of periodontal disease is still unknown.
1.6.2 Recent advances in Immunology
Immunology has developed quite rapidly in the last few 
years with advances in molecular genetic methodology, 
cloning of immunogenic cells, studies on cell surface 
receptors and their biological functions, regulatory 
mechanisms, effector mechanisms and effector mediators. 
Advances in these fields have been discussed extensively 
and the following sections will outline the basic concepts 
in immunology before discussing their hypothesised roles in 
periodontal disease.
1.6.2.1 Cells of the immune system
The immune system has evolved to protect the host against 
pathogenic microorganisms and other foreign substances. 
Recognition of these foreign molecules, functionally called 
antigens, is carried out primarily by lymphocytes. 
Lymphocyte-mediated recognition of antigen shows 
specificity as well as memory. Basically, the immune 
response is initiated once the antigen is taken up the 
antigen-presenting cell i.e. macrophages, dendritic cells, 
Langerhans cells of the skin and mucous membrane, and B- 
lymphocytes. The antigen is processed and a peptide 
fragment is presented in association with self antigen to 
the T-lymphocyte and an immune response is initiated.
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There are two types of lymphocytes: B-lymphocytes which 
develop in the bone marrow and subsequently develop into 
antibody-producing plasma cells, and T-lymphocytes (T- 
cells) which develop in the thymus. T-cells can be divided 
into two main subsets, helper T-cells, which produce helper 
factors i.e. cytokines etc to assist other cells of the 
immune system or cytotoxic T-cells, which stimulate the 
microbicidal and cytotoxic activity of other immune cells 
including macrophages. Antigen is presented to T-helper 
cells, the activated T-helper cell then produces factors 
which stimulate B-cells to undergo differentiation into 
plasma cells and eventually produce antibodies. The 
factors produced by the activated T-helper cells can also 
stimulate T-cytotoxic cells and phagocytes, arming them for 
microbicidal or cytotoxic activity. The professional 
phagocytes include macrophages, neutrophils and various 
cells of the mononuclear phagocyte system which are 
distributed throughout the body.
1.6.2.2 Major histocompatibility complex
The success of the interaction between the T-helper cell 
and antigen-presenting cell is dependent upon the ability 
of the T-helper cell to recognise processed antigen in 
association with self antigen on the surface of the 
antigen-presenting cell. These self antigens are 
responsible for rejection of grafted tissue from one 
individual to an other, they determine if the donor tissue 
will be immunologically compatible with the host and hence
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are called histocompatibility antigens. The major 
histocompatibility antigens are encoded in a set of 
clustered loci known as the major histocompatibility 
complex, and are known as the major histocompatibility 
complex antigen or the MHC. MHC as well as playing a major 
role in graft rejection also plays a very important role in 
antigenic peptide recognition. T-lymphocytes have to 
recognise foreign antigens in association with MHC i.e. 
MHC-restricted antigen recognition. In humans MHC is 
called human leucocyte antigen complex, or the HLA complex, 
which is encoded on gene complexes found on chromosomes 6 
and 15. The HLA is divided into two major classes I and 
II; each of the classes has two subclasses, alpha and beta; 
which are further divided into families and sub-families 
which are designated by capital letters. In humans the MHC 
class II alpha families are DP, DQ, DR and DN; and the MHC 
class II beta families are designated DO, DP, DQ, and DR. 
The human class II, subclass alpha families are designated 
DPA-1, DPA-2, etc; whereas in class II, subclass beta 
families are designated DRB-1, DRB-2, etc. In general, MHC 
class I antigens are found on most nucleated cells and MHC 
class II antigens are found mainly on activated T-cells and 
on B-cells.
1.6.2.3 T-cell receptor
When an antigen-presenting cell presents antigen to a T- 
cell, the T-cell simultaneously binds the antigen and the 
MHC molecule on the antigen-presenting cell, this allows
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differentiation between self and non-self. All T- 
lymphocytes express a receptor known as the T-cell 
receptor, which binds antigens and MHC molecules 
specifically. Two types of T-cell receptor exist the af} 
heterodimer and the yb heterodimer; with the ap T-cell 
receptor expressed on 90% of peripheral blood T-helper and 
T-cytotoxic lymphocytes. MHC restricted antigen
recognition is seen only with T-lymphocytes, B-lymphocytes 
possess the ability to recognise antigen alone.
1.6.2.4 Cluster of differentiation (CD) antigens
CD antigens are a family of cell surface molecules which 
were discovered by immunising rabbits, mice etc with human 
lymphocytes. The antibodies produced recognise unique 
antigens designated CD antigen (Cluster of 
differentiation). These CD antigens are useful for 
differentiating leucocyte populations, for example, the 
monoclonal CD3 is useful for distinguishing T-cells from B- 
cells; CD4 is present on T-helper cells and is the co­
receptor for class II MHC and is also a receptor for the 
human immunodeficiency virus; CD8 antigen is present on T- 
cytotoxic cells and is the co-receptor for class I MHC 
antigen complexes. Therefore, CD4+ T-helper cells 
recognise antigen in a MHC class II restricted fashion and 
CD8+ cells recognise antigen in a MHC class I restricted 
fashion.
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1.6.2.5 T-cell subsets
Human T-lymphocytes within both the class I MHC responsive 
CD8+ cytotoxic/suppressor and class II MHC responsive CD4+ 
helper/inducer sublineages can be separated into two broad 
subpopulations based on their expression of distinct 
isoforms of the common leucocyte antigen, the CD45 molecule 
(Tedder, Clement & Cooper, 1985a; Tedder, Cooper & Clement, 
1985b; Clement, Yamashita & Martin, 1988; Sanders et al., 
1988; Serra et al., 1988; Salmon, Kitas & Bacon, 1989; 
Yamashita & Clement, 1989). T-lymphocytes that express on 
their surface high molecular mass CD45 isoform (the CD45RA 
molecule) (2H4) (Streuli et al., 1988), include those 
lymphocytes which are unable to respond to previously 
encountered antigen (Morimoto et al., 1985; Smith et al., 
1986; Damle, Childs & Doyle, 1987) and these CD45RA+ T- 
lymphocytes are postulated to represent a pool of virgin or 
naive T-lymphocytes that have yet to encounter their 
respective antigen (Damle et al., 1987). T-lymphocytes 
that express on their surface the low molecular mass CD45 
isoform, the CD45RO molecule (Streuli et al., 1988), but 
not the CD45RA molecule, include T-lymphocytes that have 
the ability to respond to previously encountered antigen. 
Hence the CD45RO+ T-lymphocytes are thought to represent a 
pool of primed or memory T-lymphocytes (Smith et al., 1986; 
Damle et al., 1987; Akbar et al., 1988; Yamashita & 
Clement, 1989) and is recognised by the UCHL-1 monoclonal 
antibody (Smith et al., 1986). T-lymphocytes within these 
two mutually exclusive and maturationally distinct subsets
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are also known to possess distinct activation requirements 
and also distinct profiles of lymphokine production (Byrne, 
Butler & Cooper, 1988; Sanders et al,, 1989; Salmon et al., 
1988, 1989).
1.6,2,6 The immune response
Generally cell mediated immunity is initiated when antigen 
from subgingival plaque penetrates into the connective 
tissue through the junctional epithelium. Antigen 
presenting cells (macrophages and LCs) process the antigen 
and alter it to a form recognizable by the immune system 
i.e. an antigenic peptide in association with class II MHC. 
The T-helper cell (CD4+) recognises this association of 
foreign antigen and self MHC and becomes stimulated, 
proliferates and releases cytokines. The cytokines in turn 
then act on other lymphoid cells (ie macrophages, B-cells 
and other T-cells) to produce tissue damage, inflammation 
and bone resorption. The lymphocytes are now sensitised, 
upon re-exposure to the plaque antigens they respond by 
proliferating and synthesising cytokines. The cytokines 
then act as signals which stimulate, inhibit or even kill 
other cell types. This is similar to the delayed type 
hypersensitivity lesions where in addition to sensitised 
lymphocytes, the lesions contain non-sensitised 
lymphocytes, which probably form part of the inflammatory 
cell infiltrate in periodontal disease. They may also 
produce cytokines when stimulated by mitogenic substances
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released either by the subgingival microbiota or by other 
cells in the inflammatory reaction.
1.6.3 Damage caused by plaque microorganisms
Most forms of human periodontal disease are initiated and 
sustained by factors produced/released by subgingival 
microbiota (Kahnberg, Lindhe & Hellden, 1976). Some of 
these substances can damage host cells and tissues directly 
and others indirectly by activating endogenous cellular and 
humoral inflammatory reactions. It is therefore the 
combination of both direct and indirect pathways that 
account for periodontal injury.
Plaque microorganisms can directly damage cellular and 
structural components of the periodontium via microbial 
invasion of the soft tissues, as well as the formation of 
noxious substances by the microbiota of the gingival 
pocket. The release of soluble irritative substances by 
bacteria could cause disease, Taichman et al.'s (1984) 
group isolated a 'leukotoxin' from Actinobacillus
actinomycetemcomitans which they found to destroys 
neutrophils and monocytes. Depressing the first line of 
defence of the immune system within the gingival tissue and 
in theory increases the hosts susceptibility to periodontal 
disease. This finding that deficient numbers of PMNs may 
increase susceptibility to periodontal disease is supported 
by the studies carried out on experimentally induced
neutropenia (Attstrom & Schroeder, 1979; Schroeder &
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Attstrom, 1979), and also that individuals with underlying 
neutrophil defects have increased susceptibility to 
periodontal disease (Genco et al., 1986). The leukotoxin 
isolated by Taichman et al. (1984) has yet to be isolated 
by other investigators, and its role further investigated. 
Also, some bacterial hydrolytic enzymes can attack various 
components of the intercellular matrix of the epithelium 
and connective tissue (ie collagen, elastin, fibronectin 
and fibrin), these factors could impair gingival anti­
bacterial defense.
Indirect injury by plaque microorganisms can occur via 
inflammation. Many microbial products have little or no 
direct toxic effect on the host, instead they possess the 
potential to activate non-immune and/or immune inflammatory 
reactions which in turn actually cause the damage. For 
instance lipopolysaccharide (LPS) (endotoxins) of gram 
negative microorganisms may be responsible for a spectrum 
of inflammatory events because they interact with and 
modulate the behaviour of leucocytes. Endotoxin can act as 
a mitogen, stimulating B cell proliferation and antibody 
secretion, it can also cause macrophages to produce and 
secrete neutral proteinases and acid hydrolases. It 
promotes osteoclastic bone resorption and also has profound 
effects on the blood coagulation system. Further, 
endotoxin triggers the complement system resulting in the 
formation of numerous inflammatory peptides. These are 
only a few of the biological properties of endotoxins and
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most of these properties are shared by lipoteichoic acids 
from gram positive bacteria. Likewise, specific proteins 
and polysaccharides produced and released from several 
subgingival bacteria activate endogenous mediators of 
vascular permeability, encourage inflammatory cells to move 
into the tissue and cause them to discharge pro- 
inflammatory agents.
Many members of the gingival microbiota induce an immune 
response in the host (Seymour, 1987) and these immune 
reactions to antigens derived from the subgingival 
microbiota can be harmful to the host. One of the first 
signs that defense mechanisms are acting against the 
bacteria colonising the teeth, is the swelling of the 
vessels of the gingival margin (Egelberg, 1967). This is 
followed by an increased vascular permeability, exudation 
of gingival fluid and migration of PMNs into the gingival 
sulcus, resulting in the tissues becoming inflamed.
The gingival fluid contains both complement factors and 
specific antibody. Two pathways of complement activation 
exist. The classical pathway of complement becomes
activated when specific antibodies of IgG or IgM classes 
react with bacteria, whereas the alternative pathway of 
complement is activated by various microbial cell wall 
constituents such as LPS, lipoteichoic acids and 
polysaccharides.
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1.6.4 Leucocytes within gingival tissue
Both polymorphonuclear and mononuclear leucocytes take part 
in the phagocytic defense of the dentogingival area and 
this defense is presumably assisted by the presence of 
complement and often specific antibodies. In order to be 
effective 'defenders' the phagocytes have to recognise the 
site of microbial invasion, they have to leave the blood 
vessels and migrate through the tissue to the site of 
invasion, where they have to ingest and kill the 
microorganisms (Van Dyke et al., 1985). The leucocytes 
also have a microbicidal system that works under anaerobic 
conditions (Rice et al., 1987) which may be crucial in the 
gingival crevice. The products released by the leucocytes 
not only kill invading microorganisms but the oxygen 
products and the lysosomal proteases may also cause 
extensive host tissue injuries (Fantone & Ward, 1982).
PMNs are the predominate leucocyte found within the 
gingival crevice (Skapski & Lehner, 1976; Sigusch et al., 
1992) and appear to be phagocytic and microbicidal cells in 
healthy or moderately inflamed sites (Wilton, 1982, 1984), 
respond to external stimuli (Farber, 1989) and are 
potentially able to participate in the pathophysiology of 
periodontal disease. The possible contribution of PMNs to 
gingival inflammatory injury has been thoroughly 
investigated (Taichman et al., 1984) and it has been shown 
that as PMNs leave the circulation and move through the 
tissues, they are probably constantly secreting pro-
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inflammatory agents into the environment (Freedman et al., 
1968; Benedek-Spat et al., 1991; Miyasaki, 1991; Altman et 
al., 1992; Giannopoulou et al., 1992). Under experimental 
conditions it has been shown that PMN reactions do 
contribute to gingival injury, for example PMNs supernates 
can cause epithelial cell detachment in vitro (Altman et 
al., 1992); topical application of PMN lysosomal extracts 
onto the gingival margin promotes an increase in vascular 
permeability and leucocyte migration in experimental 
animals (Kahnberg & Hellden, 1977); short-term reduction of 
circulating neutrophils (by cytotoxic drugs or anti­
neutrophil antiserum) is accompanied by a decrease in the 
clinical signs of gingivitis in dogs (Attstrom, Tynelius- 
Bratthall & Egelberg, 1971; Rylander, Attstrom & Lindhe, 
1975; Attstrom & Schroeder, 1979) and finally intradermal 
injections of plague produced more local tissue damage in 
normal as compared to neutropenic rabbits (Taichman, 
Freedman & Uriuhara, 1966). It would therefore appear that 
PMNs can contribute to gingival injury.
Patients with neutropenia, in which the number of cells is 
markedly depressed (below 1500 per ^1 of peripheral blood) 
(Finch, 1983), present with a variety of periodontal 
manifestations. In the malignant form (agranulocytosis, 
PMN count below 500 per p.1), which is generally drug 
induced, there is ulceration and necrosis of the marginal 
gingiva. This is associated with bleeding, and occasional 
involvement of the attached gingiva (Awbrey & Hibbard,
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1973). Histologically, the ulcerated areas exhibit no PMN 
response. In more protracted forms of the disease such as 
cyclic, chronic and familial benign neutropenia the lesions 
are frequently severe. The gingivae may be oedematous, 
hyperaemic and hyperplastic with areas of partial 
desquamation (Kyle & Linman, 1970; Baer & Benjamin, 1974). 
These features are often accompanied by deep periodontal 
pockets and extensive, generalized bone loss involving the 
permanent dentition (Levine, 1959; Baehni et al., 1983). 
Occasionally bone resorption may involve the deciduous 
dentition (Cohen & Morris, 1961; Lampert & Fesseler, 1975). 
Despite the obvious decrease in host defences caused by 
neutrophil depletion in familial benign chronic 
neutropenia, periodontitis is not always inevitable (Deasy 
et al., 1980). Deasy et al. (1980) describe a family 
exhibiting familial benign chronic neutropenia and show 
that although several individuals within this family were 
neutropenic, not all were affected either by recurrent 
infections or by periodontal disease. One neutropenic 
sibling who was free from periodontal disease, had good 
oral hygiene, whereas her neutropenic brother, with poor 
oral hygiene had fiery-red oedematous gingiva and early 
generalised periodontitis. These findings might be 
explained by the variable expressivity of the disorder 
between the siblings, or on the interaction of the 
environment (e.g. the oral hygiene) on this disorder.
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Most of the substances produced and released by plaque 
microorganisms are antigenic, eliciting both cell-mediated 
and humoral mediated immune reactions. Systemic and local 
antibody synthesis by lymphoid cells may be more relevant 
in gingival defense than the systemic immune response, as 
it has been shown that gingival exudation usually contain 
higher concentrations of antibody directed against specific 
plaque organisms when compared to serum, producing an 
enriched antibody environment in the immediate vicinity of 
the infection (Lally et al., 1980; Tew et al., 1985).
Following the changes in permeability, the activation of 
complement and the influx of polymorphs, the last arrivals 
at the site of inflammation are the mononuclear cells - 
lymphocytes and monocytes. Lymphocytes are usually 
specific in their attack and only cause harm when they are 
activated non-specifically. In addition, monocytes and 
macrophages are equipped with enzymes normally used in the 
process of mopping up dead tissue cells and polymorphs, but 
which can also damage healthy cells including other 
macrophages•
1.6.5 Cell mediated immune responses within the gingiva
The role of T-lymphocytes in gingivitis and periodontitis 
has been investigated (Seymour et al., 1982; Daly, Clancy 
& Cripps, 1983a; Okada et al., 1984; Gillet et al., 1986; 
Johannessen et al., 1986; Stoufi et al., 1987; Meng & 
Zheng, 1989; Afar, Engel & Clark, 1992).
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1.6.5.1 Experimental gingivitis
The experimental gingivitis model was first introduced by 
Loe et al. (1965). They demonstrated that withdrawal of 
oral hygiene led to increased plaque levels which 
subsequently led to gingival inflammation. Removal of 
plaque results in resolution of the inflammation, with no 
long term deleterious effects. The experimental gingivitis 
model is thus an appropriate model to use when the 
initiation of gingival inflammation needs to be studied 
under experimental conditions. Some studies have utilised 
the experimental gingivitis model to elucidate the role of 
T-cells within the developing inflammatory reaction. 
Histologically normal gingival tissue is only found 
adjacent to relatively plaque-free teeth and is therefore 
relatively rare in humans. Biopsies of clinically healthy 
human gingiva contains inflammatory cells consisting of 
predominantly T-cells with few B cells or plasma cells 
(Page & Schroeder, 1976; Seymour et al., 1983a,v 1983b; 
Joachim et al., 1990). Four to seven days of plaque 
accumulation results in an influx of lymphocytes into the 
tissue (Listgarten & Ellegaard, 1973; Payne et al., 1975) 
and after three weeks of plaque accumulation the lesion is 
mainly T-cell dominated (Seymour et al., 1983a, 1983b; 
Brecx et al., 1988b). After 6 months of plaque 
accumulation the lesions are still dominated by lymphocytes 
and PMNs (Brecx et al., 1988a). Plasma cells have 
occasionally been observed in the initial and early lesion 
of the experimental gingivitis model (Brecx et al., 1987b,
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1988b), but greater than six months of plaque accumulation 
appears to be a prerequisite for plasma cells to constitute 
a significant proportion of the infiltrated connective 
tissue (Brecx et al., 1988a). Plasma cells have only been 
found to be the major component of infiltrated connective 
tissue in the advanced lesion where bone loss is evident. 
In general, within chronically inflamed tissue the numbers 
of plasma cells do appear to increase with severity of the 
lesion (Ogawa et al., 1989).
1.6.6 T-suppressor cell and T-helper cell ratios
In adult periodontitis only about 30% of the infiltrating 
cells are T-lymphocytes (Okada et al., 1984), with 
increasing numbers of T-helper cells seen (increased T 
helper:suppressor ratio); in juvenile and rapidly 
progressing periodontitis patients have decreased 
peripheral blood helper to suppressor cell ratios whilst 
the disease is active (Kinane, Johnson & Evans, 1989). 
However, a range of helper:suppressor T-cell ratios from 
low to high have been reported in patients with rapidly 
progressive periodontitis (Katz et al., 1988). Low T 
helper:suppressor (T4:T8) has been linked to redness and 
swelling of the gingiva (Stashenko et al., 1985) and also 
a correlation between probeable pocket depth and T4:T8 
ratio has been demonstrated (Stoufi et al., 1987). 
Depressed T helper to suppressor ratios in juvenile and 
rapidly progressive periodontitis may represent abnormal T- 
cell regulation of the immune response and may explain the
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rapid breakdown seen within these disease classifications. 
In comparison adult periodontitis expresses elevated 
ratios, suggesting 'over-regulation' of the immune response 
which may explain the slower rate of disease development 
when compared with juvenile and rapidly progressive 
periodontitis. But the significance of a T4:T8 balance in 
periodontal disease is still unknown (Meng & Zheng, 1989).
It has been hypothesised, that chronic adult periodontitis 
can be separated into two stages, quiescent or activated. 
It is suggested that the quiescent stage is B cell 
dominated whereas the activated stage is plasma cell 
dominated (Gillet et al., 1986). Active periodontal sites 
appear to have an increased number of B cells with a 
decreased T:B cell ratio when compared with stable/healthy 
sites (Reinhardt et al., 1988), but no significant 
differences in T4:T8 ratio could be demonstrated between 
the two sites. Before trying to attempt to identify the 
type of cell present within the mononuclear infiltrates of 
diseased gingival tissue, investigators should try to 
determine whether the site is active or inactive before 
grouping them together. If the assumption is made that the 
sites are of similar disease state, then the results of the 
type of cell present within the infiltrate may be false, as 
it has been noted by Saglie et al. (1988), that different 
cell types appear to be elevated in different disease sites 
i.e. active sites appeared to be associated with few T 
helper/inducer cells and macrophages with increased T
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suppressor/cytotoxic cells, B cells and Langerhans cells, 
whereas sites of inactivity tended to have increased T 
helper/inducer cells, NK cell, monocytes and have decreased 
T suppressor/cytotoxic cells (Saglie et al., 1988).
Recent work, has suggested that depressed spontaneous 
lymphocyte proliferation is seen in subjects with 
periodontal disease; and this decrease is due to altered T- 
cell control. Amer et al. (1990) demonstrated that 
separated B cell populations have significantly higher 
proliferative responses than unseparated mononuclear cells 
within the patient groups only. This suggests that T-cells 
were reducing the hyper-responsiveness of the B-cells (Amer 
et al., 1990) and that disturbances in the immunoregulation 
within the periodontium exist. This study used very few 
subjects and in comparison to other studies the suppression 
of the spontaneous lymphocyte proliferation seen does not 
reach the levels of the other studies (Tew et al., 1983). 
It has also been suggested that this dysfunction is 
confined to the periodontium as no difference in the 
peripheral blood lymphocyte subpopulation could be 
demonstrated when healthy individual were compared with 
individuals suffering from chronic adult periodontitis 
(Zafiropoulos et al., 1990). This suggests that 
longitudinal studies and follow up examinations (locally 
and in peripheral blood) of patients suffering from 
periodontal disease at different stages of disease are
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necessary to ascertain the true role of immunoregulation 
dysfunction within the periodontium.
1.6.7 Memory T-cells and Naive/virgin T-cells
T-lymphocytes play a crucial role during the initiation and 
maintenance of chronic inflammatory responses by releasing 
cytokines and other helper factors to propagate and 
maintain the immune response. Perivascular accumulation of 
T-lymphocytes with the CD29+ CD45RO+ memory phenotype 
(Parrott & Wilkinson, 1981) and localised increase in 
vascular endothelium permeability at the site of chronic 
inflammation (Poulter et al., 1985; Hemler et al., 1986) 
are two of the commonly observed events associated with 
chronic inflammatory responses.
It has been demonstrated that memory T-lymphocytes (CD29+ 
CD45RO+) adhere to vascular endothelial cells and augment 
their permeability to macromolecules (Damle & Doyle, 1990). 
This property of memory T-lymphocytes to modulate 
endothelial permeability may be a dominant factor 
contributing to preferential migration of memory T-cells 
into sites of chronic inflammation. Numbers of memory T- 
cells have also been shown to be increased in the skin of 
patients with systemic sclerosis (Rustin et al., 1990); 
accumulation of memory T-cells to sites of inflammation may 
be explained by their difference in ability to adhere to 
endothelial cells and their homotypic adhesion (Pitzalis et 
al., 1988).
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Recently Afar et al. (1992) have demonstrated elevated 
levels of memory T-cells (CD45RO+) in the peripheral blood 
of patients suffering from periodontal disease whereas in 
contrast Walsh et al. (1989) found that in Oral Lichen 
Planus the expression of the naive T-cell marker - CD45RA+ 
was confined to the intraepithelial lymphocytes (IELs), 
suggesting that they may play an immunoregulatory role in 
T-cell responses. It has been hypothesised that switching 
from the naive (CD45RA+) to memory (CD45RO+) does occur and 
that this switching is linked to the maturation and 
activation state of the T-cells, with an intermediate 
CD45RA+ CD45RO+ T-cell (Wallace & Beverly, 1990). This 
suggests that stimulated memory T-cells may play a role in 
in vitro recruitment of naive T-cells.
Abnormal distribution of T-lymphocyte subsets occurs within 
synovial fluid when compared with peripheral blood 
(Pitzalis et al., 1987). A virtual absence of naive/virgin 
T-cells (2H4+) was noted, with increases in the T- 
helper/inducer (4B4+) and memory T-cells (UCHL-1+). The 
exact role of memory T-cells and naive/virgin T-cells in 
any disease state is not known i.e. in rheumatoid arthritis 
(Pitzalis et al., 1987); multiple sclerosis (Morimoto et 
al., 1987) etc and especially within periodontal disease.
Other studies demonstrate that periodontal patients have 
circulating lymphocytes which are sensitized to substances 
originating from subgingival plaque organisms (Ivanyi &
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Lehner, 1970; Lang & Smith, 1977; Reed, Neiders & Genco 
1976), though these could be cross-reacting. Some 
experiments seem to suggest that a correlation exists 
between the severity of the periodontal disease and the 
number of sensitised lymphocytes i.e. as demonstrated by 
Malberg et al. (1992) that as gingival index increased so 
did the number of activated CD4+ cells; however, this 
association requires confirmation by other studies. It has 
also been suggested that periodontal lesions may contain 
subsets of T-cells which have been sensitised and are 
responding to different plaque antigens (O'Neill, Woodson 
& Mackler, 1982; O'Neill & Woodson, 1986).
1.6.8 Macrophages within the gingival tissues 
The participation of macrophages is crucial to the 
development of cell-mediated hypersensitivity reactions. 
Upon being recruited into the inflammatory lesions, 
macrophages become activated under the influence of 
lymphokines and other substances, such as endotoxin and 
bacterial cell walls. Activated macrophages are more 
adherent, phagocytose and kill bacteria more efficiently 
and they also acquire cytotoxic properties enabling them to 
attack and destroy the target cells. Activated macrophages 
synthesis and secrete numerous products which have wide- 
ranging biological potentials. These include hydrolytic 
enzymes, complement components, binding components 
(fibronectin), oxygen metabolites, arachidonic acid 
metabolites and monokines (e.g. IL-1). Lysosomal enzymes,
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collagenase and elastase probably facilitate extracellular 
breakdown of the connective tissue matrix while 
prostaglandins and monokines may have a number of effects 
on the growth and activity of other cells, including T and 
B lymphocytes, fibroblasts and osteoclasts.
Macrophage numbers over the three week experimental 
gingivitis period have been shown by some investigators not 
to change significantly in the percentage of cells present 
(Brecx et al., 1987b, 1988a; Seymour et al., 1988).
However, Topoll et al. (1989) analyzed subsets of 
macrophages over a 19-day period of experimental 
gingivitis. They found that there was no overall changes 
in the relative numbers of total macrophages present over 
the 19-day period, but a change in the type of macrophage 
present had occurred i.e. the number of anti-inflammatory 
macrophages had decreased with a simultaneous increase in 
the number of inflammatory macrophages. Inflammatory 
macrophages, are antigen elicited macrophages which process 
and present antigen efficiently resulting in the initiation 
of an inflammatory/immune response. Other investigators 
have shown that mononuclear phagocytes invariably appear in 
association with osteoclasts at sites of active bone 
resorption (Rifkin & Heijl, 1979) and that endotoxin- 
stimulated mononuclear phagocytes secrete soluble factors 
with bone resorbing activity (Gregory, 1988). This 
suggests that macrophages play a role in the pathogenesis 
of periodontal disease.
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1.7 Langerhans cells
LCs are dendritic, suprabasal cells found in most 
stratified squamous epithelia including epithelia of the 
oral mucosa (Daniels, 1984). They are of bone marrow 
origin (Katz, Tamaki & Sachs, 1979) and share many 
characteristics in common with the macrophage (Thorbecke, 
Silberberg-Sinakin & Flotte, 1980). LCs express Fc IgG 
receptors, C3 receptors (Stingl et al., 1977) as well as 
CD1 and Class II MHC antigens (Klareskog et al., 1977; 
Rowden, Lewis & Sullivan, 1977) and are capable of antigen 
presentation (Silberberg-Sinakin et al., 1980; Walsh, 
Seymour & Powell, 1988; Cruchley et al., 1989). The 
important role of the gingival LC as accessory cells in 
mitogen induced T-cell responses has been demonstrated by 
Newcomb & Powell, (1988) as has their important function as 
antigen gathering and presenting cells (Rowden, 1981; 
Newcomb & Powell, 1988).
LCs in the oral mucosa are present in numbers equivalent to 
those found in skin (Ahlfors, Larsson & Bergstresser, 1985; 
Van Loon, 1989). Sensitization of Langerhans cells may 
occur via antigens seeping through the gingival mucosa and 
in theory, these sensitised Langerhans cells could present 
antigen to T-helper cells within the gingiva 
initiating an immune response. Other investigators, have 
shown that epithelium resident human Langerhans cells are 
similar to immature precursors of lymphoid dendritic 
cells found in skin-draining lymph nodes (Romani et al., 
1989). Oral Langerhans cells can function as antigen
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presenting cells in a way similar to the skin Langerhans 
cells which present antigen in contact hypersensitivity 
(Silberberg-Sinakin et al., 1980).
It has been proposed that the LCs present within gingival 
oral epithelium vary in number due to the different 
bacterial stimulation levels, or alternatively different 
responses are seen to similar plague antigens penetrating 
the surface of the oral epithelium (Baelum, Fejerskov & 
Dabelsteen, 1989). These cells increase in number as 
plaque accumulates (Newcomb, Seymour & Powell, 1982; 
Difranco et al., 1985); are increased in inflamed tissue; 
and their numbers are increased in oral epithelium found to 
contain intragingival microorganisms (Saglie et al., 1988). 
In clinically inflamed tissues and in experimentally 
induced gingivitis the LCs morphology appears to be more 
dendritic (Newcomb et al., 1982; Difranco et al., 1985) and 
have increased numbers of granules (Newcomb & Powell, 
1986a). Inflammation increases Class II MHC expression on 
LCs and this facilitates the LC functional role by 
permitting MHC-restricted antigen presentation to T-helper 
cells (Savage, Walsh & Seymour, 1987).
Interferon-y (IFN-y) produced by activated T-lymphocytes 
can induce differential expression of Class II MHC, it 
induces HLA-DR and DQ on LCs and only HLA-DR on 
keratinocytes (Walsh, Seymour & Powell, 1986a), in addition 
LCs express more DR than DQ (Walsh, Seymour & Powell,
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1987b). The functional significance of differential 
expression of DR and DQ in gingival epithelium is very 
likely linked to the central roles of class II products in 
regulation of the immune response (Becker, 1985). The main 
restriction elements for antigen presentation are located 
on DR molecules, while DQ molecules play a minor role 
(Gonwa et al., 1983; Walsh et al., 1986a). It has been 
established that a DQ+ subpopulation of peripheral blood 
monocytes contain the entire antigen-presenting capability 
of the monocyte population (Gonwa et al., 1983). While 
both DR and DQ are important in antigen presentation by 
macrophages (Walsh et al., 1986a), further studies 
utilising various LC subpopulations are required to 
establish the role of these molecules in Langerhans cell 
function.
IL-1 produced by epithelial cells (Mergenhagen, 1984) 
augmented through epithelial cell injury increases CDl 
expression on gingival LCs precursors (Walsh et al., 1986a; 
Walsh, Seymour & Powell, 1986b). CDl is a family of cell 
surface glycoproteins of unknown function expressed on 
immature thymocytes, epidermal LCs and on a subset of B- 
lymphocytes. Increased CDl expression on gingival LCs may 
be important, as a role for CDl molecules has been 
suggested in antigen recognition. Due to structural 
similarities of CDl to the MHC molecule of known antigen 
presenting cells. It has been suggested that some 
peripheral T-cells can recognise LCs CDl molecules in
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association with an antigenic peptide (instead of MHC) and 
that this recognition triggers cellular events similar to 
those seen when T-cells interact with antigen presented by 
self-MHC molecules (Porcelli et al., 1989). It is likely 
that these CD1+ LCs may interact directly (Moulon, Peguet- 
Navarro & Schmitt, 1991) or through macrophages in T-cell 
activation.
Walsh et al. (1988) hypothesise that epithelial cells 
produce IL-1 which acts on an intraepithelial population to 
transform these cells from CDl" to CD1+. LPS and/or IFN-y 
then acts on these CD1+ cells making them at first DR+ and 
finally DQ+ as well. It is hypothesised that these cells 
(CD1+ HLA-DR+ HLA-DQ+) could then act as antigen presenting 
cells. CDl is a glycoprotein detectable on the surface of 
LCs (Murphy et al., 1981). The 0KT6 monoclonal antibody 
recognises CDla on the surface of LCs and is the most 
sensitive method available at the present time for 
detecting LCs (Harrist et al., 1983; Difranco et al.,
1985).
Hitzig et al., (1989) reported a cross-sectional study 
where gingival tissue was categorised according to clinical 
indices. These authors suggested LC numbers increase 
during early stages of inflammation and decrease in severe 
inflammation. These findings are in contrast to 
longitudinal studies where LC numbers were reported to 
increase steadily with gingival inflammation (Newcomb et
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al., 1982; DiFranco et al., 1985; Newcomb & Powell, 1986a, 
1986b).
1.8 Cytokines
1.8.1 Introduction
The first evidence that soluble factors released by cells 
were involved in immune reactions and might affect the 
accumulation of mononuclear cells in cellular 
hypersensitivity reactions was provided by Bloom & Bennet, 
(1966) and by David, (1966). These investigators 
independently described a soluble protein factor designated 
migration inhibitory factor, believed to be derived from 
lymphocytes, that inhibited macrophage migration from 
capillary tubes in vitro. Later Dumonde et al. (1969) used 
the term lymphokine to describe such lymphocyte-derived 
hormone-like substances. Similar substances produced by 
monocytes became known as monokines. When it was 
discovered that cells other than those of the immune system 
could also secrete these protein mediators they became 
known collectively as cytokines (Cohen, 1986).
Cytokines are a heterogeneous group of protein cell 
regulators variously called lymphokines, monokines, 
interleukins and interferons that have in common a number 
of features:
(1) Cytokines are soluble, secreted proteins of low 
molecular weight (<80 kDa) and are frequently glycosylated;
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(2) They are involved in inf lamination and immunity where 
they regulate the amplitude and duration of the response;
(3) They are usually produced locally and transiently and 
act in an autocrine or paracrine fashion;
(4) They are extremely potent and act by binding specific 
cell surface receptors on the target cell.
The involvement of cytokines in the inflammatory response 
in vivo was supported by their detection in the 
inflammatory exudates of delayed type hypersensitivity 
reactions (Cohen et a i m ,  1973), the synovial fluid and 
culture supernatants of synovial tissue from rheumatoid 
patients (Stastny, 1975) and in the lymph draining areas of 
antigenic challenge (Kelly, 1972; Hay, Lachman & Trnka, 
1973). Early studies of cytokine action were largely 
performed using crude tissue extracts or culture 
supernatants. More recently the availability of purified 
and recombinant cytokines has greatly facilitated their 
study and has resulted in an enormous increase in both the 
literature and our understanding of their actions in vivo. 
It is however useful to consider the cytokines studied in 
the proceeding chapters i.e. interleukin 1 (IL-1), tumour 
necrosis factor (TNF) and interferon (IFN), in more detail.
1.8.1.1 Interleukins
The name 'interleukin' was proposed in 1979 for factors 
produced and released by activated T-lymphocytes that act 
on other lymphocytes to produce biological effects i.e. the
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interleukins act as intercellular signalling agents between 
lymphocytes. Interleukins also include species produced 
primarily by cells of other hematopoietic lineages, such as 
monocytes. Interleukin-1 (IL-1) is a monokine (Platanias 
& Vogelzang, 1990), produced by monocytes in response to 
fever-inducing agents such as bacterial lipopolysaccharide 
(LPS)• It was previously known as 'lymphocyte activating 
factor' or 'endogenous pyrogen' because of its fever- 
inducing properties.
IL-1 is a pleiotropic cytokine with diverse activities 
including induction of thymocyte proliferation, PMN 
chemotaxis, fever, fibroblast mitogenesis and collagenase 
synthesis (Dinarello, 1988; Jandinski, 1988). IL-1 can be 
found in two forms, IL-la and IL-ip (March et al., 1985). 
The predominant form secreted by monocytes is IL-ip, in 
contrast, human keratinocytes also express both IL-la and 
IL-ip mRNA, but appear to produce mostly IL-la (Kupper et 
al., 1986). Since macrophages and epidermal cells are 
components of periodontal tissue, these cell types may be 
a significant source of IL-1.
1.8.1.2 Tumour necrosis factor
Tumour necrosis factor (TNF) is functionally related to IL- 
1. Two forms have been detected TNF a and TNFp, which are 
products of activated macrophages and lymphocytes
respectively. TNFa was originally discovered in the sera of 
mice and rabbits that had been infected with Mycobacterium
70
bovis strain bacillus Calmette-Gu6rin and subsequently with 
endotoxin (Carswell et al., 1975). Serum from such animals 
causes haemorrhagic necrosis and in some cases complete 
regression of certain transplanted tumours in mice. TNFp 
(also called lymphotoxin) was first characterised as a 
biological activity in mitogen-stimulated lymphocytes, 
having anti-cellular action on neoplastic cell lines 
(Charon et al., 1982a). Although originally defined by 
their cytotoxic action, it has become apparent with the 
availability of recombinant TNFa, that the TNFs are potent 
immunoregulatory molecules sharing overlapping biological 
activities with IL-1. Furthermore, several lines of 
evidence point to the existence of bidirectional 
stimulatory interactions between TNFa and IL-1 (Le & 
Vilcek, 1987).
1.8.1.3 Interferons
The name interferon (IFN) was given to a substance, 
isolated by Isaacs & Lindenmann in 1957, that protected 
cells against viral infection. Three types of IFN exist, 
a, p and y. Type I IFNs, IFNa and IFNp and are produced by 
leucocytes and fibroblasts respectively; and type II IFN, 
IFNy is known as immune IFN. IFNy is produced by 
lymphocytes following antigenic or mitogenic stimulation 
and is acid-labile. One of the main functions of IFNy is 
macrophage activating factor, i.e. IFNy can act on tissue 
macrophages found in skin, Langerhans cells; in bone, 
osteoclasts; in liver, Kupffer cells and in the central
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nervous system, microglial cells. IFNs are potent 
regulators of MHC antigens, with IFNy by far the most 
effective inducer of de novo synthesis of MHC class II 
(HLA-DR, HLA-DP and HLA-DQ) antigens. Thus, the effect of 
IFNy stimulation on macrophages is to increase the 
expression of both MHC class I and class II antigens, class 
I being required for recognition of foreign antigens by 
cytotoxic T-lymphocytes and class II being required for 
recognition of foreign antigens by T-helper cells. IFNy 
has also been shown to increase adhesion molecule 
expression on endothelial cells to facilitate cellular 
migration (Yu et al., 1985; Dustin et al., 1988; Thornhill 
& Haskard, 1990); and has also been detected in GCF from 
chronic adult periodontitis patients who have exhibited  ^
2mm clinical attachment loss (Grbic et al., 1991). This 
suggests that IFNy may play a role in the pathophysiology 
of periodontal disease.
1.8.2 Bone resorbing cytokines
The cytokines IL-la, IL-ip and TNF-a stimulate bone 
resorption (Gowen et al., 1983; Dewhirst et al., 1985; 
Bertolini et al., 1986; Stashenko et al., 1987) and inhibit 
bone formation In vitro (Bertolini et al., 1986) and in 
vivo (Sabatini et al., 1988).
IL-la, IL-ip and TNFa activity has been studied in GCF 
samples from clinically inflamed sites in humans (Charon et 
al., 1982a; Honig et al., 1989; ; Masada et al., 1990;
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Rossomando, Kennedy & Hadjimichael, 1990; Wilton et al., 
1992). Further studies have attempted to localise the 
cytokines in healthy and diseased tissue (Jandinski et al., 
1991; Stashenko et al., 1991a, 1991b). These studies
suggest that IL-ip is more important than TNFa, which in 
turn is more important than IL-la, in affecting bone 
resorption. Studies on the mechanism of IL-ip action on 
fibroblasts in vitro, suggests that IL-lp can act on the 
fibroblasts to promote cellular matrix repair (Bartold, 
1988) or destruction (Mochan, Armor & Sporer, 1988; 
Richards & Rutherford, 1990). Human gingival lymphocytes 
produce cytokines (O'Neill & Woodson, 1986) and these 
cytokines, IL-1, TNF and GM-CSF (granulocyte macrophage 
colony stimulating factor), are able to promote IL-ip gene 
expression in human peripheral blood PMNs (Marucha, Zeff & 
Kreutzer, 1991). It has also been shown that dental 
implant material can promote peripheral mononuclear cells 
to produce IL-lp and TNFa which subsequently, in theory, 
results in bone loss and loss of the implant, though the 
clinical implications are not so clear (Perala et al., 
1992).
It has been hypothesised that periodontal pathogens may 
mediate connective tissue degradation in inflammatory 
periodontal diseases through the ability of antigens from 
their cell walls to stimulate IL-1 and TNFa production by 
circulating mononuclear cells (Meikle, Heath & Reynolds,
1986). These in turn induce the synthesis of the matrix
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metalloproteinases (MMPs) collagenase, gelatinase and 
stromelysin by resident gingival cells, there by initiating 
matrix degradation (Meikle et al., 1989). Bacterial plaque 
initiates the immune response (Newman, 1990), and its 
continued presence is essential for the maintenance of the 
inflammatory state. The host response is now driven by a 
complex network of cytokines produced by the lymphocytes, 
macrophages and other cells of the inflammatory infiltrate 
which perpetuate and amplify the process. With tissue 
damage resulting more from the side effects of these 
mediators on the constituent cells of the periodontium, 
than to the direct action of bacteria and/or their 
products•
1.9 Interaction between endothelial cells and leucocytes
1.9.1 Introduction
The endothelium which lines the vasculature, structurally 
and functionally separates the blood elements from 
extravascular tissue. During a local inflammatory 
response, injury to a tissue site results in release of 
chemical mediators of inf lamination which change vasculature 
proteins and cells of the blood accumulate at the site of 
the injury; and localised adhesion of peripheral blood 
leucocytes to the endothelial cell lining occurs. Adhesion 
of leucocytes is an essential step in a variety of 
pathophysiological processes and a key event in the 
pathogenesis of certain vascular diseases. Cellular 
migration involves three main structures; these are the
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endothelial cells, the cell adhesion molecules (receptors 
and their ligands) and the extravasating cells.
1.9.2 The endothelial cells
Vascular endothelial cells (ECs) constitute the interface 
between the blood stream and the tissues and in this 
strategic position ECs appear to perform several key roles 
in the development of immune and inflammatory responses. 
In their position between the leucocytes and the 
extravascular tissue the ECs are in an ideal position to 
act as immunoregulators of the immune response. ECs can 
produce amplifying and inhibiting factors which affect the 
immunoregulation of the immune response (Roska, Geppert & 
Lipsky, 1984). T-cells at the site of inflammation can 
produce IFN-y and induce class II MHC expression on the ECs 
surface. The T-cells can then recognise antigen in 
association with self antigen (MHC class II) which results 
in the EC presenting antigen to the T-cells (Pober et al., 
1984; Wagner, Vetto & Burger, 1984). Researchers have 
developed many in vivo models to study the interaction 
between ECs and leucocytes (reviewed by Harlan et al,, 
1991) and most of the following information has been 
gleamed from these studies.
1.9.3 Adhesion of leucocytes
As inflammation develops extravasation of leucocytes to the 
site of inflammation is seen. Enhanced PMN margination 
characteristically occurs at sites of acute inflamination,
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whereas monocyte interactions with the microvasculature are 
seen more often in chronic inflammatory reactions (Allison, 
Smith & Wood, 1955; Wilkinson & Lackie, 1979; Harlan, 
1985).
The adhesion of lymphocytes is the first step in their 
passage from the circulation into the tissue, the site of 
chronic inf lamination. Lymphocytes have been shown to leave 
the blood and enter lymphoid tissue by binding to the 
endothelium of specialised postcapillary venules known as 
high endothelial venules (HEV), followed by migration into 
the perivascular space (Herman, Yamamoto & Mellins, 1972). 
HEV-like vessels are present in chronically inflamed 
gingival tissue and in gingival tissues developing 
inflammation, but are absent from healthy gingivae (Wynne, 
Walsh & Seymour, 1988). These HEV-like vessels found in 
the oral cavity are morphologically similar to lymphoid 
HEV, suggesting that these HEV may represent sites where 
the lymphocytes can enter into chronically inflamed 
lesions. HEV presence in chronically inflamed tissue may 
indicate local lymph-like tissue presence.
1.9.4 The role of cytokines in cellular migration
Adhesion of leucocytes appears to be essential in 
controlling cellular traffic into inflamed areas and it has 
been proposed that cytokines may play an important role in 
regulation of this traffic. This may be mediated in part 
by effects of cytokines on EC, both in promoting the
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expression of EC adhesion molecules for leucocytes (Pober, 
1988; Detmar et al., 1992; Kirnbauer et al., 1992) and in 
stimulating EC to facilitate leucocyte migration through 
the vessel wall (Oppenheimer-Marks and Ziff, 1988; Moser et 
al., 1989).
1.9.5 The cellular adhesion molecules
Leucocyte entry into tissues is controlled by the dynamic 
interaction between adhesion molecules expressed by 
leucocytes and the endothelium. Three families of adhesion 
molecules participate in this vital process, they are;
(1) The selectins or the lectin-epidermal growth factor- 
complement related cell adhesion molecules (LECCAMs) which 
include the L-selectin (formerly Mel-14, LAM-1 = leucocyte 
adhesion molecule-1), E-selectin (ELAM-1 = Endothelial 
leukocyte adhesion molecule 1) and P-selectin (CD62, 
GMP140);
(2) The integrins specifically the lymphocyte function 
associated antigen-1 (LFA-1) (also known as CDlla/CDl8), 
CR3 (Mac-1, or CDllb/CD18), pl50,95 (CDllc/CDl8) and very 
late antigen-4 (VLA-4) (CD49d/CD29);
(3) The immunoglobulin superfamily which includes 
intercellular adhesion molecule-1 (ICAM-1), ICAM-2 
(Staunton, Dustin & Springer, 1989) and vascular cell 
adhesion molecule-1 (VCAM-1).
A vast bank of literature exists on the above adhesion 
molecules (for review see Hynes, 1987; Stoolman, 1989;
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Osborn, 1990; Springer, 1990; Harlan & Liu, 1991). It is 
however useful to consider the adhesion molecules studied 
in the proceeding chapters i.e. ELAM-1, ICAM-1, VCAM-1 and 
LFA-1.
1.9.5.1 ELAM-1
ELAM-1, a member of the selectin family, whose primary 
sequence consists of a amino terminal lectin-like domain, 
an epidermal growth factor domain and six tandem repetitive 
motifs (approximately 60 amino acids each) related to those 
found in complement regulatory proteins (Bevilacqua et al., 
1987, 1989). The ELAM-1 ligand has been discovered to be 
rich in Lewis X and sialylated Lewis X and found in 
abundance on the surface of PMNs (Fukuda et al., 1984; 
Symington, Hedges & Hakomori, 1985; Lowe et al., 1990; 
Phillips et al., 1990; Walz et al., 1990). ELAM-1 acts as 
a selective adhesion molecule for PMNs on the surface of 
cytokine stimulated EC (Bevilacqua et al., 1987, 1989;
Picker et al., 1991; Rohde et al., 1992) and is responsible 
for their migration into tissue. ELAM-1 is also involved 
in adhesion of skin homing memory T-cells (Rustin et al., 
1990; Mackay, 1991; Picker et al., 1991, Shimizu et al., 
1991;).
PMN infiltration and ELAM-1 expression has been studied in 
vivo and it has been shown that ELAM-1 expression and PMN 
infiltration follow similar paths. Both can be seen by 6 
hours and peak at 24 hours to a level which is maintained
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for 72 hours (Norris et al., 1991). ELAM-1 expression by 
cultured EC or by endothelium in situ in cutaneous explants 
is maximal 4 to 6 hours after stimulation by IL-1 or tumor 
necrosis factor (TNF) and spontaneous decline to near 
baseline expression is seen by 24 hours in the continuous 
presence of the stimulatory cytokine (Pober et al., 1986; 
Messadi et al., 1987; Wellicome et al., 1990). EC can 
become refractory to restimulation by the same cytokine 
while retaining the ability to respond to another cytokine 
(Pober et al., 1986) and the use of combinations of 
cytokines can result in prolonged expression of the 
adhesion molecule ELAM-1 (Leeuwenberg et al., 1990; Doukas 
& Pober 1990).
Unstimulated human EC are negative for ELAM-1 (Bevilacqua 
et al., 1987). Normal human skin is also ELAM-1 negative 
but ELAM-1 expression can be found restricted to post­
capillary HEV (Rohde et al., 1992). ELAM-1 can be induced 
in vitro by cytokines i.e. by IL-1 (Bevilacqua et al., 
1985, 1987, 1989; Pober et al., 1986; Groves et al., 1992); 
TNF (Gamble et al., 1985; Doukas & Pober 1990; Thornhill & 
Haskard, 1990; Norris et al., 1991) or LPS (Schleimer & 
Rutledge, 1986; Messadi et al., 1987; Pober et al., 1986) 
but not by IFN-y (Pober et al., 1986; Schleimer & Rutledge, 
1986; Thornhill & Haskard, 1990).
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1.9.5.2 ICAM-l/LFA-1
Immune responsiveness of lymphocytes to antigen and several 
other effector activities of leucocytes requires cell-cell 
contact and adhesion (Lipsky & Rosenthal, 1975; Inaba & 
Steinman, 1984). ICAM-1 is an important adhesion molecule 
that acts as the receptor for LFA-1 (Rothlein et al,, 1986; 
Lo et al,, 1989). ICAM-l/LFA-1 is one of at least three 
mechanisms involved in lymphocyte adhesion (Dustin & 
Springer, 1988), with possibly the existence of a second 
LFA-1 ligand (Rothlein et al,, 1986) These two molecules, 
ICAM-1 and LFA-1, are important adhesion strengthening 
molecules involved in antigen presentation and other cell­
cell interactions involving lymphocytes such as 
transepithelial trafficking (Dustin et al,, 1986; Rothlein 
et al,, 1986).
ICAM-1 is a cell surface protein of molecular weight 90 kDa 
(Rothlein et al,, 1986), is a member of the immunoglobulin 
superfamily and is found on non-hematopoietic cells (ie 
vascular endothelial cells, thymic epithelial cells, other 
epithelial cell and on fibroblasts), as well as on 
hematopoietic cells (ie tissue macrophages, mitogen 
stimulated T lymphocyte blasts, antigen presenting cells 
and germinal centre dendritic cells in tonsils, lymph nodes 
and peyers patches). Interestingly, LCs have been shown to 
be ICAM-1 negative (Dustin et al,, 1986).
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LFA-1, a member of the subgroup of the integrin superfamily 
the leucocyte integrins, and is the ligand for ICAM-1. The 
integrins share a common beta subunit (CD18) associated 
noncovalently with one of three different alpha subunits, 
designated CDlla (LFA-1), CDllb (Mac-1) and CDllc 
(pl50,95). Of the three integrins, LFA-1 (CDlla/CD18) has 
been the most extensively studied, and its importance in 
adhesion is the best understood (Dustin & Springer, 1988, 
1989). LFA-1 an a|3 heterodimer (180 kDa alpha chain and 95 
kDa beta chain) is expressed on the membrane of all 
lymphocytes (Springer et al., 1982; Hildreth et al., 1983).
ICAM-1 is constitutively expressed on vascular ECs within 
skin (Majewski et al., 1991); and within lymph nodes and 
Peyers patches, ICAM-1 expression has been shown to be 
preferentially located within the T-cell areas (Dustin et 
al., 1986). During inflammation ICAM-1 expression 
increases on antigen presenting cells and on ECs, resulting 
in increased adhesion of T-cells (Lewis et al., 1989; 
Oppenheimer-Marks, Davis & Lipsky, 1990), PMNs (Barton et 
al., 1989; Lo et al., 1989) and memory T-cells (Griffiths 
& Nickoloff, 1989; Buckle & Hogg, 1990) and their 
subsequent migration into the inflamed tissue. It has also 
been suggested that ICAM-1 may be involved in the early 
stages of human thymic development (Singer et al., 1990).
ICAM-1 is constitutively expressed by EC and its expression 
can be upregulated by IL-1 (Bevilacqua et al., 1985;
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Cavender et al., 1986, 1988; Dustin et al., 1986; Haskard 
et al., 1987; Wellicome et al,, 1990; Detmar et al., 1992), 
TNF (Cavender et al., 1988; Doukas & Pober, 1990; Krutmann 
et al,, 1990), LPS (Schleimer & Rutledge, 1986; Yu et al,, 
1986; Cavender et al,, 1988) and by interferon-y activated 
ECs (Yu et al., 1985; Dustin et al., 1986, 1988; Barker, 
Allen & MacDonald, 1989; Thornhill & Haskard, 1990) and 
down-regulated by other cytokines i.e. interleukin-4 (IL-4) 
(Thornhill & Haskard, 1990). ICAM-1 expression on cultured 
ECs can be increased by the action of TNF, IL-1 and LPS 
with expression peaking at 7 to 10 hours and still being 
maintained after 72 hours (Wellicome et al., 1990). Unlike 
ECs, keratinocytes do not normally express ICAM-1, but 
expression can be induced in vitro and in vivo by cytokines 
(TNF or IFN-y but not IL-1 or LPS) (Griffiths, Voorhees & 
Nickoloff, 1989; Barker et al., 1989; Caughman, Lian-Jie & 
Degitz, 1990; Krutmann et al., 1990; Trefzer et al., 1991) 
and by ultra-violet-p (Kirnbauer et al., 1992; Krutmann et 
al., 1992).
1.9.5.3 VCAM-1
When initial studies on EC-leucocyte adhesion began, two 
cytokine-induced adhesion molecules had been characterised 
and cloned, ELAM-1 and ICAM-1. Data from a number of 
laboratories showed that neither ICAM-1 nor ELAM-1 could 
fully account for the lymphocyte adhesion to cytokine 
treated human umbilical vein endothelial cells (HUVECs) 
(Haskard et al., 1986; Dustin & Springer, 1988). Further
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more, in patients genetically deficient in CD18, and hence 
expressing no leucocyte LFA-1, lymphocyte recruitment was 
essentially normal, despite profound defects in recruitment 
of phagocytic cells (Anderson & Springer, 1987; Larson & 
Springer, 1990) indicating the existence of an ICAM-1/LFA-1 
independent adhesion mechanism for lymphocytes. Cell lines 
also existed that bound through neither ELAM-1 nor LFA-1 
providing evidence that another adhesion pathway was 
operating on the cytokine treated HUVECs (Osborn et al., 
1989). From this work, Osborn et al. (1989) cloned a new 
adhesion molecule and called it VCAM-1. VCAM-1 is 
expressed on endothelial cells and binds lymphocytes but 
not PMNs (Osborn et al., 1989), it consists of six 
immunoglobulin domains and can be placed in the 
immunoglobulin superfamily. The ligand for this new 
adhesion molecule VCAM-1 has been shown to be VLA-4, one of 
the integrins, with VCAM-1/VLA-4 playing a major role in 
mononuclear leucocyte migration to sites of inflammation, 
in vivo (Elices et al., 1990).
Following the development of monoclonal antibodies directed 
against VCAM-1 and studies on cytokine-stimulated 
endothelium in vitro (Osborn et al., 1989). It has been 
shown that cell surface VCAM-1 is detectable within two 
hours of cytokine stimulation, is maximal at 10 to 24 hours 
and is maintained for at least 72 hours in the continued 
presence of cytokine (Thornhill & Haskard, 1990; Wellicome 
et al., 1990).
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The surface expression of ELAM-1, ICAM-1 and VCAM-1 on 
HUVECs in vitro has been shown to increase after cytokines 
treatment (IL-1, TNF and LPS), with very little selectivity 
in the cytokines ability to induce expression of the 
adhesion molecules. However, recent studies suggest that 
the cytokine IL-4 shows such selectivity, by increasing 
adhesion of T-cells but not PMNs to endothelium by inducing 
an adhesion pathway which is ICAM-1/LFA-1 independent 
(Thornhill & Haskard, 1990; Thornhill et al., 1991). IL-4 
was shown to induce the antigen defined by the monoclonal 
antibody 1.4C3, later identified as VCAM-1 (Masinovsky, 
Urdal & Gallatin, 1990).
Immunohistochemical studies have been performed to evaluate 
the pathophysiologic tissue distribution of VCAM-1 and in 
general little or no vascular staining of VCAM-1 has been 
found in normal tissues. In contrast VCAM-1 is expressed 
at inflammatory sites, with positive vascular tissue seen 
in infleaned appendix, delayed hypersensitivity reactions 
and insect bites (Rice & Bevilacqua, 1989; Rice, Munro & 
Bevilacqua, 1990); within rheumatoid arthritic synovium 
(Koch et al., 1991) and more recently on vascular tissue of 
rejecting human cardiac allografts (Briscoe et al., 1991).
1.9.6 Studies on adhesion molecule expression in gingival 
tissue
Adhesion molecule expression is induced early during 
experimental inflammatory responses in the skin of monkeys
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(Munro, Pober & Cotran, 1989) and humans (Norris et al., 
1991), Within gingival tissue very few studies have been 
carried out, to date. The presence of ICAM-1 on healthy 
junctional epithelium was reported by Crawford & Hopp, 
(1990) and a subsequent study (Crawford, 1992) has 
demonstrated the presence of ICAM-1+ diseased pocket 
epithelium in subjects suffering from adult periodontitis. 
To date, no studies have examined ELAM-1 or VCAM-1 
expression in gingival tissue though a study has examined 
the presence of other adhesion molecules such as laminin, 
fibronectin, vitronectin and tenascin within baboons 
(Steffensen et al., 1992) and CDllb expression on 
crevicular neutrophils (Watanabe, Hagen & Andersen, 1991).
1.10 Aims
The main aims of this thesis were, firstly, to study the 
immune and inflammatory cellular infiltrate during the 
development of gingival inflammation utilising the 
experimental gingivitis model; secondly, to examine the 
effect of proinflammatory cytokines on adhesion molecule 
expression using gingival organ culture and finally, to 
draw conclusions on the interactions and the roles played 
by the different variables analysed in this thesis.
In order to study the development of gingival inflammation 
the experimental gingivitis model of Loe et al. (1965) was 
used. This model has many advantages, it allows gingival 
biopsies to be taken longitudinally under controlled
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experimental conditions; causes minimal discomfort to the 
volunteers; allows maximal use of the volunteers (i.e. GCF 
collection as well as gingival biopsies) and the lesions 
are reversible upon re-institution of oral hygiene (Loe et 
al., 1965).
To study the development of inf lamination within gingival 
tissue, biopsies were obtained from the subjects 
participating in the experimental gingivitis studies. The 
availability of clinically 'healthy' and experimentally 
inflamed gingival tissue allows the cellular and vascular 
adhesion molecules changes to be studied in a cross- 
sectional fashion. It was considered advantageous to 
obtain diseased tissue from patients attending the 
Periodontal Unit for routine periodontal treatment, as this 
would not interfere with normal treatment. The different 
types of tissue were classified into health, gingivitis and 
periodontitis•
Immunohistology and computerised image planimetry was 
employed. Qualitative and quantitative changes in cellular 
infiltration (PMNs; T-cells and T-cell subsets i.e. helper, 
suppressor, naive and memory) was assessed as inflammation 
developed over 21-days and 10-days. Single staining 
avidin-biotin-complex method utilising peroxidase as the 
substrate (ABC-P) was used as the immunohistological 
staining method. The ABC-P method is very sensitive and
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gives permanently stained tissue sections which allows 
enumeration to be carried out at a later date.
The expression of the adhesion molecules (ELAM-1, ICAM-1, 
VCAM-1 and LFA-1) has been studied in a variety of tissues 
(Rice & Bevilacqua, 1989; Rice et al., 1990; Majewski et 
al., 1991; Norris et al., 1991; Rohde et al., 1992). 
Adhesion molecule expression was studied in clinically 
'healthy', experimentally inflamed and diseased gingival 
tissue. This study was performed in order to determine if 
the kinetics of adhesion molecules varied within the 
different types of tissue. Studies were also performed to 
determine the effect of different cytokines on the 
intensity of adhesion molecule expression and the effects 
on the percentage of adhesion molecule positive vessels 
within cultured explants of gingival hyperplastic tissue. 
Hyperplastic tissue was used in the organ culture studies 
and was shown to be immunologically healthy but overgrown. 
Therefore, large blocks of tissue were available after 
routine gingivectomy surgery for the gingival organ culture 
experiments.
Interleukin-1 level changes within GCF was evaluated using 
a bioassay, to assess if changes in IL-ip could be related 
to the extent of gingival inflammation. GCF was collected 
during the 21-day experimental gingivitis study. In 
addition, changes in LCs numbers as well as the class II 
MHC positivity of these LCs was assessed within the human
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gingival tissues during clinical 'health' and experimental 
inflammation (21-days and 10-days). This was to determine 
if alterations within LC numbers are seen as inf lamination 
develops and if their antigen presenting capability varies 
i.e. MHC positivity.
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Chapter 2 
Subjects, Materials and Methods
2.1 Introduction
This chapter is in two parts; Part A deals with subject 
selection, clinical study design, clinical indices and the 
types of samples collected and Part B describes the 
materials and techniques used.
Part A: Clinical information
2.2 Subjects
All patients and subjects who participated in the following 
studies were associated with or were attending the 
Periodontal Unit of the Glasgow Dental Hospital & School. 
The experimental protocols were explained in detail prior 
to the commencement of the studies and copies of the 
experimental protocols given to the individuals. All 
individuals were given the option of withdrawing from the 
studies at anytime. Only one individual (subject F in the 
21 day experimental gingivitis study) exercised this 
option. Ethical approval was obtained from the local 
ethical committee.
2.2.1 Subjects for the experimental gingivitis studies
Eleven individuals (subjects A-K) consented to participate 
in these studies, where gingival inflammation was 
experimentally induced using the experimental gingivitis 
model of Loe et al., (1965). All subjects were dental 
students who had volunteered to participate in the studies. 
All were dentally aware and had no evidence of periodontal
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disease. Subjects A - F (age range 22 to 23; 5M:1F)
abolished oral hygiene procedures for 21 days and subjects 
G - K (age range 21 to 22; 5M) for 10 days.
2.2.1.1 Experimental gingivitis study design
All volunteers received oral hygiene instruction and 
frequent prophylaxis two weeks prior to the commencement of 
the experimental phase, until clinical gingival health 
(PI<1, MGI=0) was obtained. All subjects were then 
instructed to cease all oral hygiene measures and plaque 
was allowed to accumulate undisturbed for a period of 21 
days (subject A - F) or 10 days (subjects G - K). Oral 
hygiene measures were then re-introduced and volunteers 
were monitored for a further 14 days until gingival health 
was re-established.
2.2.1.2 Sample collection: 21 day study
During, before and after the experimental gingivitis phase 
clinical changes at the mid-buccal aspect (the biopsy site) 
were evaluated every 7 days for the 21 day study, using the 
plaque index (PI) of Silness & Loe, (1964) (section 2.3.1) 
and the modified gingival index (MGI) of Lobene et al. 
(1986) (section 2.3.2).
Gingival crevicular fluid (GCF) samples were taken on day 
0, 7, 14 and 21, from the mid-buccal aspect of the first 
permanent molar to be biopsied (section 2.5.1). GCF 
samples could not be reliably taken after biopsying a site
90
and therefore GCF sample numbers varied during the course 
of the study i.e. on day 0 each individual gave four GCF 
samples, day 7 three GCF samples, day 14 two GCF samples 
and on day 21 one GCF sample. Following GCF collection the 
first permanent molars were biopsied using a pre-determined 
order (section 2.7.1.1). One volunteer (subject F) 
declined to give the last two biopsies, but was still 
sampled for GCF. Thus six biopsies were taken on day 0 and 
day 7 and five on day 14 and day 21, but only five biopsies 
were used for the immunohistochemical analysis at each time 
point. In total 20 biopsies and 24 GCF strips from the 
biopsy sites were obtained for the 21 day experimental 
gingivitis study.
2.2.1.3 Sample collection: 10 day study
For the 10 day study the clinical indices PI (section 
2.3.1) and MGI (section 2.3.2) were recorded every 3 days 
at the biopsy site (i.e. mid-buccal aspect) and at the 
gingival crevicular washing site (GCW) (mesial aspect) of 
the first permanent molars. Thus on day 0 for each 
individual, eight clinical scores were recorded (four mid- 
buccal and four mesial scores), day 3 six scores, day 7 
four scores and on day 10 two scores.
Following clinical evaluation GCF strips were collected 
from the mid-buccal aspect (section 2.5.1) followed by 
gingival washing from the mesial aspect (section 2.6.2) and 
finally the gingival biopsies from the mid-buccal aspect
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(Fig. 2.1). The gingival biopsies were taken from the 
first permanent, molars with the remaining first molars 
being biopsied in a pre-determined order (section 2.7.1.1). 
In total, 20 gingival biopsies and 20 GCW (from the biopsy 
sites) were obtained during the 10 day experimental study. 
GCW were also collected from the unbiopsied sites (n=30).
2.2.2 Subjects for organ culture study
Gingival tissue from three individuals was used for the 
organ culture studies. All individuals were male 
Caucasians who suffered from drug-induced gingival 
hyperplasia, one following epanutin therapy (24 years old) 
and the others following nifedipine drug therapy (53 and 45 
years).
2.2.2.1 Tissue source
All individuals underwent routine periodontal surgery to 
remove hyperplastic gingival tissue. Informed consent was 
obtained from the individuals for the gingival tissue 
(which would be normally discarded) to be used for the 
organ culture study. Gingival tissue was processed within 
30 minutes of collection (as discussed in section 2.7).
2.2.3 Periodontitis subjects
Six individuals were selected to participate in this study. 
These individuals were all Caucasian, had no history of 
systemic disease and had not received any antibiotics for 
the past 3 months. Three of these individuals suffered
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Figure 2.1 Mid-buccal biopsy site.
from adult periodontitis (AP category), two individuals 
suffered from rapidly progressive periodontitis (RPP 
category) and one individual suffered from juvenile 
periodontitis (JP category), as determined by clinical and 
radiographic examination with JP and RPP subjects diagnosed 
according to already published criteria (Manson & Lehner, 
1974; Page et al., 1983).
Clinical evaluation for the AP, RPP and JP categories (3 
AP, 2 RPP, 1 JP) was performed prior to surgery. Gingival 
inflammation was evaluated using the MGI of Lobene et al. 
(1986) (section 2.3.2) and pocket depth assessed to the 
nearest millimetre using a Williams periodontal probe 
(section 2.3.3).
2.2.3.1 Tissue source
During routine periodontal surgery, interproximal diseased 
tissue which would be normally discarded was taken with the 
informed consent of the patient. Tissue was immediately 
embedded and snap frozen, then stored at -70°C until 
processed (section 2.7).
2.2.4 Subjects for the gingival crevicular washing and 
lactoferrin study
Twenty-one individuals were selected to participate in this 
study (age range 20 to 52 years; 7M:14F). The individuals 
were all Caucasian, had no history of systemic disease and 
had not received any antibiotics for the past 3 months.
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Sixteen of these individuals (APD category) suffered from 
advanced periodontal disease as determined by clinical and 
radiographic examination. The remaining five subjects (H 
category) were classified as periodontally healthy (no 
attachment loss, pocket depths less than 3mm and no 
significant gingival inflammation).
2.2.4.1 Sample collection
Sixty-three GCWs were collected using a modification of the 
Skapski & Lehner method, (1976) (section 2.6.2). A maximum 
of four sites were sampled per subject. Gingival 
inflammation of the sites sampled was evaluated using the 
MGI (section 2.3.2) and the pocket depth assessed (after 
GCW sampling) to the nearest millimetre using a Williams 
periodontal probe (section 2.3.3). Diseased sites (MGI^ 2, 
PD^3mm) were obtained from the periodontitis patients 
whereas healthy sites (MGIs;l, PD^2mm) were obtained mainly 
from the periodontally healthy subjects and in some cases 
from the periodontitis patients. All GCW samples were 
processed within 30 minutes of collection (section 
2.6.1.4).
2.2.5 Order of sample collection
An order of collection was followed: clinical indices (PI 
then MGI) were evaluated initially; GCF was then collected; 
followed by GCWs; and finally the gingival biopsy. This 
sequence was aimed at minimising the disruption caused by 
each sampling procedure.
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2.3 Clinical Indices
Clinical indices (PI: Silness & Loe, 1964 and the MGI: 
Lobene et al., 1986) were used to record changes in plaque 
accumulation and gingival involvement.
2.3.1 Plaque Index
The plaque index (PI) of Silness & Loe (1964) was used to 
score plaque accumulation in each of the areas of the tooth 
used for sampling. Each area was given a score of 0 - 3 
(Table 2.1) and this was the PI for the area.
2.3.2 Modified gingival index
The modified gingival index (MGI) of Lobene et al. (1986) 
uses a five point scale (Table 2.2) and permits a non­
in va si ve evaluation of the early visible changes in 
gingival tissue and allows untraumatised gingival biopsies 
to be taken. The MGI was recorded just after PI scoring to 
give site scores.
2.3.3 Pocket depth assessment
The probing depth (PD) i.e. the distance from the gingival 
margin to the bottom of the gingival pocket was measured 
using a graduated Williams periodontal probe. Pocket depth 
was assessed to the nearest millimetre.
2.3.4 Sites scored
2.3.4.1 Biopsy, GCF sites and GCW sites
During the experimental gingivitis studies the clinical
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Table 2.1 Plaque Index of Silness & Loe, (1963).
0 No film.
1 A film of plaque adhering to the free
gingival margin and adjacent area of the 
tooth.
2 Moderate accumulation of soft deposits within
the gingival pockets, or on the tooth and 
gingival margin which can be seen with the 
naked eye.
3 Abundance of soft matter within the gingival
pocket and/or on the tooth and gingival
_____margin.________________________________
Table 2.2 Modified gingival index scoring system of 
Lobene et al. (1986).
0 Absence of inflammation.
1 Mild inflammation, slight change in colour, 
little change in texture of any part of but 
not the entire marginal or papillary gingival 
unit.
2 Mild inflammation; criteria as above but 
involving the marginal or papillary gingival 
unit.
3 Moderate inflammation, glazing, redness, 
oedema and/or hypertrophy of the marginal or 
papillary gingival unit.
4 Severe inflammation, marked redness, oedema 
and/or hypertrophy of the marginal or 
papillary gingival unit, spontaneous
_____bleeding, congestion or ulceration._________
indices were recorded at each GCW site (mesial aspect), GCF 
site and biopsy site (mid-buccal aspect) prior to sampling. 
Both indices were collected every 7 days of the 21-day 
experimental phase and every 3 days of the 10-day
experimental phase, in order to monitor clinical
development of gingival inflammation.
2.3.4.2 Patient biopsy sites
PD was used to designate sites 'diseased sites' if MGI^2, 
PD^3mm. PD was assessed using the Williams periodontal 
probe (section 2.3.3) and 4 sites per biopsy (interdental 
col) were assessed (mesial-buccal, mesial-lingual, distal- 
buccal and distal-lingual). The biopsy scores for the four 
areas were added and divided by four to give the average PD 
score for each site.
2.3.5 Intra-examiner variability
Since both indices were non-invasive, intra-examiner 
calibrations were carried out. The need to assess inter­
examiner variability was avoided as only one examiner was
used during any one trial.
2.3.6 Statistical analysis
2.3.6.1 Association between clinical indices and other 
parameters
Clinical index scores were generally skewed in their 
distribution. Therefore to demonstrate association between
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the clinical indices (PI, MGI and PD) and other parameters 
the non-parametric Spearman's rank correlation coefficient 
was used. Data were analysed using the 'Minitab' 
statistical package on an IBM PC.
2.3,6.2 Repeated measures of clinical indices
Clinical indices were collected from each subject over four 
sampling time points i.e. repeated measures. Therefore to 
demonstrate if days of oral hygiene abstention had an 
effect on clinical indices the non-parametric Friedman's 
test (Minitab) was used.
Part B: (I) Materials
2.4 Materials: Buffers and Reagents
All chemicals were analytical grade, obtained from BDH 
Chemicals Ltd., Poole, Dorset (UK) unless otherwise stated.
2.4.1 General use
2.4.1.1 Phosphate buffered saline (PBS)
PBS pH 7.4, 1.5mM KH2P04, lOmM Na2HP04.H20, 0.14M NaCl and 
2.7mM KC1 was dissolved in 500ml of distilled water, pH was 
adjusted to 7.4 (using 1M NaOH and 1M HC1) and the final 
volume adjusted to 1 litre.
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2.4.2 Materials used during GCF sampling
2.4.2.1 Filter paper strips
Whatman grade 4 filter paper was obtained from Whatman 
International Ltd (UK). Using a steel ruler and a scalpel, 
2x13mm strips were cut manually, as recommended by previous 
investigators (Griffiths, Curtis & Wilton, 1988) and 
sterilized by autoclaving. Sterilized strips were stored 
at room temperature in glass universals.
2.4.2.2 GCF elution buffer
GCF elution buffer was prepared using RPMI 1640 medium 
(Gibco, UK) supplemented with 5% foetal calf serum 
(Globepharm, UK), 30^ ig/ml gentamicin (Gibco, UK) and 
2.5ng/ml Amphotericin B (Gibco, UK).
2.4.2.3 Recombinant human Interleukin-ip
Recombinant human interleukin-ip was a gift from Dr A. 
Shaw, Glaxo, Geneva, Switzerland.
2.4.2.4 3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetra- 
zolium bromide (DDT)
3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium 
bromide, analytical grade (SIGMA, UK).
2.4.2.5 Anti-Interleukin-ip
Anti-IL-ip sheep polyclonal serum (S77p) was a gift from Dr 
A. Shaw, Glaxo, Geneva, Switzerland.
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2.4.3 Materials used during crevicular PMN isolation and 
processing
2.4.3.1 Leishmans stain
Leishmans stain (SIGMA, UK) was prepared as 0.2% w/v in 
methanol i.e. 0.2g dissolved in 100ml methanol. The stain 
was filtered before use.
2.4.3.2 Coating buffer
Carbonate-bicarbonate buffer prepared by dissolving 1.5g 
Na2C03, 2.93g NaHC03 and 0.2g NaN3 in 950ml of distilled 
water with the final volume adjusted to 1 litre. The pH 
was adjusted to 9.6 using 1M HC1.
2.4.3.3 Incubation buffer (PBS-Tween 20, 0.1% BSA)
Incubation buffer (PBS-Tween 20, 0.1% BSA) solution was 
prepared by adding 0.5g of Tween 20 (0.05%) and lg
lyophylised bovine serum albumin (BSA) (0.1%) to 900ml of 
PBS, pH 7.4 (section 2.4.1.1) and the final volume adjusted 
to 1 litre.
2.4.3.4 Wash buffer (PBST)
A stock solution of 10 times concentrated incubation buffer 
(nil BSA) was prepared. This was diluted 1 in 10 prior to 
use i.e. 1 part PBSTs 9 parts distilled water.
2.4.3.5 Substrate buffer
The substrate buffer was prepared by dissolving 0.95g
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citric acid and 1.4g Na2HP04.H20 in 100ml of distilled water 
(pH 5). The substrate buffer was prepared fresh just 
before use by adding 40mg ortho-phenylene diamine (OPD) 
(SIGMA) and 40^ x1 H202.
2.4.3.6 Purified lactoferrin standard and antisera for 
ELISA
Purified lactoferrin (LF) (5mg/ml) was purchased from 
Calbiochem (Novabiochem Ltd., Nottingham, UK). The LF 
standard came lyophilised and was reconstituted according 
to the manufacturer's instructions. Goat anti-LF and 
rabbit anti-LF were obtained from Nordic Immunological 
Laboratories (Maidenhead, Berkshire, UK). The horseradish 
peroxidase (HRP) conjugated anti-rabbit IgG (goat) was 
purchased from ICN Immunobiologicals (Lisle, IL, USA) and 
were fractionated. All reagents, after reconstitution (if 
required), were aliquoted and stored at -20°C until used. 
Reagents were replaced regularly to avoid deterioration.
2.4.4 Materials used during biopsy tissue processing
2.4.4.1 Embedding medium
Optimal cutting temperature compound (O.C.T.) (Tissue-Tek 
II) was obtained from Shandon Southern Products Ltd, 
Cheshire, UK.
2.4.4.2 Vectabond reagent
Vectabond reagent was obtained from Vector Laboratories, 
Peterborough, UK. Prior to use, the entire contents of the
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bottle (7ml) was added to 350ml acetone to make the working 
solution.
2.4.4.3 Acetone
Acetone technical (Propanone) was obtained from Avondale 
Lab. Ltd, Oxon, UK.
2.4.4.4 Blocking serum
Horse serum was obtained from Vector Laboratories 
(Peterborough, UK), as part of an ABC kit. Blocking serum 
was prepared by adding 3 drops of this horse serum to 10ml 
PBS pH 7.4, to obtain the working solution.
2.4.4.5 Biotin-conjugated secondary antibodies
Biotin-conjugated horse anti-mouse IgG was obtained from 
Vector Laboratories (Peterborough, UK), as part of the 
proprietary ABC kits (ABC-peroxidase and ABC-alkaline 
phosphatase). Working solutions were prepared prior to use 
by adding 1 drop of biotin-conjugated secondary antibody to 
10ml PBS pH 7.4.
2.4.4.6 Deperoxidising solution
Deperoxidising solution was prepared by adding 1ml of 30% 
H202 to 99ml methanol to give 0.03% methanolic hydrogen 
peroxide.
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2.4.4.7 ABC-peroxidase (ABC-P) complex
ABC reagent was obtained from Vector Laboratories 
(Peterborough, UK), The solutions were in two bottles:
reagent A (Avidin DH); and reagent B (biotinylated 
horseradish peroxidase H). Two drops of reagent A were 
added to 10ml PBS (pH 7.4) and mixed, this was followed by 
2 drops of reagent B, the solution was again mixed. The 
complex was prepared 30 mins before use and was stored at 
4°C.
2.4.4.8 Peroxidase substrate - DAB
3, 3' Diaminobenzidine tetrahydrochloride (DAB) tablets
(lOmg) were obtained from SIGMA, UK. A stock solution was 
prepared of 2.5mg/5ml and 30 minutes prior to use 5pl 
hydrogen peroxide (H202) was added to give the working 
solution.
2.4.4.9 Peroxidase substrate - DAB/nickel chloride
An 8% nickel chloride solution was prepared by dissolving 
0.8g in 10ml distilled water. The DAB substrate was 
prepared as outlined in section 2.4.4.8, to this working 
solution 25pl of the 8% nickel chloride solution was added 
to give a 4% NiCl2/DAB substrate working solution.
2.4.4.10 lOOmM TRIS-HC1 buffer
A 0.2M solution was prepared by dissolving 24.23g of tris 
(hydroxymethy1) methylamine [2-amino-2-(hydroxymethy1) 
propane-1,3-diol) (TRIS)] in 900 ml distilled water,
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adjusted to a final volume of 1 litre, TRIS-HC1 buffer, pH 
8.23 was prepared with 25ml 0.2M TRIS and 22.5ml 0.1N HC1 
made up to a final volume of 200ml with distilled water.
2.4.4.11 Levamisole (O.lmM)
Levamisole solution was prepared by dissolving 0.024g in 
900ml of lOOmM TRIS-HCL, pH 8.2 (section 2.4.4.10), 
adjusted to a final volume of 1 litre to give a O.lmM 
levamisole solution in lOOmM TRIS-HCl.
2.4.4.12 ABC-alkaline phosphatase (ABC-AP) complex 
ABC-AP reagents were obtained from Vector Laboratories 
(Peterborough, UK) as part of an ABC kit. The solutions 
were in two bottles reagent A (Avidin DH) and reagent B 
(biotinylated alkaline phosphatase H). Two drops of reagent 
A were added to 10ml PBS (pH 7.4) and mixed, this was 
followed by 2 drops of reagent B, the solution was again 
mixed. The complex was prepared 30 mins before use and was 
stored at 4°C.
2.4.4.13 Alkaline phosphatase substrate
Alkaline phosphatase substrate kit I (Vector Red<R)) was 
obtained from Vector Laboratories, Peterborough, UK. 
Substrate was prepared immediately before use by adding 2 
drops of reagent 1 (ABC-AP substrate reagent 1) to 5ml of 
buffer (lOOmM TRIS-HCL, pH 8.2) and mixing well, followed 
by 2 drops of reagent 2 (ABC-AP substrate reagent 2) mixing 
well and finally 2 drops of reagent 3 (ABC-AP substrate
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reagent 3) and mixing well.
2.4.4.14 Potassium iodide (0.06M)
A 0.06M potassium iodide solution was prepared by 
dissolving 9.96g of potassium iodide in 900ml of distilled 
water and the final volume was adjusted to 1 litre.
2.4.4.15 Copper sulphate solution
A 0.5% solution was prepared by dissolving 0.5g of 
anhydrous CuS04 in 100ml distilled water.
2.4.4.16 Mayer's haematoxylin
Haematoxylin (lg) was dissolved in 1L distilled water, 50g 
of aluminum alum (A1NH4(S04)2.12H20) and 0.2g sodium iodate 
(NaI03.H20) were added and the solution boiled for 5 
minutes. After overnight incubation, 50g of chloral 
hydrate (CC13.CH(0H)2) and lg of citric acid were added and 
the solution shaken to dissolve. The 0.1% Mayer's 
haematoxylin solution was filtered before use.
2.4.4.17 Gurrs Eosin
A 0.5% solution of CaCl2 (0.5g/100ml) was prepared in 
distilled water and lg eosin powder was added to make a 1% 
eosin solution (lg/100ml).
2.4.5 Materials used during organ culture study
2.4.5.1 Hanks buffered salt solution (HBSS)
HBSS (Gibco, UK) was supplemented with 50lU/50mg
104
Penicillin/streptomycin per ml of medium (Gibco, UK).
2.4.5.2 Medium 199
Medium 199 (Gibco, UK) was supplemented with 10% foetal 
calf serum (Globepharm, UK), 2mM Glutamine (Gibco, UK) and 
50IU/50mg Penicillin/Streptomycin (Gibco, UK) per ml.
2.4.5.3 Control medium (0.1% BSA)
A 1% bovine serum albumin (BSA) solution was prepared by 
layering 0.2g BSA (SIGMA, UK) onto 15ml of PBS. The 
solution was allowed to stand at room temperature for 30 
minutes, mixed with a magnetic stirrer until dissolved and 
the final volume adjusted to 20ml. To prepare the control 
medium a 1:9 dilution was made (1 part 1% BSA: 9 parts 
Medium 199) (Section 2.4.5.2) this was the working control 
medium (0.1% BSA).
2.4.5.4 Recombinant Tumour necrosis factora 
Recombinant tumour necrosis factora was a gift from Dr A. 
Shaw, Glaxo, Geneva, Switzerland.
2.4.5.5 Lipopolysaccharide
lOmg of lyophilised lipopolysaccharide {Escherichia coli) 
was obtained from SIGMA (UK). Reconstituted with PBS (1% 
BSA) and aliguoted into IOjaI aliquots (10pg per lOpil 
aliquot) and stored at -70°C. The working solution was 
prepared by making a 1:999 dilution i.e. 1 part LPS to 999 
parts of medium 199. Thus the working solution contained
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lp,g of LPS per ml.
2.4.5.6 Interferon-y
lOOpig of recombinant human interferon-y with 2x106 IU per 
vial was obtained from Biogen (Switzerland). Reconstituted 
with PBS (1% BSA) and aliquoted into 5p,l aliquots (10,000 
IU per aliquot)and stored at -70°C. Before use 0.995ml PBS 
(1% BSA) was added to each aliquot producing a 1ml solution 
containing 10,000 IU. The working solution was then 
prepared by making a 1:39 dilution i.e. 1 part of the 
10,000 IU/ml solution to 39 parts of medium 199. Thus the 
working solution contained 250 IU of recombinant human 
interferon-y per ml.
Part B: (II) Methods
2.5 Gingival crevicular fluid
2.5.1 GCF sampling
2.5.1.1 Collection method
The individual crevicular sites were gently air-dried and 
any visible supragingival plaque removed. The area was 
carefully isolated with cotton wool rolls and saliva 
ejector to avoid saliva contamination of the samples. The 
sterilised filter paper strip (section 2.4.2.1) was 
introduced into the crevice until mild resistance was felt 
and left for 30 seconds (Fig. 2.2). Each site was sampled 
for 30s and only once. Care was also taken to avoid 
mechanical injury of the tissue.
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2.5.1.2 Quantitation of GCF volume
After GCF collection, the paper strips were transferred to 
the calibrated chairside-located Periotron (Periotron 6000, 
Harco Electronics, Winnipeg, Canada) (section 2.5.2) for 
the quantification of the fluid volume. The jaws of the 
Periotron were wiped with pure methanol between sequential 
readings to prevent cross contamination between strips. 
After collection the strips were placed in individual 
sterile microcentrifuge tubes and stored at -30°C until 
elution.
2.5.1.3 Elution of GCF
GCF was eluted from the paper strips by incubation for 30 
minutes at 4°C in 150^ ,1 of elution buffer RPMI 1640 medium 
(section 2.4.2.2). After elution, the paper strip was 
removed and the eluate was centrifuged for 2 minutes in a 
microcentrifuge to remove any particulate matter. The 
eluate supernates were then stored frozen at -20°C before 
being assayed for IL-1.
2.5.1.4 Interleukin-lfi Bioassay
Interleukin-1 activity was bioassayed using the IL-1 
sensitive cell line D10(N4)M (Helle, Boeije & Aarden, 1988; 
Hopkins & Humphreys, 1989) with the modification that the 
cell proliferation was determined by a colourimetric method 
utilizing 3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetra- 
zolium bromide (Mosmann, 1983). The potency of the 
stimulatory activity in the eluate was determined from
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dose-response curves obtained with a recombinant human DNA- 
derived IL-1 beta (rhIL-l($) standard using the computer 
programme ALLFIT (De Lean, Munson & Rodbard, 1978). 
Addition of sufficient anti-IL-ip serum (a sheep polyclonal 
serum (S77P): gift of Dr. A. Shaw, Glaxo, Geneva) to 
completely neutralise the activity of 100 pg of rhil-ip, 
inhibited at least 70% of the stimulatory activity. This 
bioassay is particularly sensitive and specific for IL-1 
and thus the remaining activity was presumed to be 
associated with IL-la.
2.5.1.5 Statistical analysis
Changes in IL-1J3 concentration (ng/jil) over time were 
analysed using the repeated measures analysis of variance 
test - MANOVA (SPSS), and if significant were further 
analysed using paired T-tests.
Associations between the clinical parameters and IL-1J3 were 
analysed using Pearson's correlation coefficient and 
Regression analysis (Minitab). Prior to analysis the mean 
IL-113 levels, mid-PI and mid-MGI scores for each subject 
was summed over the four sampling intervals (Matthews et 
al., 1990).
2.5.2 Calibration of the Periotron 6000
Prior to commencement of this study a calibration graph was 
constructed for the Periotron 6000 in order to transform 
the Periotron digital indications for each filter strip
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into volumes• Known volumes of serum diluted 1:1 in PBS 
were delivered to Whatman grade 4 paper strips with a 
Hamilton microsyringe in volumes ranging from 0.2 to ljil, 
in 0.2til increments. Each measurement was performed 6 
times and the mean values for each volume were used in a 
regression analysis (Fig. 2.3). The slope, intercept and 
correlation coefficient of the regression analysis were 
used to determine the volumes of GCF collected.
Calibration of the Periotron 6000 was carried out daily, 
prior to GCF sampling to reduce error produced by 
atmospheric humidity and strip variability. A dry strip 
was placed between the Periotron jaws after each test strip 
and when the Periotron 6000 was not in use, a dry strip was 
placed between the jaws during storage.
2.6 PMN isolation from the crevice
2.6.1 Preliminary study: Method for isolating crevicular 
leucocytes
2.6.1.1 Introduction
Gingival crevicular leucocytes can be collected by various 
techniques for quantitation and in vitro observation. We 
tested 3 methods to determine the optimal recovery of 
crevicular leucocytes for subsequent experiments.
2.6.1.2 GCF and GCW collection
In order to compare GCF and GCW methods of PMN recovery we 
set up the following experiments.
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(PU-6.6)
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Figure 2.3 Periotron 6000 calibration curve. Periotron 
units (PU) plotted against volume (jil). Mean and standard 
deviation of six readings. Inset Example of typical 
regression equation and percentage reliability.
GCF samples were collected from 13 healthy sites. Nine 
sites were sampled utilising the method employed for GCF 
collection described previously (section 2.5.1) and the 
remaining four healthy sites were sampled using a 
modification of the Skapski & Lehner, (1976) crevicular 
washing method (section 2.6.2). Briefly the teeth were 
isolated by using a salivary ejector and cotton wool rolls 
in the buccal sulcus and any visible supragingival plaque 
was removed. Aliquots of lOpil of PBS were ejected and 
reaspirated 6 times using the 100^1 Hamilton microsyringe 
(SGE, Australia) resting interdentally on the surface of 
the tooth. The gingival washings were collected from sites 
and stored in microcentrifuge tubes.
2.6.1.3 GCF processing
After GCF collection the filter strips were divided into 2 
groups; Group 1 were processed according to the method of 
Cimasoni & Giannopoulou, (1988) (method A) and Group 2 
processed according to the method of Ebersole et al. (1984) 
(method B)•
Method A - filter strips were placed in microcentrifuge 
tubes containing 150^1 PBS-Tween (section 2.4.3.3) and 
vortexed for 30s. Method B - filter strips were placed in 
a microcentrifuge tube which had a cap placed within it, 
the cap had a hole in the center to allow fluid to pass 
through. To this 50^1 of PBS-Tween was added and the tubes 
centrifuged at 3000g for 2 minutes. This was repeated 
twice giving a total of 150^1 passed through. Aliquots
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(50ja1) of the samples (method A and B) were then 
cytocentrifuged at 70g (Shandon Scientific Ltd, UK) and the 
cytospin preparation stained using the Leishman method 
(section 2.6.3). A differential count was then performed 
at x400 magnification.
2.6.1.4 GCW processing
GCW were processed using Method Cs Within 30 minutes of GCW 
collection a total cell count was performed on 5jxl of the 
sample. The remainder of the sample was used to perform a 
differential count of 200-300 cells into polymorphonuclear 
and mononuclear cells after cytocentrifuging the samples at 
70g (Shandon Scientific Limited, UK) and staining the cells 
by the Leishman method (section 2.6.3). The numbers of 
PMNs/nl of GCW was finally calculated using the formula: 
total cell count x % PMNs/100.
2.6.1.5 Choice of technique following preliminary 
experiments
Using the filter paper methods (A or B), no PMNs could be 
isolated, whereas with the GCW method (method C), 
crevicular leucocytes could be recovered from healthy 
sites.
2.6.2 Modified gingival crevicular washing method
Following the preliminary PMN isolation technique 
experiments, a modification of the semiquantitative Skapski 
& Lehner, (1976) technique was used to study crevicular
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leucocytes. Briefly GCW were collected after careful 
isolation of the site. Aliquots of 20p,l of PBS were 
ejected and re-aspirated 3 times using a 20p,l micropipette 
fitted with a flat ended pipette tip (Labsystems, UK) (Fig.
2.4). Washings were then stored in sterile microcentrifuge 
tubes at 4°C before processing (section 2.6.1.4).
Two major modifications of the Skapski and Lehner technique 
were:
(1) it was found that re-aspirating 3 times allowed better 
recovery of the initial GCW volume than re-aspirating 6 
times (as recommended by Skapski & Lehner, 1976).
(2) aliquots of 20^1 of PBS ejected and reaspirated 3 times 
using a 20jxl micropipette fitted with a flat ended 
micropipette tip (Labsystems, UK) gave better recovery of 
the washing than the use of a Hamilton microsyringe.
2.6.3 Leishmans method
Cytospin preparations of GCW were air dried thoroughly 
before neat Leishmans (section 2.4.3.1) was added. After 
three minutes the stain was diluted 1:1 with distilled 
water and left for a further 10 minutes. The preparations 
were then washed and mounted under Uvinert mountant aqueous 
solution (BDH, UK).
2.6.4 Lactoferrin quantitation
LF quantitation was performed on the eluate of the GCW. 
The LF ELISA is based on the technique described by
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Hetherington, Spitznagel & Quie, (1983). In summary (Fig.
2.5), the 96-well polystyrene microplate (Immulon IV, 
Dynatech Laboratories, Sussex, UK) was coated with the 
first antibody (goat anti-LF). The eluate of the sample 
was added and any LF present was captured by the 
immobilised antibody. Incubation with the second specific 
antiserum developed in rabbit (rabbit anti-LF) was followed 
by the addition of the HRP conjugated anti-rabbit IgG 
(goat). Visualisation was achieved by incubation with the 
substrate (OPD) and stopping the reaction with H2S04. The 
plate was read at 490nm, and optical densities obtained 
using the Dynatech Minireader II. In the sandwich assays, 
the amount of antigen present in the sample is directly 
proportional to the amount of the second antiserum 
(rabbit), which was quantified indirectly by the addition 
of the HRP conjugated anti-rabbit IgG, resulting in high 
optical densities for high antigen concentrations. The 
method is described in detail in Table 2.3. Plates 
included 10 serial two-fold dilutions of purified antigen 
for the construction of a standard curve (Fig. 2.6). Only 
the central wells were used when running standards or 
samples (in triplicate) in an effort to avoid the edge 
effect. The peripheral wells were used assaying the 
controls which are shown in Table 2.4. All controls were 
run in duplicate except for the zero-antigen (control 14; 
Table 2.4) which was run in quadruplicate. LF levels in 
GCW samples were expressed as ng/p,l GCW.
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Coating with goat antiserum
add standard/sample antigen
incubate with rabbit antiserum
Add HRP anti-rabbit IgG
Figure 2.5 ELISA methodology.
Table 2.3 Steps and reagents for the lactoferrin (LF) 
sandwich ELISA. The LF standards concentration range was
0.24 to 125 ng/ml.
Sandwich ELISA
_______________Steps and Reagents_______________
1. Wash with 200p,l/well CB thrice and dry.
2. Coat with 100p,l/well LF antiserum (1:6000 in
CB). Incubate overnight at 4°C.
3. Wash with 200pl/well PBST, 3x6 times, and dry. 
Removal of excess and loosely coated antibody.
4. Add 100p,l/well standard LF in IB or eluted 
sample. Incubate 2h at 37°C.
5. Wash with 200p,l/well PBST, 3x6 times, and dry. 
Removal of free and loosely bound antigen.
6. Incubate with lOOpl/well rabbit antiserum to
LF (1:4000 in IB), overnight at 4°C.
7. Wash with 200pl/well PBST, 3x6 times, and dry.
Removal of free and loosely bound antigen.
8. Add 100p,l/well HRP anti-rabbit IgG (Goat) 
(1:4000 in IB). Incubate for 90 min at 37°C.
9. Wash with 200pl/well PBST, 3x6 times, and dry. 
Removal of excess HRP-anti-IgG.
10. Add 100p,l/well SB Incubate for approx. 20 min 
and stop colour development with 50p,l/well 1M 
____ H2SQ4. Read at 490nm.____________________
CB: coating buffer; HRP: horseradish peroxidase; IB: incubation buffer; 
LF: lactoferrin; PBST: phosphate buffer saline - tween
Standard Curva 3 125  - 0.40 ng/m l
logn OD
1
0
-1
-2
•3
2 3 4-1 0 1
logn concentration
Figure 2.6 Lactoferrin standard calibration curve.
Table 2.4 Control tests for the lactoferrin sandwich ELISA. 
When the addition of a reagent was omitted the equivalent 
volume of the respective buffer alone was added. Coating 
refers to the goat antiserum. Standard was added at 2‘5 
dilution of its starting concentration. The antiserum 
refers to the second antibody (rabbit).
Control_____________________ Step__________________
HRP
Coating Standard Antiserum conjugate
1. - - - -
2. + - - -
3. - + - -
4. - - + -
5. - - - +
6. + + - -
7. + - + -
8. + - - +
9. - + + -
10. - + - +
11. - - + +
12. + + + -
13. + + - +
14. + - + +
15. _ + + +
2.6.5 Statistical analysis
The distribution of LF levels and PMN numbers in the GCW 
were skewed and were logarithmically transformed to the 
base 10 (log10) to normalise their distribution for further 
analysis. Association between LF levels (ng/jil GCW) and 
PMN numbers (PMN/pil GCW) was determined by the Pearson's 
correlation coefficient (section 2.7.7.3) on the log10 
transformed data. Data was analysed using the 'Minitab' 
statistical package on an IBM PC.
2.7 Gingival biopsies
2.7.1 Biopsy sites
2.7.1.1 Experimental gingivitis
Gingival biopsies (2mm x 2mm) were obtained during the 
experimental gingivitis studies. They were taken every 
three days during the 10 day study and every seven days 
during the 21 day study. The biopsies were taken using two 
vertical incisions joined by a horizontal incision from the 
mid-buccal aspect (Fig. 2.1) of the lower right first 
permanent molar on day 0 and the remaining first permanent 
molars were then biopsied in rotation (day 3 (day 7) - 
upper right, day 7 (day 14) - upper left and day 10 (day 
21) - lower left). All the biopsy sites were covered in 
Coepack dressing and healed uneventfully, in total four 
biopsies were taken from each individual. Twenty gingival 
biopsies were collected for the 21 day study and 20 for the 
10 day study.
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2.7.1.2 Patient tissue
For the studies involving periodontitis patients (section 
2.2.3) the interproximal tissue was used and in total 19 
sites were sampled. For the organ culture study the tissue 
used was removed from patients (section 2.2.2) who were 
undergoing a standard gingivectomy procedure to remove 
hyperplastic gingival tissue.
2.7.2 Sectioning and storage of gingival tissue
All tissue biopsies (experimental gingivitis, patient and 
organ culture) were embedded in Tissue Tek O.C.T. and snap 
frozen to prevent ice crystal formation. Eight micrometer 
thick serial section were then cut using a Microcryostat 
(Shandon Scientific, UK) and sections were collected on 
vectabond treated slides (section 2.4.4.2) and stored at 
-70°C until further processing.
2.7.3 Pre-treatment of glass slides
During processing of frozen tissue sections for 
immunohistochemical staining, sections commonly become 
detached from the glass slide. Vectabond reagent (Vector 
Laboratories, Peterborough, UK) chemically modifies the 
glass to form a highly adherent surface.
Vectabond pre-treatment of glass slides prevents frozen 
tissue from detaching and decreases background staining. 
Briefly, untreated glass slides were rinsed in acetone 
(BDH, UK) and placed in Vectabond reagent solution (section
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2.4.4.2) for 5 minutes, followed by a brief rinse in 
distilled water. Treated slides were then dried overnight 
at 37°C before being stored at room temperature.
2.7.4 ABC Techniques
2.7.4.1 Preliminary studies to determine optimal staining 
method
Numerous combinations of reagent were employed in an 
attempt to determine the optimal staining method for single 
staining (ABC-P or ABC-AP) and double staining (ABC-P 
followed by ABC-AP) as outlined in Table 2.5 and 2.6.
2.7.4.2 Single staining comparisons
The results from the single staining preliminary studies 
indicated (Table 2.5):
(1) Blocking before the addition of the primary monoclonal 
antibody (mAb) gave better staining with both detection 
systems (ABC-P and ABC-AP) i.e. less background 
(combinations 1 and 2 and 5 and 6);
(2) Deperoxidation to remove endogenous peroxidase if 
performed before the primary monoclonal antibody was 
labelled with biotin conjugated antibodies resulted in 
altered primary mAb such that staining was reduced 
(combination 3). Staining was optimal if deperoxidation 
was carried out after biotin labelling (combination 4);
(4) ABC-AP substrate Vector red gave better staining if 
levamisole (O.lmM) was included in the solution 
(combination 7 and 8);
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Table 2.5 Combinations of single staining used during 
preliminary studies in order to determine optimal staining 
procedure•
Single staining procedures combinations Result
1 F + mAb + biotin + ABC*-P + DAB +
2 F + B + mAb + biotin + ABC-AP + DAB +++
3 F + B + Dp ■f mAb + biotin + ABC-P + DAB -
4 F + B + mAb + biotin + Dp + ABC-P + DAB +++
5 F + mAb + biotin + ABC*-AP + Vector red
(no levamisole)
+
6 F + B + mAb + biotin + ABC-AP + Vector red
(no levamisole)
+++
7 F + B + mAb + biotin + ABC-AP + Vector red
(no levamisole)
+
8 F + B + mAb + biotin + ABC-AP + Vector red 
(levamisole)
+++
9 F + B + mAb + biotin + Dp + ABC-P + DAB ++++
10 F + B + mAb + biotin + Dp + ABC-P + DAB-NiCl2 ++
11 F + B + mAb + biotin + ABC-AP + Vector red 
(levamisole)
++
12 F + B + mAb + biotin + Dp + ABC-P + DAB 4°C +
13 F + B + mAb + biotin + Dp + ABC-P + DAB 22°C +++
14 F + B + mAb + biotin + Dp + ABC-P + DAB 37°C ++
ABC-AP: avidin biotin alkaline phosphatase complex; ABC-P: avidin biotin 
peroxidase complex; B: block; DAB: diaminobenzidine 3,3'
tetrahydrochloride; DAB-NiCl2: diaminobenzidine 3,3' tetrahydrochloride/ 
nickel chloride substrate; Dp: deperoxidation; F: fixation; mAb: primary 
monoclonal antibody
Table 2.6 Combinations of double staining used during 
preliminary studies in order to determine optimal 
staining procedure.
Double staining comparisons made__________ Result
1 F + lBt mAb + biotin + ABC-P +
+ DAB /wash/ 2nd mAb + biotin + ABC-AP
+ Vector red (levamisole)
2 F + Bp + lBt mAb + biotin + ABC-P +++
+ DAB /wash/ 2nd mAb + biotin + ABC-AP
+ Vector red (levamisole)____________________
3 F + Bp + lBt mAb + biotin + ABC-P +++
+ DAB /wash/ 2nd mAb + biotin + ABC-AP
+ Vector red (levamisole)
4 F + Bp + lBt mAb + biotin + Dp + ABC-P +
+ DAB /wash/ 2nd mAb + biotin
+ ABC-AP + Vector red (levamisole)____________
5 F + Bp + lBt mAb + biotin + ABC-P +
+ DAB /wash/ acetic acid + 2nd mAb
+ biotin + ABC-AP 
+ Vector red (levamisole)
6 F + Bp + lBt mAb + biotin + ABC-P +++
+ DAB /KI/ + 2nd mAb + biotin + ABC-AP
+ Vector red (levamisole)____________________
ABC-AP: avidin biotin alkaline phosphatase complex; ABC-P: avidin 
biotin peroxidase complex; B: block; DAB: diaminobenzidine 3,3' 
tetrahydrochloride; Dp: deperoxidation; F: fixation; mAb: primary 
monoclonal antibody
(5) DAB (3, 3" Diaminobenzidine tetrahydrochloride) 
substrate gave the best staining with vector red and DAB- 
NiCl2 giving slightly less clear staining (combinations 9-
ii);
(6) Finally the optimal temperature for ABC-P staining was 
22°C (combination 12-14).
2.7.4.3 Double staining comparisons
The results from the double staining preliminary studies 
indicated (Table 2.6):
(1) Comparison 1 and 2 indicated that blocking before the 
first primary monoclonal antibody gave better staining than 
not blocking at all;
(2) Deperoxidation after the addition of biotin gave better 
staining (comparisons 3 and 4);
(3) Chaotropic agent (potassium iodide) used between the 
two staining methods gave better staining than just washing 
(comparisons 5 and 6);
(4) Non-specific staining and cross-reactivity between the 
two detection systems could not be eliminated.
2.7.4.4 Choice of staining method following preliminary 
studies
ABC-P method using DAB as the substrate gave the best 
staining results in comparison to ABC-P/DAB-NiCl2, ABC-AP 
and double staining. Therefore the optimal staining method 
for these studies was ABC-peroxidase and if two antigens 
were of interest within the same section then serial
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sections were used to determine if they were localised 
within the same area.
2.7.4.5 ABC-peroxidase (ABC-P) method
Tissue sections were stained using the ABC method of Hsu, 
Raine & Fanger, (1981) and is outlined in detail in Table 
2.7. Briefly, sections were processed using seven major 
steps,
(a) Fixation - Frozen cryostat sections of the specimens 
were air dried and fixed in cold acetone;
(b) Blocking - Following fixation the sections were blocked 
with horse serum (section 2.4.4.4) to decrease non-specific 
background staining;
(c) Primary antibody - Unlabelled primary monoclonal 
antibodies were added at optimal dilutions and sections 
incubated at room temperature (Table 2.8);
(d) Biotinylated antibody - Biotinylated horse anti-mouse 
secondary antibody (section 2.4.4.5) was used to label the 
primary monoclonal antibodies;
(e) De-peroxidation - The sections were deperoxidised to 
remove endogenous peroxidase using methanolic hydrogen 
peroxide (section 2.4.4 .6);
(f) ABC complex - Preformed avidin-biotinylated peroxidase 
complex (section 2.4.4.7) was then added;
(g) Reaction development - The reaction was developed 
using the substrate DAB (section 2.4.4.8) and staining 
enhanced by incubation of the sections in 0.5% CuS04 
solution (section 2.4.4.15) before counterstaining with
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Table 2.7 Immunostaining Procedure for Avidin-Biotin-
complex - peroxidase (ABC-P) technique.
1* Frozen cryostat sections air dried (60 mihs)
2* Immediately before staining, fix sections
with cold acetone (BDH, UK) (10 mins)
3* Transfer slides into PBS (3 changes) (10 
mins)
4 Block sections with diluted normal horse 
serum (Vector Laboratories, UK) (20 mins)
5 Blot excess serum from sections
6 Incubate sections with primary monoclonal 
antibody (mouse anti-human) diluted in PBS 
for 60 mins
7 Wash slides in 3 changes of PBS (10 mins)
8 Incubate sections with biotinylated secondary
antibody (horse anti-mouse IgG (H and L) 
(Vector Laboratories, UK) diluted in PBS for 
30 mins
9 Wash slides in 3 changes of PBS (10 mins)
10 Incubate the sections in methanolic hydrogen
peroxide (0.3%) for 30 mins
11 Wash slides in 3 changes of PBS (20 mins)
12* Incubate sections with avidin-biotin-
peroxidase complex1 (ABC) (Vector 
Laboratories, UK) for 45 mins
13 Wash slides in 3 changes of PBS (10 mins)
14 Incubate sections in substrate1 (0.01% H202 
and 0.5% diaminobenzidine tetrahydrochloride) 
(DAB) in PBS pH 7.4 for 5-10 mins
15 Wash slides in PBS (5 mins) followed by 
distilled water (5 mins)
16* Incubate sections in 0.5% copper sulphate
solution for 5 mins
17 Wash slides in PBS (5 mins) followed by 
distilled water (5 mins)
18 Counterstain, dehydrate and mount_________
'Modifications to Hsu, Raine & Fanger, (1981*) method, 
hnake up 30 mins prior to use.
All incubations carried out at room temperature and in a moist 
chamber.
Table 2.8 Monoclonal antibodies optimal dilution used 
in the immunohistochemistry procedures. The source of 
the monoclonal antibody and the antigen it is directed 
against is indicated.
mAb Antigen Source Optimal
dilution
Reference
0KT6 CDla Ortho1 1/50 Harrist et al., 1983 
Fithian et al., 1981
0KT3 CD3 A.T.C.C. 1/50 Hoffman et al., 1980
UCHT-1 CD3 S.A.P.U. 1/4
0KT3 CD3 Ortho 1/50
0KT4 CD4 A.T.C.C. 1/50 Hoffman et al., 1980
RFT4 CD4 S.A.P.U. 1/4
0KT8 CD8 Ortho 1/50 Hoffman et al., 1980
RFT8 CD8 A.T.C.C. 1/50
0KT8 CD8 S.A.P.U. 1/4
TS1/22 CDlla Donation2 1/20 Sanchez-Madrid et al., 1982
2H4 CD45RA Coulter 1/50 Morimoto et al., 1985
UCHL-1 CD45RO Donation2 1/25 Smith et al., 1986
UCHL-1 CD45RO Donation3 1/25 Norton et al., 1986
6.5B5 CD54 Donation2 1/30 Wellicome et al., 1990
1.2B6 ELAM-1 Donation2 1/20 Wellicome et al., 1990
1.4C3 VCAM-1 Donation2 1/10 Wellicome et al., 1990
EN4 EC Seralab 1/100 Cui et al., 1983
RFDRl HLA-DR S.A.P.U. 1/4 Lampson & Levy 1980
NP57 PMN
elastase
Dako 1/300 Pulford et al., 1988
1 Orthodiagnostics
2 Dr D.O. Haskard (London, UK)
3 Prof. P.C. Wilkinson (Glasgow, UK)
Mayer's haematoxylin (section 2.4.4,16). One section from 
each biopsy was also stained with haematoxylin and eosin 
(section 2.7.4.8).
Monoclonal antibody specificities were confirmed using 
human tonsil and human skin as control tissue and 
appropriate negative control sections treated with 
nonspecific primary antibodies.
2.7.4.6 ABC-alkaline phosphatase (ABC-AP) method
The basic principals of this method are identical to the 
ABC-P method (section 2.7.4.5) except the substrate 
differs. The ABC-AP method is outlined in Table 2.9, the 
sections were fixed in cold acetone, blocked with horse 
serum, labelled with primary monoclonal antibody followed 
by biotinylated horse anti-mouse secondary antibody. ABC- 
AP complex was then added (section 2.4.4.12) and the 
reaction developed using the commercially available Vector 
Red(R> (section 2.4.4.13) containing O.lmM levamisole 
(section 2.4.4.11) to remove endogenous alkaline 
phosphatase.
2.7.4.7 Double staining method
The double staining method was employed in an attempt to 
stain two antigens within the same tissue section i.e. 
ELAM-1 and PMN-elastase. The two detection systems 
utilised were ABC-P and ABC-AP. The ABC-P method was used 
initially to pick up the first primary monoclonal antibody
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Table 2.9 Immunostaining Procedure for Avidin-Biotin-
complex - alkaline phosphatase (ABC-AP) technique.
1 Frozen cryostat sections air dried (60 mins)
2 Immediately before staining, fix sections 
with cold acetone (BDH, UK) (10 mins)
3 Transfer slides into PBS (3 changes) (10 
mins)
4 Wash slides in 3 changes of PBS (10 mins)
5 Block sections with diluted normal horse 
serum (Vector Laboratories, UK) (20 mins)
6 Blot excess serum from sections
7 Incubate sections with primary monoclonal 
antibody (mouse anti-human) diluted in PBS 
for 60 mins
8 Wash slides in 3 changes of PBS (10 mins)
9 Incubate sections with biotinylated secondary 
antibody (horse anti-mouse IgG (H and L) 
(Vector Laboratories, UK) diluted in PBS for 
30 mins
10 Wash slides in 3 changes of PBS (10 mins)
11 Incubate sections with avidin-biotin- 
peroxidase - AP complex1 (ABC-AP) (Vector 
Laboratories, UK) for 45 mins
12 Wash slides in 3 changes of PBS (10 mins)
13 Incubate sections in AP-substrate kit I 
vector red (made up in lOOmM Tris-HCl, pH
8.2) for 15-20 mins in the dark.
14 Wash slides in distilled water (5 mins)
15 Counterstain, dehydrate and mount
1make up 30 mins prior to use.
All incubations carried out at room temperature unless otherwise 
stated and in a moist chamber.
(i.e. ELAM-1) and the ABC-AP kit used to label the second 
primary monoclonal antibody (i.e. PMN-elastase). Basically 
the ABC-P method as outlined in Table 2.7 was followed 
until step 15, then the ABC-AP method (Table 2.9) was 
followed beginning at step 3 in order to stain for the 
second antigen. Potassium iodide (0.06M, 30 mins, RT)
(section 2.4.4.14) a chaotropic agent was used between the 
two methods in order to prevent cross-reaction between the 
two detection systems. Appropriate staining for ELAM-1 and 
PMN-elastase would stain ELAM-1+ blood vessels brown and 
PMN-elastase positive cells red.
2.7.4.8 Haematoxylin and eosin sections
Tissue sections were thoroughly air-dried and then placed 
in Mayer's haematoxylin (section 2.4.4.16) for 10 minutes, 
rinsed under running water, then placed in 0.1% eosin 
(section 2.4.4.17) for 10 seconds. Sections were finally 
dehydrated in a range of alcohols and mounted under xylene.
2.7.5 Primary monoclonal antibodies
A range of primary mAbs were used to stain the gingival 
tissue (Table 2.8). All mAbs were mouse anti-human and of 
various isotypes. Optimal dilutions for the mAbs were pre­
determined by titration before use in the ABC technique 
(Table 2.8).
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2.7.6 Enumeration
2.7.6.1 Areas
The experimental gingival biopsies were divided into four 
areas for enumeration as shown in Figure 2.7. An imaginary 
line (AB) was dropped from the crest of the gingiva to 
divide the tissue into two halves - the junctional 
epithelium/sulcular epithelium (JE/SE) and the oral 
epithelium (OE). A second imaginary line was drawn 
horizontally (CD) just below the termination of the JE 
perpendicular to the first line AB (interception point - E) 
(Fig. 2.7). The four areas were labelled as follows,
(i) JE/SE - junctional epithelium/sulcular epithelium,
(ii) OE - oral epithelium,
(iii) JE/CT - connective tissue subjacent to the JE,
(iv) OE/CT - connective tissue subjacent to the OE.
For enumeration the methods employed were cell counting, 
grading of the leucocyte infiltrate size, grading of blood 
vessel staining intensity and also calculation of the 
percentage of adhesion molecule positive vessels 
(percentage positivity) compared to the total number of 
vessels.
2.7.6.2 Grading of overall cellular infiltrate
Haematoxylin and eosin sections were viewed under low 
magnification (xlOO) and cellular infiltrate scored as +: 
very little infiltration; ++: small infiltrate; +++
i ■
moderate infiltration and ++++: large infiltrate(Fig. 2.7a)
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OEJE/SE
JE/CT OE/CT
Figure 2.7 A r e a s  u s e d  f o r  e n u m e r a t i o n ,  j u n c t i o n a l / s u l c u l a r  
e p i t h e l i u m  ( J E / S E ) ;  o r a l  e p i t h e l i u m  ( O E ) ;  c o n n e c t i v e  t i s s u e  
s u b j a c e n t  t o  j u n c t i o n a l / s u l c u l a r  e p i t h e l i u m  ( J E / C T )  a n d  
c o n n e c t i v e  t i s s u e  s u b j a c e n t  t o  o r a l  e p i t h e l i u m  ( O E / C T ) .
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u s e d  t o  e n u m e r a t e  t h e  c e l l u l a r  i n f i l t r a t i o n ;  ( i )  g r a d e d  + 
v e r y  l i t t l e  i n f i l t r a t i o n ,  ( i i )  g r a d e d  + +  s m a l l  i n f i l t r a t e ,  
a n d  ( i i i )  + + +  m o d e r a t e  i n f i l t r a t e  ( H & E ,  m a g . x 2 0 0 ) .
2.7.6.3 Counting method
Positive cells within the four areas (section 2.7.6.1) were 
counted using an ocular grid (5 x 5). Using computer 
assisted image analysis (Video Vector Dynamics, Glasgow UK) 
the 5x5 ocular grid was superimposed onto an S8-stage 
micrometer (1mm/0.01 divisions) (Graticules Ltd, Kent, UK) 
to measure the length of 5 squares and depending on the 
magnification used the scale was then entered into the 
computer (Table 2.10). Using high power magnification 
(x400) and a light cursor the area covered by the inner 
nine squares of the ocular grid was measured and a fixed 
counting area established (area = field = 0.018mm2). The 
ocular grid was superimposed onto the section to be counted 
and positive cells within the area covered by the inner 
nine squares (=field) were counted.
For Langerhans cell enumeration (CDla+ or HLA-DR+) 10 high 
power fields (x400 magnification, area=0.018mm2) within the 
OE were counted for each biopsy minimum of 3 sections per 
biopsy taken during the experimental gingivitis studies and 
results expressed as the mean number of positive cells per 
high power field (n=10 fields). For the remaining 
leucocytes 3 high power fields were counted within the OE 
and JE/SE and results expressed as number of positive cells 
per mm2.
For the two connective tissue areas (JE/CT and OE/CT) 
positive cells were counted in the most densely infiltrated
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Table 2.10 Scaling used during computerised image 
analysis enumeration of positive cells. Lengths of 5 
squares on ocular grid depending on the magnification 
used.
Magni f ication Scale
xlO 905nm
xl6 570nm
x25 368(xm
x40 226 \m
field within the area, with only one field counted in any 
one section (maximum n=3 sections). For each biopsy, 
results were expressed as the mean number of positive cells 
per mm2 (n=3 fields).
All fields were chosen randomly and counting was performed 
'blind' i.e. counted without prior knowledge of 
experimental treatment (days of plaque accumulation).
2.7.6.4 Grading of leucocyte infiltrate
To grade leucocyte infiltration of the tissue semi- 
quantitative ordinal scales were used. For PMN
infiltration the whole area was taken as the unit of area 
and PMN infiltrate was graded as 1 if 1-10 cells were 
present in the unit area, 2; 11-30 cells, 3; 31-100 cells 
and 4; )100 cells in the area unit. For remaining
leucocytic infiltration a slightly different ordinal scale 
was used (1; 1-10 cells, 2; 11-20 cells, 3; 21-75 cells and 
4; >75 cells), with cells being graded within high power 
(x400 magnification) connective tissue fields in the most 
densely infiltrated area.
2.7.6.5 Grading of blood vessel staining intensity
Counting positive cells is relatively straight forward, if 
a cell is positive it is counted, if it is negative then it 
is ignored. Staining of blood vessels on the other hand 
can cause problems with enumeration as positive vessels can 
vary in length and therefore can give false results.
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Grading staining intensity and calculating the percentage 
positive vessels can overcome and reduce the possibility of 
false results.
Blood vessel staining intensity was graded semi-
quantitatively on a 4-poipt scale using the pethod of Messadi
i
| et al, (1987) (Table 2.11) (Fig. 2.7b). Keratinocyte staining
I
was graded in a similar fashion: - no staining; -/+ very 
weak staining; + weak staining; ++ moderate staining; +++ 
strong staining and ++++ very strong staining. Vessels 
were graded within JE/CT and OE/CT areas (ELAM-1, ICAM-1 
and VCAM-1) and ICAM-1 staining of the keratinocytes within 
OE, SE and JE when present. Each section was assessed 
twice in random order and 'blind'. This method of 
quantification was reproducible as shown by the following 
Spearman's rank correlation coefficients between the two 
readings of the 20 biopsies (21-day study); ELAM-1 CT 
r=0.800: ICAM-1 CT r=0.915: ICAM-1 SE keratinocyte r=0.864 
and ICAM-1 JE keratinocyte r=0.829.
2.7.6.6 Calculation of the percentage of adhesion molecule 
positive vessels
Percentage positive vessels were calculated using EN4 
monoclonal antibody (Seralab, UK) as a positive control. 
Serial sections were stained with EN4 mAb and adhesion mAbs 
(ELAM-1, ICAM-1 and VCAM-1). High power fields were chosen 
in adjacent serial sections and the number of positive 
vessels counted. The percentage of adhesion molecule
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Table 2.11 Messadi et al. (1987) grading scale.
- no staining
+ weak focal granular staining
++ moderate staining of vessels
+++ strong staining of vessels
++++ very strong staining of vessels
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positive vessels were then calculated as,
number of adhesion mAb 
positive vessels
% positive vessels = -----------------------  xlOO
number of EN4 positive 
vessels
Three high power fields were counted per biopsy and results 
expressed as the mean percentage positive vessels.
2.7.6.7 Presentation of organ culture results
The percentage of adhesion molecule positive vessels was 
calculated as discussed previously (section 2.7.6.6) and 
grading of the intensity of staining within the connective 
tissue subjacent to the epithelium was performed as
outlined in section 2.7.6.5. The results were expressed in
/
two formats;
( i ) The results for the blocks cultured in control media 
were expressed as the percentage of positive vessels per 
block or as overall staining intensity.
(ii) For blocks cultured in cytokine-enriched media
(section 2.8.2) the results were expressed as the net
change in the percentage of positive staining vessels,
corrected for background changes and the net changes in
staining intensity. Thus the overall change in the
percentage positivity was calculated as,
% net change = cytokine - control
% positive % positive
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and the overall change in vessel staining intensity
calculated as,
net change = cytokine - control 
staining intensity intensity intensity.
2.7.7 Statistical analysis
A variety of statistical procedures were used depending on 
the type of sample collected (repeated measures, paired t- 
tests, two sample, pooled t-test) and the type of analysis 
required.
2.7.7.1 Repeated measures analysis of variance (MANOVA)
For the experimental gingivitis study the leucocyte 
infiltrate were obtained from the same individual at 
regular time points and this thus constitutes a repeated 
measures design. The data followed a normal distribution 
and were analysed using the repeated measures analysis of 
variance (MANOVA) using the statistical package SPSS on an 
IBM personal computer.
If the MANOVA test was statistically significant ie if 
'day' had a statistically significant effect on changes in 
leucocyte number then paired t-tests were used to further 
analyse where these changes were occurring. Since multiple 
comparisons were used, a Bonferroni correction was needed. 
The Bonferroni correction employed was calculated as, 
probability value (0.05) divided by the number of possible 
comparisons (n=6). The acceptable level therefore is
p<0.01.
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2.7.7.2 Friedman's test
Repeated measures data on grading of adhesion molecule 
intensity obtained from the experimental gingivitis study, 
collected on an ordinal scale and hence usually gave a non­
normal distribution were analysed using the Friedman's test 
(Minitab PC), which is the non-parametric equivalent of the 
MANOVA. If the Friedman's test is statistically 
significant, then further analysis is used to decide which 
population is different. The test used was determined by 
the distribution of the differences between the 
populations, if the difference is normally distributed then 
the Wilcoxon signed rank test is used (Minitab PC), if the 
distribution of the difference is non-normally distributed 
then the sign test is used (Minitab PC).
2.7.7.3 Correlation
To demonstrate association between grading of staining 
intensity between areas, two different correlations were 
used. Pearson's correlation coefficient was used if the 
samples demonstrated a normal or Gaussian distribution and 
Spearman's rank correlation if the distribution was skewed. 
Both analyses were carried out on using the 'Minitab' 
statistical package on an IBM PC.
2.8 Organ culture study
2.8.1 Tissue source
Tissue for the organ culture studies was obtained as 
mentioned previously (section 2.2.2). After collection the
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tissue was immediately placed on gauze and transported to 
the laboratory where it was set up in organ culture within 
30 mins of its removal from the mouth.
2.8.2 Organ culture method
Tissue samples were washed in several changes of HBSS 
(section 2.4.5.1) in order to remove adherent blood clots 
before being sectioned to 1mm cubes. The explants were 
then transported with the connective tissue side down onto 
lens paper and placed on stainless steel grids within the 
organ tissue culture (OTC) dishes (Falcon Plastics/Becton 
Dickinson, UK Ltd) (Fig. 2.8) (Bernstein, Preisig & 
Schroeder, 1988) with 0.75 ml of medium 199 (section 
2.4.5.2) containing 0.1% BSA (Sigma, UK) (control) or 
cytokines IL-ip, TNFa or LPS or rhlFy (sections 2.2.5.3 -
2.2.5.7 respectively) was added to each OTC dish to the 
level of the steel grid. Cultures were maintained at 37°C 
in a humidified incubator in 5% C02 in air for varying 
times ranging between 6-72 hours. The culture medium was 
not replaced during the culture period. Pre-incubation 
controls were prepared in the manner described above, but 
were immediately removed from the culture dish before the 
addition of the culture medium. After incubation the 
explants were removed from the OCT dishes and blotted on 
filter paper to remove excess fluid and then embedded in 
tissue tek OCT and immediately frozen. Eight micrometer 
sections were collected on vectabond treated slides, 
allowed to air dry and then stored at -70°C. The sections
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F i g u r e  2 . 8  ( a )  O r g a n  c u l t u r e  d i s h  s e t u p ,  ( b )  C l o s e u p  o f
w e l l  s h o w in g  t i s s u e  b l o c k  ( T B )  s e p a r a t e d  f r o m  t h e  c y t o k i n e  
s o u r c e  (C )  b y  a m e t a l  g r i d  ( G ) .
were then processed using the ABC method previously 
described (section 2.7.4.5).
2.8.3 Vessel enumeration
The percentage of adhesion molecule positive vessels were 
calculated as discussed previously (section 2.7.6.6 ) and 
intensity of blood vessel staining was determined within 
the subjacent connective tissue (section 2.7.6.5).
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Chapter 3 
Results
3.1 Experimental gingivitis studies
The experimental gingivitis model (Loe et al,, 1965) was 
used to study the development of gingival inf lamination. 
Two studies were performed. In the first study 
inflammation was induced experimentally by abolishing oral 
hygiene procedures for 21 days and in the second study this 
period was reduced to 10 days.
3.1.1 Twenty-one day experimental gingivitis study
Six individuals (A-F) commenced this study and five fully 
completed the study (A-E) (section 2.2.1). Clinical 
indices, GCF samples and gingival biopsies were collected 
and processed as previously described.
3.1.1.1 Clinical indices
At baseline i.e. in clinically 'healthy' gingiva, all 
subjects had minimal plaque (PI=0) except subject B who had 
PI=1 at one site and no clinically visible gingival 
inflammation (MGI=0) (Fig. 3.1). Over the 21 day 
experimental period the PI of the biopsy sites rose and the 
rise in the MGI lagged behind by a few days. Both indices 
increased significantly with time (PI, p=0.002 and MGI, 
p=0.001) (Friedman's test, Minitab) and further analysis 
demonstrated that indices were significantly higher at day 
14 and day 21 when compared with day 0 (Wilcoxon Sign Rank 
Test, Minitab).
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Spearman's rank correlation showed that over the 21-day 
period the site PI and MGI demonstrated a strong 
relationship with each other and a slightly weaker 
correlation with the day of oral hygiene abstention (Table 
3.1).
3.1.1.2 Haematoxylin and eosin sections
Clinically 'healthy' gingival tissue exhibited a wide range 
in the extent of cellular infiltrate (Table 3.2). Some 
subjects exhibited more cellular infiltrate than others 
(subject B compared with subject D), with no relationship 
between the size of cellular infiltration and days of 
plaque accumulation (Spearman's rank correlation 
coefficient, Minitab).
Histologically the clinically 'healthy' gingival tissue 
(day 0) was well structured, but as inflammation developed 
(day 7 to day 21) their was a marked change with rete peg 
proliferation, increased vascularisation as noted by the 
appearance of capillaries within the JE/SE and JE areas and 
also migration of cells into the JE/SE epithelium area. 
Overall with the development of inflammation their were 
marked histological changes.
3.1.1.3 ELAM-1 and ICAM-1 expression
Within clinically 'healthy' gingiva (day 0) (Subjects A-E) 
both ELAM-1 and ICAM-1 staining were seen (Tables 3.3 and
3.4 respectively). ELAM-1+ blood vessels were present in
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Table 3.1 Regression analysis of clinical indices during 
the 21-day experimental gingivitis study. Spearman rank 
correlation coefficient (r) and probability values (p) are 
shown. Sites examined were the mid-buccal aspects of first 
molars i.e. the biopsy sites.
Parameters r P
PI vs Day 0.833 <0.001
MGI vs Day 0.893 <0.001
PI vs MGI 0.916 <0.001
MGI: Modified Gingival Index; PI: Plague Index
Table 3.2 Size of cellular infiltration during the 21-day 
experimental gingivitis study.
Size of cellular infiltrate
ibject
Day 0 Day 7 Day 14 Day 21
A + ++ +++ +
B +++ +++ ++ +++
C +++ +++ +++ ++
D ++ ++ + +
E + ++ ++ +++
Table 3.3 ELAM-1 staining intensity within JE/CT and OE/CT 
areas, for each subject at each sampling time during the 
21-day experimental gingivitis study.
Day Subject Intensity of 
JE/CT
ELAM-1 staining 
OE/CT
0 A +++ ++
B +++ ++++
C ++ +
D +++ +++
E +++ ++
median +++ ++
7 A + +
B +++ ++
C +++ ++
D +++ ++
E ++ +
median +++ ++
14 A * *
B ++ +++
C * *
D +++ +
E ++ +
median ++ +
21 A ++++ +++
B +++ ++
C * *
D ++ ++
E ++ +
median ++/+++ ++
* missing value
Table 3.4 ICAM-1 staining intensity for each subject at 
each time point during the 21-day experimental gingivitis 
study.
Day Subject Intensity of ICAM- 
JE/CT OE/CT
1 staining 
JE OSE OE
0 A * * ★ * *
B +++ ++ +++ ++ -
C ++ + +++ ++ -
D +++ ++ +++ ++ -
E +++ +++ +++ ++ -
median +++ ++ +++ ++ -
7 A ++++ ++++ ++++ +++ —
B ++ + ++ ++ -
C +++ +++ +++ ++ -
D ★ * +++ ++ -
E +++ +++ +++ ++ -
median +++ +++ +++ ++ -
14 A +++ ++ +++ ++ —
B ★ * +++ ++ -
C ++ +++ +++ + -
D ++ +++ ++ ++ -
E ++++ ++++ ++ ++ -
median ++/+++ +++ ++ ++ -
21 A +++ +++ ++ ++ —
B ++++ +++ +++ ++ -
C +++ ++ ++ + -
D +++ +++ ++ + -
E +++ +++ ++/+++ ++ -
median +++ +++ ++ ++ -
* missing value
both the JE/CT and OE/CT of healthy gingiva (day 0), 
although expression was mainly concentrated in the JE/CT 
area (Fig. 3.2). As inflammation developed the 
concentration and intensity of staining in the JE/CT area 
became more marked as demonstrated by a 15% increase in the 
numbers of biopsies with stronger staining vessels at the 
JE/CT (day 21 compared with day 0) (Table 3.5).
ICAM-1 staining of blood vessels in the connective tissue 
also showed a similar distribution and pattern of staining, 
with a 20% decrease in the numbers of biopsies with 
stronger staining vessels at the JE/CT area (day 0 compared 
with day 21) (Table 3.5). Interestingly, clinically 
'healthy' tissue also demonstrated intense ICAM-1 staining 
of the keratinocytes at the JE, with moderate staining of 
SE keratinocytes and no staining of OE keratinocytes (Fig.
3.3). With the subsequent development of inflammation 
there was little change in the intensity or distribution of 
ICAM-1 staining and no spread of ICAM-1 positivity to the 
OE keratinocytes (Table 3.4), although small parts of the 
keratinocytes within the stratum spinosum demonstrated very 
weak staining and on further analysis these exhibited the 
dendritic appearance of LCs (Fig. 3.4).
Throughout the 21 days the ICAM-1 staining of the JE 
keratinocytes appeared to demonstrate a gradient effect, 
with the most intense ICAM-1 staining towards the 
crevicular/tooth aspect and decreasing staining intensity
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Figure 3.2 E LA M -1  p o s i t i v e  v e s s e l s  i n  t h e  c o n n e c t i v e  t i s s u e  
a r e a  o f  a  d a y  0 b i o p s y ,  t h e  m o s t  i n t e n s e  s t a i n i n g  E L A M -1 + 
v e s s e l s  l o c a t e d  a t  t h e  j u n c t i o n a l  e p i t h e l i u m / c o n n e c t i v e  
t i s s u e  a r e a  ( s o l i d  a r r o w ) ,  w i t h  w e a k e r  s t a i n i n g  E L A M -1 + 
v e s s e l s  l o c a t e d  t o w a r d s  t h e  o r a l  e p i t h e l i u m / c o n n e c t i v e  
t i s s u e  a r e a  (o p e n  a r r o w )  ( I m m u n o p e r o x i d a s e , m a g .  x l 2 5 ) .
Table 3.5 Percentage of biopsies with stronger staining 
vessels at JE/CT compared with OE/CT within the same 
biopsies taken during the 21-day experimental gingivitis 
study.
JE/CT > OE/CT
Day 0 Day 7 Day 14 Day 21
ELAM-1 60% 100% 66% 75%
ICAM-1 60% 20% 25% 40%
Figure 3.3 I n t e n s e  IC A M -1  s t a i n i n g  o f  j u n c t i o n a l  e p i t h e l i u m  
k e r a t i n o c y t e s  ( s o l i d  a r r o w )  w i t h  m o d e r a t e  s t a i n i n g  o f  SE 
k e r a t i n o c y t e s  (o p e n  a r r o w )  a n d  r e l a t i v e  a b s e n c e  o f  IC A M -1  
s t a i n i n g  o f  o r a l  e p i t h e l i u m  k e r a t i n o c y t e s  i n  a  D a y  7 b i o p s y  
( Im m u n o p e r o x i d a s e , m a g . x7  8 . 7 5 ) .
Figure 3.4 D ay 0 b i o p s y  d e m o n s t r a t i n g  IC A M - 1 + L a n g e r h a n s  
c e l l s  w i t h i n  t h e  o r a l  e p i t h e l i u m  ( s o l i d  a r r o w s )  
( I m m u n o p e r o x id a s e ,  m a g . x 2 0 0 ) .
towards the basal layers (Fig. 3.5). Apical JE, when 
present, also expressed ICAM-1.
Since intensity was graded on an ordinal scale data 
analysis was by the repeated measures Friedman's Test 
(section 2.7.7.2). Due to technical difficulties full data 
for all four sampling times were available for only 3 of 
the 5 subjects for ELAM-1 intensity (subjects B, D, and E) 
and only 2 of the 5 subjects for ICAM-1 (subjects C and E). 
The Friedman's test demonstrated no significant day effect 
on ELAM-1 staining intensity within the two connective 
tissue areas studied (JE/CT and OE/CT), however there was 
a trend, which can be seen in Table 3.3, for ELAM-1 
intensity to decrease with time (day 0 compared with day 
21). Only two subjects possessed full data set for ICAM-1 
therefore Friedman's analysis was not carried out. The 
lack of significant day effect may reflect the low numbers 
of subjects with complete data sets (n=3) in the analysis. 
Subject did have a significant affect on OE/CT ELAM-1 
vessel staining (p=0.037) in that subject B tended to have 
higher staining intensity over the sampling period (Table 
3.3).
Since JE/CT and OE/CT blood vessel staining differed within 
the same biopsies, the Spearman's rank correlation 
coefficient was used to measure the relationship between 
intensity of blood vessel staining in the two areas. ICAM- 
1 JE/CT and OE/CT staining (Spearman's rank correlation
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Figure 3.5 D ay 7 b i o p s y  s h o w in g  a n  IC A M -1  g r a d i e n t ,  w i t h  
m a x im a l  s t a i n i n g  a t  t h e  j u n c t i o n a l  e p i t h e l i u m / t o o t h  
i n t e r f a c e  ( s o l i d  a r r o w s ) ,  w i t h  w e a k e r  s t a i n i n g  i n  t h e  b a s a l  
l a y e r s  o f  t h e  j u n c t i o n a l  e p i t h e l i u m  ( o p e n  a r r o w s )  
( I m m u n o p e r o x i d a s e ,  m a g . x 3 1 2 . 5 ) .
coefficient and Regression analysis; r=0.568, p=0.013) 
correlated just as well as ELAM-1 JE/CT and OE/CT (r=0.588, 
p=0.017) i.e. the biopsies which had high JE/CT staining 
tended to have high OE/CT staining (but lower than JE/CT) 
and vice-versa.
3.1.1.4 Neutrophils
PMN numbers over the 21 day period did not change 
significantly in the four areas of the gingival biopsy 
examined (JE/SE, OE, JE/CT and OE/CT) (MANOVA, SPSS) (Figs. 
3.6 & 3.7). However as inflammation developed, there were 
significantly more PMNs present in the JE/CT than the OE/CT 
(p<0.05 in each case) (Mann-Whitney, Minitab). PMNs were 
not observed in the OE but were present at all time points 
in the JE. Furthermore, within the JE/SE PMNs were found 
to be more concentrated towards the gingival crevice (Fig. 
3.8) except at day 7 when no PMNs were detected within the 
JE/SE.
PMNs when graded within specified gingival areas (section 
2.7.6.4), and when compared with the intensity of ELAM-1 
staining demonstrated weak associations between PMN grading 
and the grading of ELAM-1 staining within JE/CT and OE/CT 
(r=0.034 and r=0.280 respectively, Spearman's rank 
correlation coefficient).
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Figure 3.8 PMNs l o c a t e d  a t  t h e  j u n c t i o n a l  e p i t h e l i u m / t o o t h  
i n t e r f a c e  o f  a D ay  0 b i o p s y  ( s o l i d  a r r o w s )
( I m m u n o p e r o x i d a s e ,  m a g . x 3 1 2 . 5 ) .
3.1.1.5 T cells
Within clinically 'healthy' tissue, cells which stained 
positive for the pan T cell marker CD3 were noted in 
abundance and with developing inflammation cells were noted 
in all areas (JE/SE, OE, JE/CT and OE/CT) and at all time 
points. CD3+ cells appeared to be preferentially located 
within JE/CT when compared with OE/CT (Fig. 3.9) and within 
JE/SE when compared with OE (Fig. 3.10), with CD3+ cells 
only significantly elevated after 14 days of plaque 
accumulation (p=0.0122) (Mann-Whitney Test, Minitab). 
Interestingly, when cells were noted within the OE/CT they 
appeared to cluster around the OE rete pegs (Fig. 3.11) and 
this feature was seen in all biopsies at all time points. 
Positive cells were also located within the epithelium. 
These intraepithelial lymphocytes (IEL) were basally 
located in clinically 'healthy' tissue (within the first 
cell layer just above the basement membrane) and with the 
development of inflammation the IELs shifted and were now 
seen within the basal, stratum spinosum and stratum 
granulosum layers of the OE (Fig. 3.12a). JE/SE contained 
numerous CD3+ IELs (Fig. 3.12b).
T cell infiltrate was expressed as positive cells per mm2. 
CD3+ cells were present in all tissue compartments at all 
time points, with CD3+ cells only being elevated 
significantly within OE over time (p=0.024, n=4 subjects 
with full data sets B, C, D and E, MANOVA, SPSS) and on 
further analysis (paired t-test, SPSS), CD3+ cells were
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Figure 3.11 D ay 14 b i o p s y  s h o w in g  T - c e l l s  (C D 3 +) c l u s t e r e d  
a r o u n d  t h e  o r a l  e p i t h e l i u m  r e t e  p e g  t i p  ( s o l i d  a r r o w s )  
( I m m u n o p e r o x id a s e ,  m ag . x 5 0 0 ) .
Figure 3.12 (a) CD3+ T - c e l l s  l o c a t e d  w i t h i n  t h e  b a s a l
l a y e r ,  s t r a t u m  s p in o s u m  a n d  s t r a t u m  g r a n u l o s u m  l a y e r  o f  t h e  
o r a l  e p i t h e l i u m  ( s o l i d  a r r o w s ) ;  (b) I n t r a e p i t h e l i a l  
l y m p h o c y t e s  (C D 3 + T - c e l l s )  s e e n  w i t h i n  t h e  j u n c t i o n a l  
e p i t h e l i u m  ( I m m u n o p e r o x i d a s e ,  m a g . x 5 0 0 ) .
increased between day 0 and day 7 and decreased between day 
7 and day 21 (p=0.041 and p=0.044, respectively). Subject 
also had a significant effect on CD3+ cell accumulation 
(p<0.02) (MANOVA, SPSS).
With the exception of the OE where a few T cells but no 
PMNs were present, there was no significant difference in 
the numbers of T cells compared to the numbers of PMNs in 
the different tissue compartments at day 0. However, by 
day 7 as inflammation developed, there were significantly 
more T cells than PMNs present in each of the tissue 
compartments (p<0.05 in each case) (Mann-Whitney, Minitab) 
although by day 14 and day 21 these differences were still 
only significant in the OE and OE/CT (Table 3.6).
3.1.1.6 T cell subsets - T helper cells
Generally it was found that CD4+ cells were located in all 
four areas (JE/SE, OE, JE/CT and OE/CT) (Figs. 3.13 & 
3.14), with the numbers of cells in JE/CT higher than the 
numbers of cells within OE/CT (individual subject basis). 
These differences were only significantly elevated after 7 
days of plaque accumulation i.e. when no CD4+ cells were 
seen within OE/CT (p<0.001, Mann-Whitney, SPSS).
CD4+ cells within the connective tissue were seen around 
the OE rete pegs and some positive cells were also 
clustered around the tips of the rete pegs (similar to CD3+ 
cells). IELs were present in some of the biopsies located
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Table 3.6 PMN:T ratios during 21-days of experimentally 
induced gingival inflammation.
Ratios T cells and PMNs compared in
Day p value JE/CT OE/CT JE/SE OE
0 PMN:T * 1:0.7 1:4 1:1 0:28
p value NS NS NS <0.001
7 PMN:T 1:7 1:37 1:15 0:193
p value <0.05 <0.005 <0.05 <0.001
14 PMN:T 1:3 0:285 ND 0:108
p value NS <0.001 <0.001
21 PMN:T 1:2 1:15 1:1 0:59
p value NS <0.05 NS <0.001
ND: Not Done; NS: Not Significant
* ratios calculated using the average number of PMNs and T-cells
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within the basal, stratum spinosum and stratum granulosum 
layers of the OE. Overall JE/CT contained more CD4+ cells 
than the OE/CT, OE/CT had more than JE/SE and JE/SE had 
more than OE on an individual subject basis.
MANOVA was not performed on the CD4 data as only two full 
data sets were available.
3.1.1.7 T cell subsets - T cytotoxic/suppressor cells
All 4 tissue areas (JE/SE, OE, JE/CT and OE/CT) of the 
gingival biopsies examined contained CD8+ cells (Figs. 3.15 
& 3.16), although differences in cell numbers were not 
statistically significant with time when analysed by MANOVA 
(SPSS, n=3 subjects B, C, D).
Cells appeared to be located in higher numbers in JE/CT 
than OE/CT (on an individual subject basis), although 
differences were not statistically significant (Mann- 
Whitney, Minitab). IELs were also present and seen in all 
biopsies, unlike CD4+ cells. The CD8+ IELs were located in 
basal and stratum spinosum layers of the OE but as 
inflammation developed (day 7), IELs were noted within the 
stratum granulosum layer, and by day 14 and day 21 the 
cells were located again at the basal layer. Positive 
cells were also detected within connective tissue areas 
with some cells tending to cluster around the tip of the OE 
rete pegs as seen with the CD3+ and CD4+ cells.
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The number of T helper to T cytotoxic/suppressor cells 
within JE/CT and OE/CT at different time points were 
compared and it was found that the T4:T8 ratio did not vary 
significantly, except at day 7, when within OE/CT there 
were no detectable CD4+ cells.
3.1.1.8 T cell subsets - T memory cells
Cells positive for the memory marker (UCHL-1+) were found 
within all biopsies at all time points (Figs. 3.17 & 3.18). 
Changes in memory T cell number were not significant when 
analysed over time or by subject (MANOVA, SPSS).
Generally UCHL-1+ cells were seen more within JE/CT than 
OE/CT, although differences were only significant at day 7, 
where T memory cells in JE/CT were higher in number 
(p=0.0048) (Mann-Whitney, Minitab). IELs when present
within OE, were located within the basal and stratum 
spinosum layer and only one day 7 biopsy had IEL within the 
stratum granulosum layer. Positive cells within connective 
tissue were seen around the OE rete peg tips (Fig. 3.19). 
Overall positive cells were located within JE/CT with lower 
numbers of T memory cells within OE/CT, JE/SE and OE.
3.1.1.9 Langerhans cells
At day 0 in healthy gingiva, CDla+ LCs were seen within the 
oral and sulcular epithelia. Generally they were dendritic 
and were found within the stratum spinosum of the gingival 
OE, with only a few cells present within the sulcular
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Figure 3.19 (a) D ay 0 (b) D ay  14 b i o p s y  s h o w in g  m em o ry  T- 
c e l l s  ( U C H L -1 + ) c l u s t e r e d  a r o u n d  t h e  o r a l  e p i t h e l i u m  r e t e  
p e g  t i p s  ( s o l i d  a r r o w s )  ( I m m u n o p e r o x i d a s e , m a g .  x 4 0 0 ) .
epithelium. Junctional epithelium was often incomplete and 
variable and the term sulcular epithelium was used to 
include both junctional and oral sulcular epithelium. As 
plaque accumulated there was a shift of LCs from the 
stratum spinosum to the stratum granulosum (day 0 to day 7) 
and by day 14 the CDla+ LCs were more basally positioned 
(Fig. 3.20). HLA-DR+ dendritic cells were found within the 
gingival OE and were morphologically identical to the CDla+ 
LCs (Fig. 3.21), strongly suggesting that the two 
monoclonal antibodies detected the same cell type within 
the gingival OE. HLA-DR antigens were detected on 50-85% 
of CD1+ LCs (calculated from serial sections). 
Keratinocytes only faintly stained for HLA-DR and combined 
with their morphological appearance permitted clear 
distinction from LCs to be made.
As the clinical indices increased, the density of CDla+ LCs 
within the gingival OE increased slightly during the first 
seven days of oral hygiene abstention. Following this 
initial increase, CDla+ LC numbers decreased with further 
plaque accumulation and development of gingival 
inflammation (day 7 to day 14). However, as inflammation 
developed, the numbers of CDla+ LCs detected within the 
gingival OE decreased back to baseline levels by day 21. 
The number of HLA-DR+ LCs however increased and plateaued 
between day 7 and day 14, then decreased to baseline levels 
by day 21 (Fig. 3.22).
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MANOVA (SPSS) demonstrated significant changes in the 
numbers of CDla+ LCs with time (p=0.005) and further 
analysis (paired t-tests, SPSS) demonstrated that the 
decrease in CDla+ LCs which occurred between day 7 and 21 
and between day 14 and 21 were statistically significant 
(p=0.003 and p=0.028 respectively). However, no
statistically significance was demonstrated when MANOVA was 
used to analyses HLA-DR+ LCs changes. Subject had a
significant effect on the levels of expression of HLA-DR
and CDla (p=0.008 and p=0.001 respectively). These p 
levels are still statistically significant despite 
correction for the multiple comparisons (n=6) which reduces 
the statistically significant threshold to 0.02.
3.1.1.10 Interleukin-1
GCF was collected mid-buccally from the first permanent 
molars (section 2.5.1), prior to biopsing the sites. Four 
GCF strips were collected from each subject (one at each 
time point, n=24 strips). IL-1 levels and GCF volume 
variations for the six subjects are shown in Figures 3.23 
and 3.24 respectively. As plaque accumulated (day 0 to day 
21) there was an overall increase in GCF volume which was 
not statistically significant when analysed by MANOVA
(SPSS),| although subject had a significant effect (p=0.003) 
(MANOVA, SPSS).
The IL-1 concentration (ng/jxl) increased with plaque 
accumulation and in advance of subsequent gingival
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inf lamination. The average IL-1 level for the 21 day 
experimental gingivitis group began to drop well before 
normal oral hygiene was reinstituted and returned to 
baseline levels ahead of the inflammation index (MGI) 
though not statistically significant (MANOVA, SPSS) (Fig. 
3.25).
Pearson's correlation coefficient and regression analysis 
was performed on the mean IL-1 levels, mid-PI and mid-MGI 
for each subject summed over the four sampling intervals 
(Table 3.7). Mid-PI and IL-1 levels were both positively 
correlated with the mid-MGI, although the relationship 
between mid-PI and IL-1 was less strong. There was 
intersubject variation in the quantity of crevicular IL-1 
(p=0.046, n=6 subjects) (MANOVA, SPSS). Two of the
subjects developed a rise in crevicular IL-1 activity which 
peaked within 7 days of withdrawing oral hygiene, 3 
demonstrated minimal crevicular IL-1 activity and the 
remaining subjects crevicular IL-1 activity peaked at day 
14 (Fig. 3.23).
3.1.2 Ten-day experimental gingivitis study
Five individuals (G-K) participated and completed this 
study (section 2.2.1). Clinical indices, GCW samples and 
gingival biopsies were collected and processed as 
previously mentioned.
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Figure 3.25 Shows the change in the interleukin-1 (IL-1) 
concentration mean for the individual subject means (n=6), 
during the 21-day experimental gingivitis study.
Table 3.7 Regression analysis of clinical indices and 
crevicular IL-1 (ng/jxl). Pearson's correlation coefficient 
(r) and probability values (p) are shown. Samples 
collected from mid-buccal aspect of biopsy sites.
Parameters r P
PI vs IL-1 (ng/p.1) 0.667 NS
PI vs MGI 0.765 0.077
MGI vs IL-1 (ng/ixl) 0.860 0.028
MGI: Modified Gingival Index; MS: Mot Significant; 
PI: Plague Index
3.1.2.1 Clinical indices
Clinical indices were collected every 3 days of the 10 day 
experimental phase. PI (Silness & Loe, 1964) and MGI 
(Lobene et al., 1986) were scored for the mesial and mid- 
buccal aspect of the first permanent molars prior to GCW 
collection and subsequent biopsing.
In clinically 'healthy' gingiva (day 0) all subjects had 
minimal plaque (PI=0) and no clinically visible gingival 
inflammation (MGI=0) mid-buccally (Fig. 3.26) or mesially 
(Fig. 3.27).
At the mid-buccal aspect plaque accumulated at different 
rates within the different individuals, i.e. Subject I had 
no plaque at all whereas subject G showed continuous 
accumulation, though when analysed with Friedman's test 
(section 2.7.7.2) these subject and time effects were not 
significant (Friedman's test, Minitab). Gingival
inflammation within the individual also developed at 
different rates, 3 subjects had MGI scores of 0 at day 7, 
one subject developed visible inflammation by day 3 and the 
remaining subject developed visible gingival inflamination 
after 7 days of oral hygiene abstention.
Mesially the clinical indices increased with time with the 
mesial-PI rise preceding the rise in mesial-MGI (Fig. 
3.27). There was large subject variation though this did 
not reach statistical significance (Friedman's test,
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Minitab). The mesial aspect when analysed for the effect 
of day on the indices both mesial-PI and mesial-MGI 
increased significantly the longer oral hygiene was 
abandoned (p=0.027 and p=0.016 respectively, Friedman's 
Test, Minitab).
Associations between clinical indices and days oral hygiene 
abstention were analysed using the non-parametric 
Spearman's rank correlation coefficient and bi-variate 
regression analysis. Mid-PI, mid-MGI and mesial-MGI 
demonstrated positive correlations with time (Table 3.8).
3.1.2.2 Haematoxylin and eosin sections
Clinically 'healthy' gingival tissue exhibited a wide 
variation in the extent of cellular infiltration. Some 
subjects exhibited more cellular infiltrate than others 
(subject G compared with subject H). During the 
development of inflammation (day 3 to day 10) changes in 
the size of cellular infiltration were seen but were not 
consistent (Table 3.9). No correlation between the size of 
cellular infiltration and days of plaque accumulation or 
mid-MGI was seen even though a strong correlation existed 
with mid-PI (r=0.525, p=0.017) (Spearman's rank correlation 
coefficient and regression analysis, Minitab) (Table 3.10).
Histologically the clinically 'healthy' gingival tissue 
(day 0) was well structured, but as inflammation developed 
their was a slight loss of tissue integrity; rete peg
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Table 3.8 Regression analysis of clinical indices obtained 
during the 10-day experimental gingivitis study. Spearman 
rank correlation coefficient (r) and probability values (p) 
are shown.
Parameters r P
Mid-PI vs Day 0.465 0.039
Mid-MGI vs Day 0.606 0.005
Mid-PI vs Mid-MGI 0.517 0.020
Mesial-PI vs Day 0.331 NS
Mesial-MGI vs Day 0.686 0.001
Mesial-PI vs Mesial MGI 0.430 NS
Mesial-MGI: Modified Gingival Index (mesial aspect); 
Mesial-PI: Plague Index (mesial aspect);
Mid-MGI: Modified Gingival Index (mid-buccal aspect); 
Mid-PI: Plague Index (mid-buccal aspect);
NS: Mot Significant
Table 3.9 Size of cellular infiltration for each subject at 
each time point during the 10-day experimental gingivitis 
study.
Size of cellular infiltrate
ib j ect
Day 0 Day 3 Day 7 Day 10
G + + ++ +++
H +++ +++ + +
I + ++ + +
J ++ + + ++
K + ++ + ++
Table 3.10 Regression analysis of clinical indices and 
cellular infiltrate size during the 10-day experimental 
gingivitis study. Spearman's rank correlation coefficient 
(r) and probability values (p) are shown. Biopsies were 
taken from the mid-buccal aspect of the first molars.
Parameters r P
Day vs Infiltrate size -0.001 NS
PI vs Infiltrate size 0.525 0.017
MGI vs Infiltrate size 0.142 NS
MGI: Modified Gingival Index; MS: Mot Significant; 
PI: Plague Index
proliferation and increased vascularisation as noted by the 
appearance of capillaries within the JE/SE and JE areas.
3.1.2.3 Gingival crevicular PMNs
Prior to biopysing, gingival crevicular washings (GCWs) 
were collected from the mesial aspect of the first 
permanent molars and processed (section 2.6.2). In total 
20 GCW were collected from subjects G-K. The percentage of 
PMNs found within the GCW and the calculated numbers of 
PMNs/p,l (Figs. 3.28 & 3.29 respectively) were analysed 
using the Friedman's test (Minitab). The Friedman's test 
demonstrated no day or subject effect on the percentage of 
PMNs obtained or on the calculated numbers of PMNs/jil GCW, 
although a positive correlation existed between the mesial 
PI and percentage PMNs (Table 3.11).
3.1.2.4 ELAM-1, ICAM-1 and VCAM-1 expression
The 10 day study tissue was examined for expression of the 
same two adhesion molecules as the 21 day study (ELAM-1 and 
ICAM-1), as well as for VCAM-1. All three adhesion 
molecules demonstrated blood vessel staining within 
clinically 'healthy' tissue (day 0, subjects G-K) and in 
experimentally inflamed tissue (day 3 - 10) (Tables 3.12 -
3.14).
Staining was seen within JE/CT and OE/CT with ELAM-1 
demonstrating a 20% decrease in the number of biopsies with 
stronger staining vessels at JE/CT when compared with OE/CT
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Table 3.11 Regression analysis of clinical indices, 
percentage PMNs and PMNs/pi gingival crevicular washing 
during the 10-day experimental gingivitis study. 
Spearman's rank correlation coefficient (r) and probability 
values (p) are shown. The mesial aspect of the first 
molars were sampled.
Parameters r P
PI vs Percentage PMNs 0.536 0.015
PI vs PMN/pl(log10) -0.196 NS
MGI vs Percentage PMNs 0.220 NS
MGI vs PMN/pl(log10) -0.036 NS
MGI: Modified Gingival Index; NS: Not Significant; 
PI: Plague Index
Table 3.12 ELAM-1 staining intensity for the five subjects
during the 10-day experimental gingivitis study.
Day Subject Intensity of 
JE/CT
ELAM-1 staining 
OE/CT
0 6 ++ ++
H ++/+++ ++/+++
I ++/+++ ++/+++
J ++ +
K +++ ++
median ++/+++ ++
3 G +/++ +/++
H -/+ -/+
I + +
J + +
K -/+ -/+
median + +
7 G ++ +
H ++ +
I ++ +
J + +
K ++ ++
median ++ +
10 G + +
H ++ ++
I ++ ++
J ++ +
K ++/+++ ++/+++
median ++ ++
Table 3.13 ICAM-1 staining intensity for the five subjects
during the 10-day experimental gingivitis study.
Day Subject Intensity of ICAM-1 staining
JE/CT OE/CT JE OSE OE
0 6 +++ +++ * -/+ -
H +++ +++ * ★ -
I +++ ++ * * -
J ++++ ++++ * + -
K ++++ +++ ++/+++ ★ -
median +++ +++ ++/+++ -/+ -
3 G ++++ ++++ ++/+++ -/+ —
H ++++ ++++ ++++ -/+ -
I ++ +++ ++/+++ -/+ -
J +++ +++ * - -
K +++ +++ +++ -/+ -
median +++ +++ +++ -/+ -
7 G ++ +++ +++ -/+ —
H +++ ++ * * -/+
I +++ +++ +++ -/+ -
J +++ +++ ++ + +
K ++++ ++++ ★ -/+ -/+
median +++ +++ +++ -/+ -/+
10 G +++ +++ * * —
H +++ ++++ ★ * -
I +++ +++ ★ -/+ -/+
J ++ +++ ++ - -
K +++ +++ ++++ -/+ -
median +++ +++ +++ -/+ -
* missing value
Table 3.14 VCAM-1 staining intensity for the five subjects
during the 10-day experimental gingivitis study.
Day Subject Intensity of VCAM-1 staining 
JE/CT OE/CT
0 G + +
H * *
. I + +
J + +
K + +
median + +
3 G + +
H -/+ -/+
I + +
J + +
K + +
median + +
7 G + +
H + +
I + +
J + +
K + +
median + +
10 G + +
H * *
I + +
J -/+ -/+
K + +
median + +
* missing value
within the same biopsy, ICAM-1 a 40% decrease and VCAM-1 
exhibiting no difference in JE/CT when compared with OE/CT 
staining (day 10 compared with day 0) (Table 3.14).
ELAM-1 and ICAM-1 positive vessels were located in the same 
areas as previously described for the 21 day study (section 
3.1.1.3), with VCAM-1 staining seen only within the 
connective tissue areas (JE/CT and OE/CT). VCAM-1 staining 
within JE/CT and OE/CT exhibited equivalent staining 
intensity in both areas (Fig. 3.30).
Full data sets were available for all 5 subjects (G-K) and 
the Friedman's test was carried out on ELAM-1 and ICAM-1 
staining intensity within JE/CT and OE/CT (as VCAM-1 
staining did not differ when JE/CT was compared with 
OE/CT). Only JE/CT staining of ELAM-1 demonstrated a 
significant day effect (p=0.015) and on further analysis 
(sign test, Minitab statistical package) the difference in 
staining intensity appeared after 3 days of plaque 
accumulation; for all 5 subject ELAM-1 staining within 
JE/CT decreased with time. No subject effect was evident 
for any of the adhesion molecules.
Spearman's rank correlation coefficient for association 
between JE/CT and OE/CT staining demonstrated that ELAM-1 
staining (r=0.799, p<0.0001) correlated better than ICAM-1 
staining (r=0.562, p=0.01).
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Figure 3.30 Weakly staining VCAM-1+ vessels within 
connective tissue (solid arrows) (Immunoperoxidase, 
x500) .
The percentage of positive vessels found within the 
connective tissue compartment was calculated for all 3 
adhesion molecules (Figs. 3.31-3.33). Statistical analysis 
was carried out using repeated measures analysis of 
variance (MANOVA, SPSS). For all 3 adhesion molecules day 
had no statistically significant effect, whereas subject 
had a significant effect (p<0.05) (MANOVA, SPSS) on the 
percentage of positive vessels.
3.1.2.5 LFA-1+ leucocytes
CDlla+ (LFA-1+) cells were present within gingival tissue 
throughout the 10-days of gingival inflammation. Cells 
were preferentially located within the JE/CT compared with 
OE/CT at day 0, 3, 10 (p<0.05 in all cases) (Mann-Whitney, 
Minitab) (Fig. 3.34). The number of positive cells within 
JE/CT area and OE/CT area, when analysed by MANOVA (SPSS), 
demonstrated no significant change in numbers with days of 
oral hygiene abstention or subject variation.
CDlla+ cells were also seen within epithelium, these IEL 
were located basally at day 0 (Fig. 3.35a), only 3 out of 
the 5 biopsies on day 3 had basally located IELs, 2 out of 
the 5 day 7 biopsies had IELs basally, 1 out of 5 had IELs 
within the basal and stratum spinosum (Fig. 3.35b) and the 
remaining 2 biopsies had no demonstratable IELs. By day 10 
very few cells were seen within the OE. CDlla+ cells were 
also seen located around the rete pegs with some cells also 
clustering around OE rete peg tips (Fig. 3.36).
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F i g u r e  3 . 3 6  Day 3 biopsy showing LFA-1 (CDlla+) cells 
clustered around the oral epithelium rete peg tip (solid 
arrows) (Immunoperoxidase, mag. x500).
When CDlla+ cell numbers were converted to grading scores, 
no relationship was demonstrated with ICAM-1 grading within 
the same areas (JE/CT and OE/CT) (r=-0.053 and r=-0.194 
respectively, Spearman's rank correlation coefficient, 
Minitab)•
3.1.2.6 Neutrophils
PMNs were graded within the 4 areas of the gingival 
biopsies studied (JE/CT, OE/CT, JE/SE and OE) (section 
2.7•6.4). PMNs appeared to be located in greater number 
within JE/CT than OE/CT and within JE/SE than OE (Table
3.15). Only two of the clinically 'healthy' biopsies 
contained detectable cells within the OE, most PMNs were 
present at the interface between JE/SE and tooth and within 
JE/CT (Fig. 3.37a). Some PMNs were also noted at the base 
of the biopsy (Fig. 3.37b). Friedman's test (Minitab) 
demonstrated no statistically significant difference in 
changes in cellular infiltration over days or between 
subjects•
Comparison of intensity of ELAM-1 staining and PMN grading 
demonstrated that within JE/CT their was a positive 
correlation (r=0.406; Spearman's rank correlation 
coefficients), although not statistically significant with 
time (p=0.076).
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Table 3.15 PMN grading for each subject within each area
during the 10-day experimental gingivitis study.
Day Subject PMN graded within whole area 
JE/SE SE/CT OE/CT OE
0 G + ++ - -
H + +++ + +
I + ++ - -
J + +++ + +
K + +++ + -
median + +++ + -
3 G ++ +++ — —
H + + + -
I + ++ ++ -
J + ++ + -
K ++ ++ + -
median + ++ + -
7 G ++ +++ + —
H * ++ - -
I ++ ++ + -
J + + + -
K ++ + - -
median ++ ++ + -
10 G + +++ — —
H + +++ - -
I + + - -
J ++ +++ + -
K + ++ - -
median + +++ - -
Figure 3.37 (a) PMNs located at the junctional epithelium 
/tooth interface of a Day 7 biopsy (solid arrows) (mag. 
xl25); (b) PMNs located at the base of a Day 7 biopsy
(solid arrows) (Immunoperoxidase, mag. x312.5).
3.1.2.7 T cells
CD3+ T cells were located within all 4 area (JE/CT, OE/CT, 
JE/SE and OE). Cells within JE/CT outnumbered cells within 
OE/CT at day 0, 7 and 10 (p<0.05 in all cases) (Mann-
Whitney, Minitab) (Fig. 3.38). MANOVA analysis (SPSS) 
showed no significant day effect on cell accumulation, 
although subject had effect in both areas (JE/CT and OE/CT) 
(p=0.000 and p=0.031 respectively).
Positive cells histologically were seen located around OE 
rete pegs and clustered around OE rete peg tips (seen in 
all biopsies). IEL at day 0 were located within the basal 
and stratum spinosum layers, by day 3 IEL were only located 
within the basal layers and by day 7 and 10 a spread of 
positive cells to the stratum spinosum and stratum 
granulosum was seen (Fig. 3.39).
CD3+ IELs were present when no CDlla+ IELs were seen within 
biopsy sections. CDlla IELs were mostly suprabasally and 
basally located with very few cells seen within the spinous 
cell layer. CD3+ IELs were seen within all layers (basal, 
spinous and granular).
3.1.2.8 T cell subsets - T memory cells
Within clinically 'healthy' gingiva T memory cells (UCHL- 
1+) were noted in abundance within the connective tissue 
areas (JE/CT and OE/CT) (Fig. 3.40). Significantly higher 
numbers of cells were found within JE/CT than OE/CT at all
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time points (p<0.05 in all cases) (Mann-Whitney, Minitab), 
T memory IEL were found within the basal layers of one 
biopsy only, the remaining biopsies contained no IELs.
Repeated measures analysis of variance showed that day had 
no effect on T memory cell accumulation within JE/CT, but 
did have a significant effect within OE/CT (p=0.043) 
(MANOVA, SPSS). On further analysis a decrease in T memory 
cell numbers was noted between day 3 and day 7 (p=0.04) and 
between day 3 and day 10 (p=0.008). Subject had a
significant affect within both JE/CT and OE/CT (p=0.016 and 
p=0.008). Since multiple comparisons were used a 
Bonferroni correction of the significance level has to be 
employed which means the standard 5% level of significance 
is reduced to a p<0.01 threshold for declaring differences 
are statistically significant (section 2 .7.7.1).
3.1.2.9 T cell subsets - T naive/virgin cells
Positive cells (2H4+) were seen throughout the 10-days of 
oral hygiene abstention. Cells were located within JE/CT, 
OE/CT and JE/SE, no cells were seen within OE i.e. no IELs. 
Cell numbers in JE/CT, when compared with OE/CT (Fig. 
3.41), demonstrated statistically significantly elevated 
numbers only at day 3 (p<0.05, Mann-Whitney, Minitab),
though there is a trend for JE/CT naive cell numbers to be 
elevated over OE/CT numbers in all biopsies.
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MANOVA analysis demonstrated that day has a significant 
affect on naive cell accumulation within the JE/CT 
(p=0.019) and on further analysis it was shown that a 
decrease in cell number was seen between day 0 and day 7 
(p=0.041) and between day 3 and day 7 (p=0.000) (3 full
data sets, subjects H, J and K). Since multiple 
comparisons were used a Bonferroni correction has to be 
employed, p<0.01 (section 2.7.7.1). Subject had a 
significant effect within JE/CT (p=0.008) and within OE/CT
(p=0.016).
Comparisons of T naive/virgin and T memory cells (Tn/v:Tmem 
ratio) within JE/CT and OE/CT over the four time points 
were reasonably consistent over time except T memory cells 
were significantly elevated over T naive/virgin at day 3 
within the OE/CT area (p=0.0112) (Mann-Whitney, Minitab), 
i.e. when very few T naive/virgin cells were present.
3.1.2.10 Langerhans cells
CDla+ LCs were seen within OE and SE of clinically 
'healthy' and experimentally inflamed tissue (Fig. 3.42a). 
Within clinically 'healthy' tissue LCs were dendritic in 
appearance and located within basal, stratum spinosum and 
stratum granulosum layers of the OE (Fig. 3.42a). As 
inf lamination developed a slight shift in cells towards the 
stratum granulosum layer was seen and by day 7 cells were 
still seen within basal and stratum spinosum layers but 
were more concentrated within the stratum granulosum and
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F i g u r e  3 . 4 2  ( a )  Day 0 biopsy: Highly dendritic Langerhans 
cells within the oral epithelium (OE) (solid arrows); ( b )  
Day 7 biopsy: Dendritic Langerhans cells with OE (solid 
arrows) and ( c )  Less dendritic Langerhans cells (solid 
arrows) (Immunoperoxidase, mag. x312.5).
more dendritic in appearance compared with CDla+ LCs in day 
0 and day 3 tissue (Fig. 3.42b). By day 10 there was a 
large shift in cell location from the stratum granulosum to 
basal and stratum spinosum layers and LCs appeared less 
dendritic (Fig. 3.42c). In a few biopsies when JE was 
present CDla+ cells were noted (Fig. 3.43).
HLA-DR identified cells with the same dendritic morphology 
as CDla+ cells and were identified in serial sections.
Day had no effect on CDla+ or HLA-DR+ LCs within the OE. 
Subject had a significant effect on CDla+ or HLA-DR+ LCs 
(p<0.001 and p=0.005 respectively) (MANOVA, SPSS) (Fig. 
3.44) .
3.2 Organ culture
3.2.1 ELAM-1 - percentage of positive vessels
The percentage of ELAM-1+ vessels are presented as 
previously discussed in (section 2.7.6.7). Briefly, 
control results are expressed as percentage of positive 
vessels and cytokine-enriched media results as percentage 
net change after correction for background.
3.2.1.1 No addition
Changes in the percentage of ELAM-1 positive vessels with 
time can be seen in Figure 3.45a. The percentage of ELAM- 
1+ vessels changed very little with incubation time, 
although a slight peak occurred at 48 hours.
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F i g u r e  3 . 4 3  A day 10 biopsy with a CDla+ Langerhans cell 
within the junctional epithelium (solid arrow) 
(Immunoperoxidase, mag. x500).
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3.2.1.2 Interleukin-lfi
IL-1B at 24 hours increased the percentage of positive 
vessels and at 48 hours percentage positivity had decreased 
in both blocks 1 and 3 (Fig. 3.45b).
3.2.1.3 Tumour necrosis factor-a
TNFa increased the percentage of ELAM-1+ vessels seen after 
24 hours incubation but by 48 hours the percentage had 
decreased within both blocks 1 and 3 (Fig. 3.45c)
3.2.1.4 Lipopolysaccharide
LPS had different effects in both blocks, at 24 and 48 
hours, percentages of ELAM-1+ vessels increased in one 
block 3 and decreased in block 1 (Fig. 3.45d).
3.2.1.5 Interferon-y
IFN-y displayed similar effects as LPS. Block 2 displayed 
increased ELAM-1+ positivity at 24 and 48 hours and block 
3 decreased (Fig. 3.45e) which was opposite to the effects 
seen due to LPS (Fig. 3.45d).
3.2.2 ELAM-1 staining intensity
Staining intensity results were processed and presented as 
previously discussed (section 2.7.6 .7). Briefly, control 
results are expressed as intensity changes over time and 
cytokine-enriched media results as net change in staining 
intensity after correction for background.
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3.2.2.1 No addition
Changes in ELAM-1 staining intensity within blocks 
differed. Block 1 exhibited no change in staining 
intensity with time, whereas block 2 staining intensity 
remained stable until 24 hours and then displayed increased 
staining intensity by 48 hours and then finally block 3 
displayed minimal staining initially (24 hours) followed by 
a large increase by 48 hours (Fig. 3.46a).
3.2.2.2 Interleukin-113
IL-113 caused ELAM-1 staining intensity within block 3 to 
increase after 24 hours and then decrease after 48 hours 
whereas block 1 displayed no change in ELAM-1 staining 
intensity after 24 hours and decreased intensity after 48 
hours (Fig. 3.46b).
3.2.2.3 Tumour necrosis factor-a
TNFa displayed similar effects on blocks 1 and 3 at 24 
hours as IL-113, with one block displaying increased ELAM-1 
staining intensity and the other block exhibiting no change 
in intensity. After 48 hours incubation both blocks 
displayed no change in staining intensity when compared 
with the controls (Fig. 3.46c).
3.2.2.4 Lipopolysaccharide
After 24 hours incubation with LPS both blocks (1 and 3) 
demonstrated increased ELAM-1 staining intensity but after 
48 hours block 3 continued to exhibit increased staining
153
(a)
 
Co
nt
ro
l
° T «» •?
-P >1 •*» 
C -P —  ■H ’H CD. 
0 CO
a c 
0
-P
o cid *p
i —PI >- M fP ^3
0
i•H
■P
co•H
■Pid
XI3Oc•H
CD.'
rH
Ic
•P
a
0
>-
ic
o
p
0HH
P
0
■P
c
•H
0
r0 *"0 S 0 S c
•das '0
■P O  V* Qj 
•H 
(0 
C
Jai«d 
•p -p ® p
a) >i 
c<c ® 
o a>4->
S-9
c c
8
3
■
<d
cn-t-> 
C *H 
•H to 
C 15 
•H Q) <0 +J 
-P C00 "rH
intensity and block 1 decreased in ELAM-1 staining 
intensity when compared with the controls (Fig. 3.46d).
3.2.2.5 Interferon-y
IFN-y at 24 hours exhibited similar effects on ELAM-1 
staining intensity after 24 hours and 48 hours within both 
blocks (Fig. 3.46e). But the block that displayed 
increased staining intensity after 48 hours with LPS 
demonstrated decreased staining intensity with IFN-y (block 
3 ) .
3.2.3 ICAM-1 - percentage of positive vessels
Percentage of ICAM-1 positive vessels from the organ 
culture studies are presented using the method discussed 
previously (section 2 .7.6 .7).
3.2.3.1 No addition
The changes in the percentage of ICAM-1+ vessels with 
incubation time can be seen in Figure 3.47a. Over time, 
vessel staining remained fairly constant, with a slight 
increase by 48 hours.
3.2.3.2 Interleukin-lfi
Both blocks exhibited increased percentage of ICAM-1+ 
vessels after 24 hours but after 48 hours block 1 continued 
to increase with block 3 decreasing in its percentage of 
ICAM-1+ vessels (Fig. 3.47b).
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3.2.3.3 Tumour necrosis factor-a
After 24 hours in culture, block 1 increased and block 3 
decreased in the percentage of ICAM-1+ vessels seen. By 48 
hours both blocks had decreased percentages when compared 
with controls (Fig. 3.47c).
3.2.3.4 Lipopolysaccharide
LPS caused opposite effects in the two blocks, after 24 
hours block 1 increased whereas block 3 decreased and by 48 
hours the opposite occurred. With the block that 
previously exhibited an increase now decreasing and vice- 
versa (Fig. 3.47d).
3.2.3.5 Interferon-y
Decreases in the percentage of ICAM-1+ positive vessels at 
24 and 48 hours was seen within block 3 whereas block 2 
demonstrated a decrease at 24 hours and an increase at 48 
hours (Fig. 3.47e).
3.2.4 ICAM-1 staining intensity
Results expressed as discussed previously (section 
2 .7.6 .7).
3.2.4.1 No addition
Blocks 1 and 3 displayed moderate ICAM-1 staining intensity 
with block 2 displaying strong staining at 0 hours. By 24 
and 48 hours all blocks displayed strong ICAM-1 staining 
(Fig. 3.48a).
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3.2.4.2 Interleukin-lfi
At 24 hours, ICAM-1 staining intensity did not change 
within the blocks when compared with the controls, but by 
48 hours both (blocks 1 and 3) exhibited decreased staining 
intensity (Fig. 3.48b).
3.2.4.3 Tumour necrosis factor-a
No change in staining intensity was seen after 24 hours in 
culture, by 48 hours block 1 still exhibited no change with 
block 3 increasing in ICAM-1 staining intensity (Fig. 
3.48c)•
3.2.4.4 Lipopolysaccharide
LPS induced no change in intensity after 24 hours 
incubation (Fig. 3.48d), similar changes seen with TNFa 
(Fig. 3.48c) and IL-1J3 (Fig. 3.48b). After 48 hours, block 
3 exhibited increased ICAM-1 staining intensity and block 
1 decreased in staining intensity (Fig. 3.48d).
3.2.4.5 Interferon-y
IFN-y in block 3 demonstrated no change in ICAM-1 staining 
intensity and increased staining intensity in block 2 after 
24 hours. But by 48 hours both blocks exhibited increased 
ICAM-1 staining intensity (Fig. 3.48e). Interestingly IFN- 
y was the only cytokine which caused OE KC to express ICAM- 
1, which also demonstrated a gradient of staining from the 
connective tissue towards the outer aspect, as seen in 
Figure 3.49.
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F i g u r e  3 . 4 9  ICAM-1 staining gradient effect seen a t  t h e  
base of the oral epithelium rete pegs (solid a r r o w s )  c a u s e d  
by interferon-y (direction of cytokine source i n d i c a t e d  by  
solid triangles) (Immunoperoxidase, mag. 125).
3.3 Adhesion molecule expression in diseased tissue
Adhesion molecules, ELAM-1 and ICAM-1 were evaluated in 
diseased tissue, the percentage of positive vessels as well 
as the intensity of staining was appraised.
3.3.1 Adult Periodontitis
3.3.1.1 ELAM-1 expression
ELAM-1 expression in the adult periodontitis tissue was 
concentrated within the blood vessels. Positive staining 
blood vessels were preferentially located subjacent to the 
epithelium (Fig. 3.50) and within the cellular infiltrate 
when present. In two cases ELAM-1 staining of 
keratinocytes was also seen. Staining intensity of the 
vessels varied (Table 3.16) with vessels within each 
section exhibiting the same intensity of staining.
The percentage of positive vessels per biopsy were also 
calculated and were shown to range from 18.7 to 44.1% 
(Table 3.17) .
3.3.1.2 ICAM-1 expression
ICAM-1 demonstrated staining of vessels within areas of 
high cellular infiltration (Fig. 3.51). Epithelium also 
exhibited keratinocyte staining within the outer 2-3 cell 
layers, when deeper staining was seen ie 6-7 cell layers 
thick, an ICAM-1 gradient was noted (Fig. 3.52). One 
biopsy had no demonstratable ICAM-1 epithelium staining. 
Variable quantities of JE were available on each biopsy due
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F i g u r e  3 . 5 0  Adult periodontitis tissue: ELAM-1+ vessel seen 
subjacent to the epithelium (solid arrow)
(Immunoperoxidase, mag. x312.5).
Table 3.16 ELAM-1 and ICAM-1 staining intensity in diseased 
tissue obtained from subjects suffering from adult 
periodontitis (AP), rapidly progressive periodontitis (RPP) 
and juvenile periodontitis (JP).
Disease Biopsy ELAM-1
intensity
ICAM-1
intensity
AP 1 + *
AP 2 + +
AP 3 ++ +++
AP 4 ++ ++
AP 5 ++ ++
AP 6 + ++
AP 7 + ++/+++
AP 8 + +++/++++
AP 9 + +
AP 10 +/+++ ++/+++
RPP 11 + +
RPP 12 +/+++ ++
RPP 13 ++/+++ +++
RPP 14 + +/++
RPP 15 ++/+++ +++/++++
RPP 16 + +++
RPP 17 + ++/+++
JP 18 + ++
JP 19 +/++ +++
JP 20 +/++ ++/+++
* missing value
Table 3.17 Percentage of ELAM-1 and ICAM-1 positive blood 
vessels in diseased tissue obtained from subjects suffering 
from adult periodontitis (AP)r rapidly progressive 
periodontitis (RPP) and juvenile periodontitis (JP).
Disease Biopsy % ELAM-1+ %ICAM-1*
AP 1 27.3 (0.8) *
AP 2 29.7 (1.8) 51.7 (7.5)
AP 3 44.1(12.0) 56.4(15.2)
AP 4 32.5(15.3) 69.5(24.4)
AP 5 19.2 (2.6) 38.9
AP 6 19.4 (8.2) 59.3 (4.5)
AP 7 30.6 (9.6) 75.0
AP 8 18.7 (1.1) 57.4 (1.6)
AP 9 21.0 (5.8) 60.5(27.0)
AP 10 30.9 (8.2) 65.2 (8.9)
RPP 11 18.0 (2.4) 59.1(19.5)
RPP 12 23.2 (4.7) 68.7(10.3)
RPP 13 34.4 (2.9) 74.1 (4.3)
RPP 14 16.7 (7.2) 65.6 (9.4)
RPP 15 25.9 (3.6) 75.1(11.6)
RPP 16 21.3 (2.2) 82.5(12.5)
RPP 17 26.6 (4.6) 44.0 (2.8)
JP 18 36.9 (1.9) 76.6 (8.4)
JP 19 30.5 (6.0) 69.9 (5.9)
JP 20 23.2 (7.6) 71.6(16.4)
* missing value
Figure 3.51 Adult periodontitis tissue: 
within inflammatory infiltrate 
(Immunoperoxidase, mag. x500).
ICAM-1+ 
(solid
Figure 3.52 Juvenile periodontitis tissue: ICAM-1 gradient, 
with the most intense staining towards the outer aspect 
(solid arrow) (Immunoperoxidase, mag. x500).
to surgical variation. Intensity of ICAM-1 staining varied 
between biopsies but within a biopsy staining intensity of 
the blood vessels was fairly constant (Table 3.16).
The percentage of ICAM-1 positive vessels per biopsy were 
also calculated. The values ranged from 38.9 to 75.0% 
(Table 3.17) .
3.3.2 Rapidly progressive periodontitis
3.3.2.1 ELAM-1 expression
ELAM-1 positive vessels were located within areas of 
cellular infiltration, one biopsy exhibited ELAM-1 
keratinocyte staining. Intensity of staining also varied 
between biopsies but not within biopsies (Table 3.16).
The percentage of ELAM-1 positive vessels ranged from 16.7 
to 34.3% (Table 3.17).
3.3.2.2 ICAM-1 expression
Epithelium ICAM-1 staining was seen in most biopsies, with 
some biopsies exhibiting preferential staining (Fig. 3.53) . 
When epithelium staining was present it exhibited a 
gradient. Vessel staining within connective tissue was 
seen located within the cellular infiltrate, if present. 
Intensity of staining varied between biopsies but not 
within biopsies (Table 3.16).
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Figure 3.53 Rapidly progressive periodontitis tissue: ICAM- 
1 staining of the outer layers of the oral epithelium 
(solid arrow) (Immunoperoxidase, mag. x500).
The percentage of ICAM-1+ vessels were calculated and found 
to range from 44.0 to 82.5% (Table 3.17).
3.3.3 Juvenile periodontitis
3.3.3.1 ELAM-1 expression
ELAM-1+ vessels were located within cellular infiltrate, if 
present. Intensity of staining can be seen in Table 3.16.
The percentage of ELAM-1+ vessels varied from 23.2 to 36.9% 
(Table 3.17).
3.3.3.2 ICAM-1 expression
ICAM-1 positive keratinocytes were demonstrated with 
connective tissue vessel staining seen within the cellular 
infiltration. Staining intensity varied between biopsies 
(Table 3.16).
The percentage of ICAM-1 positive vessels ranged from 69.9 
to 76.6% (Table 3.17) .
3.4 Gingival crevicular washings
GCW was obtained from a total of 63 sites (section 
2.2.4.1). The mean MGI and PD of the sites were 1.87 
(±1.28) and 3.19 mm (±2.2) respectively (mean ± standard 
deviation in parenthesis). Both LF levels (ng/jxl GCW) and 
PMN numbers (PMNs/pil) were determined in each sample. The 
relationship between GCW LF levels and PMN numbers was 
examined, the Pearson's correlation was determined
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(r=0.531, p<0.001) and the least squares method was used to 
plot the best fitting line (Fig. 3.54). The association 
between both GCW LF levels and GCW PMN numbers and the 
clinical indices was also assessed (Table 3.18). GCW LF 
levels and PMN numbers correlated positively and 
significantly with both MGI and PD but LF demonstrated 
consistently higher correlation coefficients than PMNs with 
both clinical indices (Table 3.18).
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Figure 3.54 PMNs/jxl gingival crevicular washing (GCW) as 
function of GCW lactoferrin levels (ng/jxl GCW) in n=6 3 
GCWs. Both variables are transformed to log10. The Pearson 
correlation coefficient (r=0.531, p<0.001) was determined 
and the best fitting line plotted by the least squares 
method (regression analysis).
Table 3.18 Spearman rank correlation coefficient (r) 
between clinical indices and GCW LF levels and PMN numbers 
of n=63 GCWs obtained. Probability levels (p) shown in 
parenthesis.
Parameter LF(ng/iil GCW) PMNs (PMNS/(xl GCW)
MGI r=0.452 (p<0.001) r=0.279 (p<0.030)
PD r=0.513 (p<0.001) r=0.388 (p<0.003)
LF: Lactoferrin; MGI: Modified gingival index; 
PD: Pocket depth
Chapter 4 
Discussion
4.1 Introduction
The aims of this thesis were, firstly, to study the immune 
and inflammatory cellular infiltrate during the development 
of gingival inflammation utilising the experimental 
gingivitis model; secondly, to examine the effect of 
cytokines on adhesion molecule expression using gingival 
organ culture; thirdly, to assess inflammatory changes 
within diseased periodontal tissue; and finally, to draw 
conclusions on the interactions and the roles played by the 
different variables analysed in this thesis.
In order to present this work clearly, the discussion is 
arranged into sections dealing with particular topics, but 
interactions between particular areas are also developed.
4.2 Clinical parameters
Clinical parameters of plaque and gingival inflammation 
increased and peaked after 21-days of oral hygiene 
abstention with plaque accumulation preceding the rise in 
gingival inflammation (Fig. 3.1). Within the 10-day 
experimental gingivitis study minimal changes in the 
clinical indices were detected (Fig. 3.26). When Loe et 
al. (1965) first described the experimental gingivitis 
model they pointed out that at least 10 to 15 days of oral 
hygiene abstention were required in order to observe 
clinically detectable gingival inflammation and more 
recently, other investigators have pointed out that 
histopathological changes within the gingiva may be
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occurring even within the clinically healthy situation 
(Brecx et al., 1987a); and that initial changes within 
gingiva are not necessarily clinically detectable (Brecx et 
al., 1987b). Therefore, the 21-day study was used to
determine if changes within adhesion molecules and 
periodontal cellular infiltrate were occurring during 
clinically detectable inflammation; and then the 10-day 
study was designed to investigate very early changes in 
gingival inflammation by concentrating the 4 biopsy and 
sampling procedures within the first ten days. The 10-day 
study was to ascertain if any of the changes noted in the 
21-day study were seen when inflammation was histologically 
detectable, albeit not clinically detectable.
4.3 Interleukin-1
IL-1 has been implicated in the pathogenesis of periodontal 
disease i.e. bone loss (Mochan et al., 1988; Richards & 
Rutherford, 1990; Stashenko et al., 1991a, 1991b). Studies 
on GCF have demonstrated that elevated levels of IL-1 are 
present in disease sites when compared with healthy sites. 
Some studies indicate that the predominate IL-1 is IL-la 
(Kabashima et al., 1990), whereas other studies suggest 
that the important IL-1 is IL-lp; and therefore have only 
looked for this cytokine (Honig et al., 1989; Jandinski et 
al., 1991; Wilton et al., 1992). One study looked at both 
IL-la and IL-ip, and found that more IL-ljJ was present than 
IL-la in sites manifesting active periodontitis (Masada et 
al., 1990). The GCF IL-1 levels during the 21-day
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experimental gingivitis study show an initial peak and then 
a drop to baseline levels. The early peak in IL-1 levels 
reported here (section 3.1.1.10) is consistent with the 
'burst hypothesis' (Socransky et al., 1984) of periodontal 
disease progression, and if this dramatic change in IL-1 
levels occurs in periodontitis sites it could be an 
indicator of incipient breakdown at those sites.
Although IL-1 was originally considered to be a product of 
mononuclear phagocytes, recent evidence suggests that 
keratinocytes and gingival fibroblasts can also produce IL- 
1 in response to stimulation by bacterial components 
(Walsh, Seymour & Powell, 1985; Hanazawa et al., 1985, 
1988; Takada et al., 1991). IL-1 is one of the factors 
known to stimulate bone resorption and collagenase 
production by fibroblasts, both of which are features of 
periodontal destruction (Gowen et al., 1983; Postlethwaite 
et al., 1983). In addition, as changes in IL-1 levels were 
detected well in advance of clinically recognisable 
gingival changes, IL-1 may have a role as an early marker 
of gingival inflammatory changes.
4.4 Langerhans cells
Conflicting data exists on the dynamics of LC numbers 
during gingival inflammation. Many workers have suggested 
that as inflammation develops there is an increase in the 
number of LC present within gingival OE (Newcomb et al., 
1982; DiFranco et al., 1985; Newcomb & Powell, 1986a,
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1986b). However, a recent cross-sectional study by Hitzig 
et al, (1989) where tissue was categorised according to 
clinical indices, suggested that during initial 
inf lamination there was an increase in LC numbers, and in 
severe inflammation this decreased, contradicting previous 
studies. This work provides an insight into the changes in 
LC number within the gingival OE as inflammation develops. 
The results from the 21-day experimental gingivitis study 
(section 3.1.1.9) support the view of Hitzig et al. (1989) 
that there is initially an increase in LC numbers followed 
by a decrease as inflammation develops.
Difranco et al, (1985), however compared treated and 
untreated lesions within the same individual using 0KT6, S- 
100 and HLA-DR markers. These workers found that the 
numbers of LCs present in the inflamed tissue were 
significantly increased, and that the best marker for LCs 
was OKT6 which gave a maximum number of LCs in the gingival 
epithelium of 9.8 LC/mm2. This is extremely low when 
compared to the maximum number of LCs reported in the 
present studies (261 and 389 LC/mm2; 10-day and 21-day 
respectively) and when compared to the study of Hitzig et 
al, (1989) (117 LC/mm2). These comparisons would suggest 
that the absolute number of LCs found in the Difranco et 
al, (1985) study, was either severely depressed or their 
detection or enumeration system was not as sensitive as 
more recent techniques. Ahlfors et al, (1985) suggest that 
the requirement for the induction of hypersensitivity is
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>150 cells/mm2, this requirement was met by both recent 
studies. Interestingly, Hitzig et al. (1989) used thinner 
sections 6^ m, than the 8^m of the present studies, and this 
plus a more restrictive criteria for LC determination may 
account for the higher numbers seen between the present 
studies and theirs. Newcomb et al. (1982) employed 
adenosine triphosphatase to compare LC numbers in gingival 
tissue obtained after 0, 8 and 21 days of plaque
accumulation. These workers found a statistically 
significant increase in the numbers of LC present as plaque 
accumulated (day 0 to day 8). However, with the 
development of gingival inflammation (day 8 to day 21), 
there was no difference in the number of LCs present. 
These results contradict the results of the 10-day 
experimental gingivitis study which indicated no change in 
the number of LCs as plaque accumulated (section 3.1.2.10); 
also the 21-day experimental gingivitis study reports a 
peak in the number of LCs present after 7 days of plaque 
accumulation (which failed to reach statistical 
significance), and a statistically significant decrease in 
CD1+ LCs seen between days 7 and 21 and days 14 and 21 
(section 3.1.1.9). Newcomb & Powell, (1986b) have more 
recently demonstrated that adenosine triphosphatase is not 
as specific for LCs as the 0KT6 monoclonal antibody.
The above studies examined LC numbers in different 
individuals; diseased compared with healthy individuals or 
at different time points, sites within the same diseased
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individual. Closer evaluation of the data from these 
studies suggests that the numbers of LCs detected within 
disease tissue are severely decreased in comparison with 
the present studies, where inflammation is induced 
experimentally. This suggests that with long-term 
periodontal inflammation LC numbers decrease.
In the 10-day experimental gingivitis study the changes in 
HLA-DR expression on LCs corresponds to the pattern of 
change seen in CDla+ LCs (Fig. 3.44); but with the 21-day 
experimental gingivitis study the number of Class II MHC 
positive (HLA-DR+) LCs plateaued between day 7 and day 14 
and returned to baseline levels by day 21. The number of 
CD1+ LCs decreased between day 7 and day 14 and this might 
be explained if the CDla+ LCs present on day 0 consisted of 
some HLA-DR' cells which become HLA-DR+ cells as 
inflammation developed (Walsh et al., 1988). The HLA-DR 
specific monoclonal antibody could also be detecting 
macrophages. Further histochemical analysis however, using 
the macrophage specific 0KM1 monoclonal antibody (Ortho), 
suggested that macrophages were too infrequent within the 
epithelium to appreciably effect the numbers of HLA-DR+ 
cells.
The inflammatory reaction produced in experimental 
gingivitis results in various cells releasing cytokines and 
lymphokines (Charon et al., 1982a; Mergenhagen, 1984; 
O'Neill & Woodson, 1986). The differential effects of
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cytokines on LCs surface antigen expression may modulate 
the subpopulation of LCs present (Walsh et al., 1988; Ishii 
et al., 1990). Walsh, Seymour & Powell, (1990b) have 
demonstrated that Class II MHC positive (HLA-DR+) LCs are 
required for effective antigen presentation and that this 
expression is important for gingival LCs to initiate a T 
lymphocyte response to antigen. It is unclear of what 
significance the LC number changes reported here are, but 
a flux of LCs into and out of the gingival epithelium may 
be occurring analogous to the changes seen in the number of 
LCs present at the reaction site during contact 
hypersensitivity (Silberberg-Sinakin et al., 1980). The 
flux in LCs may demonstrate movement of these antigen 
presenting cells to lymph nodes and thus demonstrate a 
typical mucosal immune antigen detecting and responding 
process operating in the gingiva.
4.5 Periodontal cellular infiltrate
From the experimental gingivitis studies it was found that 
within clinically 'healthy' gingival tissue all of the cell 
types studied (PMNs? T-cells; T-cell subsets: CD4+, CD8+, 
T-memory and T-naive/virgin) were present even when 
clinical indices approached zero. This suggests that 
clinically 'healthy' gingiva is not necessarily 
histologically healthy (Brecx et al., 1987b) and that 
minimal inflammatory infiltrate i.e. mild inflammation is 
compatible with health (Brecx et al., 1987a). Two areas of 
infiltration were apparent, the JE/CT area and the OE/CT
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area. The JE/CT area always contained more inflammatory 
cells than the OE/CT area, suggesting that the immune cells 
were preferentially located within this area, due to the 
fact that the gingival sulcus harbours the antigenic 
source, bacterial plaque, which is the main cause of 
gingival inflammation (Loe et al., 1965? Listgarten, 1988; 
Christersson et al., 1991). As inf lamination developed all 
cell types were still detected within the gingival tissues, 
with some quantitative variations.
The abundance of PMNs within healthy gingiva (Figs. 3.6? 
3.7 & Table 3.15) and their preferential location at the 
JE/CT and JE/SE areas appear to substantiate their 
postulated role as the primary line of defense within the 
gingival tissue (Brecx et al., 1987a). As inflammation 
developed a loss of cells from the JE/SE was seen, 
suggesting that the cells were being lost from the gingival 
crevice? we have demonstrated that as plaque accumulates 
there is a tendency for PMNs to migrate into the gingival 
crevice (Table 3.11) (Kowashi et al., 1980). Although no 
statistically significant difference was detected in the 
number of PMNs in the JE/SE or JE/CT areas at different 
time points this does not mean that the number of PMNs 
trafficking through the tissues did not increase during the 
course of experimental gingivitis. It simply reflects the 
difficulty of trying to assess the dynamic flow of cells 
into and out of the tissues by counting those caught in the 
middle at one particular moment in time. In other words/ if
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the recruitment of PMNs into the tissues is balanced by 
their loss into the gingival crevice there may be little 
change in PMN numbers in the tissues even if there is an 
increase in the rate of traffic over the 10-days or 21-days 
of plaque accumulation.
It was found that alkaline phosphatase and peroxidase could 
not be used successfully to double stain two antigens 
within the same tissue section, due to the fact that both 
primary monoclonal antibodies were from the same animal 
species i.e. mouse anti-human, which resulted in problems 
with cross-reactivity. We were also using frozen cryostat 
sections which do not maintain their tissue structure 
during extended periods of staining; and also alkaline 
phosphatase was found not to be a good marker for surface 
antigens, which were of primary interest in this study. 
Therefore single staining immunoperoxidase was utilised to 
stain for cell types of interest.
All experimental gingivitis histopathological studies have 
demonstrated that the infiltrate in the developing lesion 
is of lymphocytic character, mainly the T-cell type 
(Seymour et al., 1983b, 1988; Brecx et al., 1987b, 1988a, 
1988b), with greater than 6 months of plaque accumulation 
required for plasma cells to dominate the lesion (Brecx et 
al., 1988a). With the present 21-day and 10-day 
experimental gingivitis studies we have demonstrated that 
the experimental lesion is T-cell and PMN dominated (Figs.
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3.6; 3.7; 3.9; 3.10; 3.38 & Table 3.15) (Brecx et al.,
1988a, 1988b). T-cells were found in great abundance
within all areas of healthy and experimentally inflamed 
gingival tissue. Analysis of T-lymphocyte subsets within 
the 21-day experimental gingivitis study demonstrated no 
variation in T4:T8 ratio (Seymour et al., 1988). Seymour 
et al. (1983a, 1983b) comment on the sparse T-lymphocyte 
infiltrate within 7 to 10 days of experimental gingivitis. 
The immunohistochemistry technique employed in the present 
study is very specific and sensitive and accordingly T cell 
numbers are found in greater numbers than with previous 
techniques. CD3+ intraepithelial lymphocytes were also 
detected within the OE, which also appeared to be CD4+ or 
CD8+. Interestingly CD3+ cells (pan T-cells) appeared to 
cluster around the tips of the OE rete pegs and on more 
specific analysis these cells were noted to comprise both 
CD4+ and CD8+ cells. Within OE rete pegs LCs can be found 
which are recognised antigen presenting cells (section 
3.1.1.9 and 3.1.2.10). It can be postulated that this 
clustering of CD4+ or CD8+ T-cells around the tips of the 
OE rete pegs is essential for LCs to be able to initiate an 
immune response.
No study to date has looked at the accumulation of 
T-naive/virgin (CD45RA+) or T-memory (CD45RO+) within 
experimental gingivitis, though Colasante et al. (1992) 
have demonstrated elevated numbers of T-memory cells in 
healthy gingiva. The 10-day experimental gingivitis study
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demonstrated that within healthy gingival tissue both 
subsets CD45RO (memory) and CD45RA (naive/virgin) were 
present (Figs. 3.40 & 3.41 respectively); and that the 
detectable number of both cell types was elevated within 
the JE/CT area when compared with the OE/CT area. 
Interestingly within healthy gingiva, the ratio of T-memory 
to T-naive/virgin cells (i.e. CD45RO:CD45RA) was elevated, 
but as inflammation develops the ratio of CD45RO:CD45RA 
decreased. This suggests that only within clinically 
'healthy' gingival tissue does the number of detectable 
T-memory cells supersedes the number of detectable 
T-naive/virgin cells. As inflammation developed (i.e. days 
of plaque accumulation) the number of T-memory cells did 
not vary within the JE/CT, but rather the number of 
T-naive/virgin cells decreased. Contradicting previous 
studies, carried out in different tissue types, where an 
increase in T-memory cells is noted as inflammation 
develops (Griffiths & Nickoloff, 1989; Rustin et al., 1990; 
Gilmore, Benson & Kelly, 1991; Picker et al., 1991; Shimizu 
et al., 1991). It is possible that within the 
experimentally inflamed gingival tissue, loss of activated 
T-memory cells into the gingival crevice may be occurring 
because T-memory cells are better adapted to respond to 
antigen (Mackay, 1991). Also, as no change is seen in the 
number of T-memory cells, it is feasible that although a 
deficit is occurring due to the flux of T-memory cells into 
the crevice, it is being filled by the naive cells maturing 
and switching to the memory cell phenotype (Wallace &
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Beverley, 1990; Gilmore et al., 1991).
Quantitative and qualitative changes within periodontal 
cellular infiltrate during experimental gingivitis was 
occurring. But the changes were not apparent when one time 
point was compared to another. It must be remembered that 
the immune response is a dynamic process, and that even 
with sequential biopsies it is difficult to determine 
exactly the specific changes occurring.
4.6 Adhesion molecules
The studies presented in this thesis demonstrate the 
presence of the adhesion molecules, ELAM-1, ICAM-1 and 
VCAM-1, in clinically healthy, experimentally inflamed and 
diseased gingival tissue. Whereas previous studies have 
shown that normal 'uninflamed' tissue is negative for ELAM- 
1 (Cotran et al., 1986; Bevilacqua et al., 1987; Munro et 
al., 1989; Munro, Pober & Cotran, 1991; Rohde et al., 1992) 
and expresses low levels of ICAM-1 (Lewis et al., 1989; 
Majewski et al., 1991), with minimal VCAM-1 expression
(Norris et al., 1991; Groves et al., 1992).
In vitro studies have shown that ELAM-1 acts as a highly 
specific endothelial cell ligand for the binding of 
peripheral blood PMNs (Bevilacqua et al., 1987, 1989; Rohde 
et al., 1992), especially ones rich in sialylated Lewis X 
antigen (Fukuda et al., 1984; Symington et al., 1985; Lowe 
et al., 1990; Phillips et al., 1990; Walz et al., 1990) and
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for T-memory cells (Picker et al., 1991, Shimizu et al., 
1991). In vivo studies have confirmed a strong correlation 
between ELAM-1 expression on blood vessels and the 
accumulation of PMNs and memory-T cells in the tissues 
during inflammatory responses (Munro et al., 1989, 1991; 
Norris et al., 1991; Picker et al., 1991, Shimizu et al., 
1991). The intensity of ELAM-1 staining of the blood 
vessels was high at each time point with the strongest
expression of ELAM-1 occurring in the same areas (JE and
JE/CT) where PMN and T-memory cells were located in 
greatest abundance.
ICAM-1 has been shown to play a role in the adhesion of 
PMNs and T—cells to endothelial cells and it is also 
important in facilitating the trans-endothelial cell 
migration of leucocytes (Dustin et al., 1986; Rothlein et 
al., 1986; Lewis et al., 1989; Majewski et al., 1991),
especially cells of the memory phenotype (Griffiths &
Nickoloff, 1989; Buckle & Hogg, 1990) and cells expressing 
LFA-1 (CDlla) (Dustin et al., 1986). ICAM-1 expression on 
the blood vessels changed very little in relation to its 
distribution throughout the 10 and 21 days and this was 
reflected in the T—cell numbers not changing within the 
different tissue compartments (Figs. 3.9 & 3.10).
Within gingival tissue the percentage of biopsies with 
greater JE/CT than OE/CT ICAM-1 staining was low (range 0 
to 40%) (values calculated from Table 3.4) i.e. staining
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within JE/CT and OE/CT was similar. Cells within gingival 
tissue expressing the ICAM-1 ligand CDlla, were elevated 
within JE/CT and interestingly within OE/CT as well (Fig 
3.34). This elevated number of CDlla+ cells within the 
OE/CT and the unbiased expression of ICAM-1 suggests that 
ICAM-1 may be important in targeting CDlla+ cell migration 
to OE/CT, for antigen presentation by gingival LCs and 
initiation of an immune response.
It was noted that junctional epithelium, and to a lesser 
extent sulcular epithelium, remained strongly positive for 
ICAM-1 throughout the 10 and 21 days of experimental 
gingivitis. At no point was ICAM-1 positivity of the 
adjacent oral epithelium noted and the transition from 
ICAM-1 positive junctional and sulcular epithelium to oral 
epithelium was always quite distinct and marked (Fig. 3.3). 
The staining showed a gradient of intensity with the most 
intense staining at the crevicular aspect and the weakest 
on the connective tissue aspect (Fig. 3.5). The intensity 
of the ICAM-1 staining at JE is greater than is often seen 
in other epithelial tissues even in the presence of an 
immune mediated inflammatory response or direct cytokine 
stimulation. Taken together these observations suggest 
that junctional epithelium may be specially adapted to 
constitutively express ICAM-1. Since ICAM-1 expression on 
keratinocytes facilitates leucocyte-keratinocyte adhesion 
and transmigration (Dustin & Springer, 1988) this adaption 
may help to explain the special ability of junctional
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epithelium to permit leucocyte traffic into the gingival 
crevice. Unlike endothelial cells, keratinocytes do not 
normally express ICAM-1, however, keratinocyte ICAM-1 
expression can be induced both in vivo and in vitro by the 
action of interferon-y but not by interleukin-1 or LPS 
(Barker et al., 1989; Krutmann et al., 1990). Epithelial 
cell ICAM-1 expression is therefore only observed during 
immune mediated inf lammatory processes such as delayed type 
hypersensitivity (Norris et al., 1991) and mucosal lichen 
planus (Walsh et al., 1990a). Even then epithelial cell 
ICAM-1 staining is not usually very strong and is 
restricted to areas with the most intense lymphocytic 
infiltrates. It was therefore unexpected to find very 
intense ICAM-1 staining of JE even in clinically 'healthy' 
gingivae. During the development of the experimental 
gingivitis there was no significant alteration in the 
intensity or pattern of staining. These observations 
strongly suggest that JE may be adapted to express ICAM-1 
constitutively even in the absence of interferon 
stimulation. In theory IL-1 or LPS in the gingival crevice 
could upregulate ICAM-1 expression and this may explain the 
gradient effect seen in the JE, with the most intense 
staining seen on the outer aspect and may reflect the fact 
that JE is the site of extensive PMN migration in both 
health and disease (Attstrom & Egelberg, 1970; Schiott & 
Loe, 1970; Scully & Challacombe, 1979).
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VCAM-1 expression within gingival tissue did not change in 
its intensity when JE/CT area was compared with OE/CT area, 
or when biopsies at different time points were compared. 
VCAM-1 expression has been linked with T-cell migration 
(Osborn et al., 1989; Graber et al., 1990), but not PMNs 
(Osborn et al., 1989). The ligand for VCAM-1 has been 
elucidated as the VLA-4 integrin (Elices et al., 1990).
Kinetical expression of the adhesion molecules has been 
studied in vitro and in vivo, and has been shown to differ. 
In vitro, ELAM-1 expression can be detected by 4-6 hours 
and returns to baseline by 24 hours (Bevilacqua et al., 
1987, 1989; Messadi et al., 1987). In vivo ELAM-1
expression is detected at 6 hours, maximal at 24-72 hours 
if immune-mediated, or returns to baseline by 24 hours if 
non-immune mediated (Norris et al., 1991). ICAM-1 
expression is detectable at 10-24 hours and is maintained 
for 72 hours (Pober et al., 1986; Wellicome et al., 1990). 
In contrast, VCAM-1 is detected at 2 hours, maximal at 6-10 
hours and returns to baseline by 24 hours if stimulated by 
IL-1 or LPS, and is maintained if stimulated by TNF 
(Thornhill & Haskard, 1990; Wellicome et al., 1990). It 
appears that ELAM-1 expression increases initially followed 
by VCAM-1 and finally by ICAM-1. The fact that the 
adhesion molecules ELAM-1, ICAM-1 and VCAM-1 are detected 
throughout the 10 and 21 days of experimentally induced 
inflammation suggests one of two possibilities, either the 
blood vessels in gingiva are functionally specialised and
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constitutively express ELAM-1 and VCAM-1 plus high levels 
of ICAM-1 to facilitate leucocyte traffic into the gingival 
crevice or the gingival vessels are permanently activated 
even in 'health' due perhaps to the constant ingress of 
bacterial products such as LPS across the junctional 
epithelium. Further support for the idea that gingival 
post-capillary venules may be specialised to express ELAM-1 
and VCAM-1 constitutively, is provided by the fact that 
they do not appear to exhibit the normal modulation of 
ELAM-1 and VCAM-1 expression seen in other situations 
(Munro et al., 1989, 1991; Thornhill & Haskard, 1990;
Wellicome et al., 1990; Norris et al., 1991).
When the relationship between JE/CT and OE/CT staining was 
compared for ELAM-1 and ICAM-1, it was found that ELAM-1 
staining correlated better at 10-days than at 21-days 
(r=0.763 and r=0.528, respectively); whereas ICAM-1 showed 
the opposite effect, with 21-days correlating better than 
10-days (r=0.751 and r=0.518, respectively). This suggests 
that ELAM-1 is important in early inflammation and that 
ICAM-1 becomes more important as inflammation develops. 
This would correlate with our understanding of the sequence 
of inflammatory cell infiltration in acute inflammatory 
lesions i.e. PMNs first followed by the chronic 
inflammatory cells, macrophages and lymphocytes.
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Cytokines increase the expression of the adhesion molecules 
(Pober et al., 1986; Wellicome et al., 1990; Norris et al., 
1991). Our organ culture studies have demonstrated that 
cytokines have differing effects on gingival tissue, 
depending upon its state of activation i.e. depending which 
block of tissue is used (Figs. 3.45 - 3.48). Again
suggesting that gingival tissue is an unusual inflammatory 
situation. In addition, the 21-day experimental gingivitis 
study indicated IL-l's presence and its dynamics in the 
crevice which may be involved in upregulating adhesion 
molecules•
The appearance of high endothelial venules (HEV) during the 
development of experimental gingivitis is one indication 
that gingival blood vessels may become altered to support 
leucocyte traffic (Wynne et al., 1988). HEV were first 
described in lymphoid tissue and represent specialised 
postcapillary venules across which large numbers of 
lymphocytes traffic during their recirculation from the 
blood into lymphoid tissue and back to blood via the 
lymphatics. Instead of having the normal flat morphology 
of EC they have a much more cuboidal appearance. HEVs have 
also been observed in several long standing chronic 
inflammatory situations in which large numbers of 
lymphocytes accumulate (Nightingale & Hurley, 1978; 
Freemont & Ford, 1985). In lymphoid tissue, HEV express 
organ specific 'addressin' molecules that enable 
subpopulations of lymphocytes, including B cells, and
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plasma cells, to recirculate through specific lymphoid 
organs (Jalkanen et al,, 1987). The appearance of HEV in 
inflammatory periodontal lesions may therefore mark the 
development of a lesion through which specific 
subpopulations of lymphocytes are recirculating in large 
numbers and also a lesion to which B cells and plasma cells 
are able to home (Jutila et al,, 1989).
4.7 Conclusion
It could be hypothesised that within clinically 'healthy' 
tissue mild inflammation is always present and that the 
gingiva is never really healthy, perhaps due to the 
constant presence of the antigenic stimulus - bacterial 
plaque and the fact that junctional epithelial cells are 
loosely bound and permit passage of molecules between 
cells. The continued onslaught of antigenic challenge 
keeps the gingiva in a mild state of inflammation where the 
immune cells are playing an immunosurveillance role keeping 
the gingiva clinically 'healthy'. With the accumulation of 
plaque, as in the experimental gingivitis model, changes 
start to occur histologically at first and then clinically 
visible changes appear. Histologically the size of the 
inflammatory infiltrate starts to increase, at different 
rates within different individuals (Table 3.2 and 3.9) (Loe 
et al,, 1965) and there is an early peak in IL-1 levels. 
PMNs within healthy gingiva are found at the 
crevicular/tooth aspect (section 3.1.1.4) (Brecx et al,, 
1987a) and as inflammation develops, loss of PMNs from the
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gingival tissue is seen (section 3.1.1.4), with PMNs 
migrating into the gingival crevice (Sigusch et al., 1992). 
Simultaneously changes occur in LC numbers within the first 
weeks of gingival inflammation. This may reflect movement 
in and out of gingival epithelium and suggests that these 
LCs are active in antigen presentation even at this early 
stage of inf lamination. Migration of gingival LCs into the 
lymphoid system results in stimulation of lymphocytes and 
initiation of an immune response. This flux of LCs may 
represent an important early "immune triggering" event in 
the gingival immune response to plaque. ECs play an 
important role in orchestrating inflammatory and immune 
events. Central to this is the key role played by 
cytokines and 'adhesion molecules' in regulating leucocyte- 
EC adhesion, the first step in leucocyte migration. The 
preliminary evidence presented in this thesis suggests that 
the gingival tissues may be specifically adapted, with 
regard to their expression of adhesion molecules, to 
facilitate the migration of PMNs and other cell types into 
the gingiva and into the crevice as part of the normal 
defence of the periodontium. Immunological cellular 
infiltration is seen within the tissues as gingival 
inflammation develops. The spatial and temporal changes in 
the composition of the cellular infiltrate illustrates the 
difficulty in interpretation using sequential biopsies.
The importance of these endothelial and leucocyte adhesion 
mechanisms in protecting against periodontal disease is
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highlighted by the rapid and severe periodontitis that 
characterises LAD (leucocyte adhesion deficiency) (Anderson 
& Springer, 1987; Page et al., 1987; Waldrop et al., 1987). 
It is important that the kinetics of adhesion molecule 
expression and the dynamics of leucocyte trafficking are 
studied in greater detail in order to ascertain if defects 
in adhesion molecule expression play a part in determining 
an individuals susceptibility to periodontal disease.
4.8 Future research
These studies have demonstrated the presence of adhesion 
molecules and cellular infiltrate within gingival tissue 
and have also suggested that changes in Langerhans cell 
numbers within oral epithelium are occurring early on in 
gingival inflammation. Changes within gingival cellular 
infiltrate may be occurring but as we are looking at a 
dynamic process in a cross-sectional manner, it is 
difficult to visualise the true changes occurring. Future 
research should be aimed at examining the flux of cells 
into the crevice, into the connective tissue and/or 
arriving at the blood vessels, using time-lapse video 
analysis. Also, studies need to be performed to obtain a 
more specific understanding of the role of these adhesion 
molecules in chronic inflammatory periodontal disease; and 
also to examine the manner in which adhesion molecules 
control the accumulation of lymphocytes into chronic 
inflammatory tissue.
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Studies so far have demonstrated that blood vessels within 
the gingiva are specialised, future research should focus 
on trying to elucidate the effect of various cytokines on 
the expression of their cellular adhesion molecules. Do 
the cytokines effect gingival tissue in the classical way 
they act on other types of tissue? or do gingival vessels 
express unique kinetics? Cytokines within GCF also need to 
be elucidated to ascertain whether a single cytokine or a 
combination of cytokines and/or LPS is responsible for the 
gradient ICAM-1 effect seen in junctional epithelium. The 
answers to these questions may further clarify the role of 
adhesion molecule expression and cellular infiltrate within 
gingival tissue.
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Moughal SA . Adonogianaki E. Thornhill MH. Kinane DFr Endothelial cell 
leukocyte adhesion molecule'I ( ELAM' I )  and intercellular adhesion molecule-1 
(ICAM'I)  expression in gingival tissue during health and experimentally-induced 
gingivitis. J  Periodont Res 1992; 27; 00-00.
The changes in vascular adhesion molecule expression and numbers of infiltrating 
leukocytes during a 21 -day experimental gingivitis episode were investigated 
immunohistochemicaily. Monoclonal antibodies to ELAM-1 (1.236). ICAM-1 
(6.5B5), CD3 (O K T3- pan-T cell) and neutrophils (PMN-eiastase) were used 
to identify positive vessels and leukocytes within gingival biopsies taken on d 0.
7.14 and 21. Vascular endothelium expressed ELAM-1 and ICAM-1 both in 
clinically ‘healthy’ tissue (d 0) and in experimentally inflamed tissue (d 7 to 21). 
Positive vessels were found mainly in the connecnve tissue subjacent to the junc­
tional epithelium where the highest numbers of T  ceils and neutrophils were also 
seen. Although T ceils were found in all tissue areas studied, neutrophils were 
largely concentrated in the junctional epithelium and the subjacent connective 
tissue but were absent from the oral epithelial region. As the experimental gingi­
vitis developed, the number of T  cells or neutrophils in the different tissue regions 
did not change significantly although the most intense vascular ICAM-1 and ELA- 
M-l staining redistributed to the CT adjacent to the junctional epithelium. A 
prominent feature was the intense ICAM-1 -positive staining of the junctional epi­
thelium and its absence in the closely adjacent oral epithelium, in both clinically 
‘healthy’ and inflamed tissue. The gradient of ICAM-1 in junctional epithelium, 
with the strongest staining on the crevicular aspect plus the vascular expression 
ofELAM-l and ICAM-1 in both clinically ‘healthy’ and inflamed tissue may be 
crucial processes which direct leukocyte migration towards the gingival crevice.
Keywords; adhesion molecules -experim en­
tal g ingivitis- inflammation—leucocyte infil­
tration
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Introduction
Recruitment of leukocytes into areas of injury or 
infection is essential for host defence. The constant 
migration of T  ceils and other leukocytes to sites 
throughout the body allows the full repertoire o f
Abbreviations: CT -  connective tissue; ELAM-1 -  endothelial 
leukocyte adhesion molecule 1: ICAM-1 -  intercellular adhesion 
molecule I; JE -  junctional epithelium; IE / CT -  connective tissue 
subjacent to junctional epithelium; OE -  oral epithelium; OE/ 
CT -  connective tissue subjacent to oral epithelium; PMN -  poly­
morphonuclear leukocyte or neutrophil; SE -  sulcular epi­
thelium.
the immune system to protect the tissues from a 
variety o f  antigenic challenges. Leukocyte mi­
gration into tissues is particularly prominent dur­
ing inflammatory responses and results from the 
cytokine-induced expression of adhesion molecules 
on the surface o f vascular endothelial cells (ECs) 
(1-7). Endothelial leukocyte adhesion molecule 1 
(ELAM-1) (8) and intercellular adhesion molecule 
1 (ICAM-1) are two adhesion molecules which ap­
pear to be crucial for cellular trafficking.
Although not normally expressed on uninflamed 
endothelium. ELAM-1 expression may be transi­
ently induced on endothelium in almost any in-
2 Mougnai c t al.
Hamed tissue: however, expression on inflam ed cn- 
dotnenum of skin may be enhanced or prolonged  
comDared to other sites (9). In contrast, ICAM-1 
is constim tiveiy expressed on ECs and exhibits no 
tissue-SDcaric restriction in its expression (3. 10).
I CAM-1 expression may be enhanced in vitro by 
the acaon o f  cytokines (11—13) and this is reflected 
:n vivo by a greater intensity o f  expression on ECs 
at sues o f  inilammation (14-16).
Adhesion molecule expression is induced eariv 
during experimental inflammatory responses ;n the 
skin o f monkeys (16) and hum ans (17). Similar 
experiments have not previously been performed  
in gingival tissue although Crawford and Hopp  
(1990) (18) have reported IC A M -l expression in 
healthy gingival tissue.
The aim o f  this study was to exam ine im m uno- 
histocnemicaily the changes in T-ceil num bers, neu­
trophil (PM N) numbers and ELAM -1 and IC AM - 
l expression during 21 d o f  experim entally-induced  
gingivitis.
Material and Methods
C lin ica l m a la ria l
Biopsy material was obtained using the experim en­
tal gingivitis m odel o f  Loe, T heiiaoe and Jensen 
(1965) (19). Ethical approval was granted by the 
local ethics com m ittee. Six dental students (5 male.
1 female) who consented to participate in the study 
received oral hygiene instruction and frequent 
prophylaxis until maximal ciinical gingival health 
was obtained. All subjects were then instructed to 
cease ail orai hygiene measures and plaque was 
allow ed to accum ulate undisturbed for a period o f  
21 d. The clinical indices were recorded (every 7 
d), at eacn biopsy site, using the plaque index (PI) 
o f  Silness and Loe (1964) (20) and the m odified  
gingival index (M G D o f  Lobene et at. (1986) (21). 
T he MGI is a m odification o f  the Loe and Silness 
(1963) (22) gingival index (GI); it om its the blccd- 
ing-upon-probing com ponent o f  the GI and per­
mits a non-invasive evaluation o f  the early visible
Fig. 1(a). ELAM-1* vessels in the connective tissue area of a day-0 biopsy (solid arrows); (b) A day-21 biopsy with the most 
intense staining ELAM-1* vessels located at the JE /C T  area (solid arrows), with weaker staining ELAM-1 * vessels located towards 
the connective tissue (open arrows) (Immunoperoxidase. Magnification 225 x ). (inset) Areas used to quantify cellular infiltrate. 
(JE—junctional epithelium; O E—orai epithelium; JK /C T—junctional epithelium subjacent to connective tissue; OE/CT — orai 
epithelium subjacent to connective tissue).
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Fig. 2(a). Intense [CAM-! staining of JE iceratinocytes (solid arrow) with moderate staining of SE Iceratinocytes (open arrow); 
[b) Absence of ICAM-1 staining of OE Iceratinocytes in clinically healthy tissue (day 0) (Magnification 140 x ); (c) Day-7 biopsy 
showing an ICAM-1 gradient, with maximal staining at the JE/tooth interface (solid arrows), with weaker staining in the basal 
layers of the JE (open arrows) (Immunoperoxidase. Magnification 462 x ).
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Table I. PMN and T-cell numbers over the 2! days of expert- 
mental inflammation. Values shown are means and standard 
errors (in parenthesis) of the leukocytes per square millimeter 
within each region____________________________________
CD3* T cells PMNs
Dav JE/CTOE/CT JE OE JE/CTOE/CT JE OE
0 1S42 180 178 23 1258 41 321 0
(9571 (109) (110) (19) (678) (21) (130) (0)
7 3326 311 895 193 449 22 59 0
(399) (265) (498) (34) (78) (13) (59) (0)
14 2620 285 736 108 374 0 ND 0
(1044) (52) (347) (30) (347) (0) (0)
21 1846 554 978 59 924 27 684 0
(748) (184) (174) (30) (348) (13) (361) (0)
NO «  not done.
changes in the extent and severity o f gingivitis. One 
examiner was used throughout the experiment to 
record the clinical indices (E.A.). Gingival biopsies 
(2 mm x 2 mm) were obtained surgically on d 0 of 
the experimental gingivitis phase from the mid- 
buccal aspect of the lower right first permanent 
molar. The remaining first permanent molars were 
then biopsied in rotation (d 7, 14 and 21). In total, 
four biopsies were taken from each individual.
Immunohistochemistry
All tissue biopsies were embedded in Tissue Tek 
and snap frozen. S /un-thick sections were cut and 
stained using the ABC method of Hsu and Raine 
(1981) (23). Frozen cryostat sections of the speci­
mens were air-dried and fixed in cold acetone. Fol­
lowing fixation the sections were blocked with hor­
se serum before the addition of the primary mono­
clonal antibodies. The primary antibodies (mouse 
anti-human monoclonal antibodies 1.2B6 (anti- 
ELAM-l, 1:20 dilution), 6.5B5 (and-ICAM-1. 1:30 
dilution), OKT3 (CD3, 1:25 dilution) and PMN- 
Elastase (1:300 dilution, DAKO, U.K.) were re­
acted for I hour at 20°C. Monoclonal antibodies 
against ELAM-1 and ICAM-1 were the kind do­
nation of Dr. D. 0 . Haskard (Royal Postgraduate 
Medical School, London. U.K.) and anti-CD3 
monoclonal antibody supernatant was produced 
from the OKT3 hybridoma cell line obtained from 
the American Type Culture Collection. The pri­
mary monoclonal antibodies were then labelled 
with biotinylated anti-mouse immunoglobulin. Be­
fore the addition o f avidin-biotinylated peroxidase 
complex (Vector Laboratories. Petersborough.
U.K.) the sections were dcperoxidized (0.03% hy­
drogen peroxidase in methanol) to remove en­
dogenous peroxidase. The reaction was developed 
using the substrate diamino benzidine tetrahydro- 
chloride and to enhance staining the sections were 
incubated in 0.5% copper sulphate solution before 
counterstaining with Mayer's hematoxylin. Be­
tween each incubation the slides were washed with 
phosphate-buffered saline (pH 7.4). Monoclonal 
antibody specificities were confirmed using human 
tonsil and human skin as control tissue and appro­
priate negative control sections treated with non­
specific primary antibodies. One section from each 
biopsy was also stained with hematoxylin and 
eosin.
Enumeration
Due to clinical and surgical restrictions incumbent 
in biopsying gingival of teeth which were not ex­
tracted, it was difficult to obtain complete apical 
junctional epithelium (JE); therefore, in order to 
quantify the biopsy, it was divided into four areas 
-  junctional epithelium/sulcular epithelium (JE/ 
SE), orai epithelium (OE), CT subjacent to the JE 
(JE/CT) and CT subjacent to the OE (OE/CT) 
(Fig. I inset). A five-point scale (0-4) was used to 
document the changes in intensity and global ex­
tent of antigen expression within the biopsies, with 
ELAM-1 and ICAM-1 being quantified according 
to the criteria of Messadi et al. (1987) (24) (0, 
no staining; 1, weak focal granular staining; 2, 
moderate staining of vessels; 3, strong staining of 
vessels, and 4, very strong staining of vessels). 
ICAM-1 graded in the four areas and ELAM-1 
graded only in the JE /C T  and O E /C T  (JE and OE 
were ELAM-1-negative). T  cells and PMNs were 
quantified as CD3+ or PMN-Elastase* cells within 
the four areas. Positive cells within these four areas 
were counted ‘blind* at x400 magnification and 
the area measured from each section using com­
puter-assisted image analysis (Video Vector Dy­
namics, Glasgow, U.K.) and the results expressed 
as mean number of positive cells per square milli­
meter (mnr) for each biopsy.
Statistical analysis
The Mann-Whitney test was utilised to determine 
if T  cells numbers differed from PM Ns numbers 
within the same area over time. In addition, analy-
Fig. S. Photomicrographs of fa) ELAM-1* vessels (solid arrows): (b) PMNs (solid arrows); (c) ICAM-1* vessels (solid arrows); 
and (d) CD3* staining (solid arrows) at the JE/CT area within the same day-0 biopsy. (Immunoperoxidase. Magnification 140 x ).
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sis of variance (ANOVA) was used to determine if 
T cell or PMN numbers changed within any one 
given area over time. Both tests were carried out 
using the Minitab statistical package on an IBM 
PC.
Results
Following withdrawal of orai hygiene procedures 
the PI at the biopsy sites rose (d 0) (0.17 ±0.4) and 
peaked at d 21 (2.2±0.4) with the MGI following 
closely behind (d 0) (0±0) to d 21 (2.2±0.4) (mean 
and standard deviation).
ELAM-1 * blood vessels were present in both 
the JE /C T  and OE/CT of healthy gingiva (d 0) 
(Fig. la), although expression was mainly concen­
trated in the JE/CT area. As the inflammation 
developed, the concentration and intensity of stain­
ing in the JE /C T area became more marked, as 
demonstrated by a 25% increase in the numbers of 
biopsies with stronger staining vessels at the JE / 
CT (d 21 compared with d 0) (Fig. lb). ICAM-1 
staining of blood vessels in the connective tissue 
also showed a similar distribution and pattern of 
staining.
Ginically ‘healthy' tissue also demonstrated in­
tense ICAM-l staining of the keratinocytes at the 
JE. with moderate staining of SE keratinocytes and 
no staining of OE keratinocytes (Figs. 2a & 2b). 
With the subsequent development of inflammation 
there was little change in the intensity or distri­
bution of ICAM-1 staining and no spread of 
IGAM-l positivity to the OE keratinocytes. 
Throughout the 21 d the JE keratinocytes ICAM- 
1 staining showed a gradient, with the most intense 
ICAM-l staining towards the crevicular/tooth as­
pect and decreasing staining intensity towards the 
basal layers (Fig. 2c). Apical JE, when present, 
also expressed ICAM-1. Unpublished observations 
from within our clinic and laboratories indicate 
that surgical biopsy tissue from chronically in-
Table L PMN:T-cell ratios during 21 days of experimentally- 
induced gingival inflammation. Values shown are means and 
standard errors (in parenthesis) of the leukocytes per square 
millimeter within each region___________________________
Ratios T cells and PMNs compared in
Day p value JE/CT OE/CT JE OE
0 PMN:T 1:1 1:4 1:1 0:28
p value NS NS NS <0.001
7 PMN:T 1:7 1:37 1:15 0:193
p value <0.05 <0.005 <0.05 <0.001
14 PMN:T 1:3 0:285 ND 0:108
p value NS <0.001 <0.001
21 PMN:T 1:2 1:21 1:1 0:59
p value NS <0.05 NS <0.001
N D -not done.
flamed periodontal sites also exhibits ELAM -l- 
and ICAM-1-positive vessels.
PMN numbers and T-ceil numbers over the 21- 
d period did not change significantly in the four 
areas of the gingival biopsy examined (JE. OE, JE / 
CT and OE/CT) (Table I), except the increase in 
T ceil numbers as inflammation developed, d 0 
to d 7 (ANOVA p <  0.01). However, there were 
significantly more PMNs present in the JE /C T  
than the O E/C T at all time points (Mann-Whitney 
p <  0.05 in each case), whereas T-ceil numbers were 
only elevated significantly at d 14 (Mann-Whitney 
p <  0.05) and this corresponded to the distribution 
o f ICAM-1- and ELAM-1-positive blood vessels. 
Interestingly, in the connective tissue CD3* T  ceils 
showed a tendency to cluster around the tips of 
the oral epithelial papillae and this was a feature 
of biopsies taken at ail time points. In the epithel­
ium, T cells were noted both in the OE and the JE 
although by d 21 the numbers o f T  ceils in the JE 
were significantly higher than the number in the 
OE (p<0.05). In contrast, PMNs were not ob­
served in the OE but were present at ail time points 
in the JE. Furthermore, within the JE PM Ns were 
found to be concentrated towards the crevicular/ 
tooth aspect, where adhesion molecule staining was 
most intense. Generally the greatest concentration 
o f T  cells and PMNs in the JE /C T  and JE area 
coincided with the location of the most intense 
ELAM-1 and ICAM-l staining (Figs. 3a-3d).
With the exception of the OE where a  few T cells 
but no PMNs were present, there was no significant 
difference in the number of T  cells compared to 
the number of PMNs in the different tissues com­
partments at d zero. However, by d 7, as inflam­
mation developed, there were significantly more 
T  cells than PMNs present in each of the tissue 
compartments (p <  0.05 in each case), although by 
d 14 and 21 these differences were still only signifi­
cant in the OE and O E/C T (Table 2). Differences 
in T-ceil and PM N number, and in ELAM-1 and 
ICAM-l intensity between subjects were noted 
during the 21 d of experimentally-induced gingi­
vitis. These interindividual variations, however, 
were not statistically significant and the overall 
changes were similar for all individuals.
Discussion
This study demonstrated the presence o f adhesion 
molecules in clinically healthy and in experimen­
tally-inflamed gingival tissue, whereas previous 
studies have shown that normal ‘uninflamed’ tissue 
is negative for ELAM-1 (16, 17, 25, 26). In vitro 
studies have shown that ELAM-1 acts as a  highly 
specific endothelial cell ligand for the binding of 
peripheral blood PMNs (8. 27) and in vivo studies
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have confirmed a strong correlation between ELA- 
M-l expression on blood vessels and the accumu­
lation of PMNs in the tissues during experimental 
inflammatory responses (16, 17. 25). The intensity 
of ELAM-1 and ICAM-l staining of the blood 
vessels was high at each time point with the strong­
est expression of these molecules occurrind in the 
same areas (JE and JE/CT) where PMN and T  cells 
were located in greatest abundance (Fig. 3a-3d). 
Seymour et al. (28,29) comment on the sparse T- 
lymphocyte infiltrate within 7 to 10 d of experimen­
tal gingivitis. The immunohistochemistry tech­
nique employed in the present study is very specific 
and sensitive and accordingly T cell numbers were 
found in greater numbers than with previous tech­
niques. The greater presence of ELAM-1 and 
ICAM-1 at the JE and JE /C T  area compared with 
OE may influence and explain the increased leuko­
cyte traffic (PMN and T  cells) in these areas, result­
ing in local defence of the periodontal tissue.
Although no significant difference was detected 
in the number of PMNs in the JE /S E  o r JE /C T  
areas at different time points, this does not mean 
that the number of PMNs trafficking through the 
tissues does not increase during the course of ex­
perimental gingivitis. It simply reflects the diffi­
culty of trying to assess the dynamic flow of ceils 
into and out of the tissues by counting those caught 
in the middle at one particular moment in time. In 
other words if the recruitment of PM Ns into the 
tissues is balanced by their loss into the gingival 
crevice there may be little change in PM N numbers 
in the tissues even if there is an increase in the rate 
of traffic over the 21 d (Table I). The fact that 
ELAM-1 expression was detected throughout the 
21 d of experimentally-induced inflammation sug­
gests one of two possibilities: either the blood ves­
sels in gingiva are functionally specialized and 
constitutively express ELAM-1 plus high levels of 
ICAM-l to facilitate leukocyte traffic into the gin­
gival crevice; or, the gingival vessels are perma­
nently activated even in ‘health’ due perhaps to the 
constant ingress of bacterial products such as LPS 
across the junctional epithelium. Further support 
for the idea that gingival post-capillary venules 
may be specialized to express ELAM-1 constitut- 
iveiy, is provided by the fact tha t they do not 
exhibit the normal modulation of ELAM-1 ex­
pression seen in other situations (16, 17, 25).
IGAM-1 has been shown to play a role in the 
adhesion of PMNs and T cells to ECs and it is also 
important in facilitating the trans-endotheiial cell 
migration of leukocytes (3, 10, 30). ICAM-l ex­
pression on the blood vessels changed very little in 
relation to its distribution throughout the 21 d 
and this was reflected in the T-ceil numbers not 
changing within the different tissue compartments
(Table 1). It was noted that junctional epithelium, 
and to a lesser extent sulcular epithelium, remained 
strongly positive for ICAM-l throughout the 21 d 
o f experimental gingivitis. At no point was ICAM- 
1 positivity o f the adjacent oral epithelium noted 
and the transition from ICAM -l-positive junc­
tional and sulcular epithelium to oral epithelium 
was always quite distinct and marked (Fig. 2a 3c 
2b). The intensity of the ICAM-l staining at JE is 
greater than is often seen in other epithelial tissues 
even in the presence of an immune-mcdiated in­
flammatory response or direct cytokine stimula­
tion. Taken together, these observations suggest 
that junctional epithelium may be specially adapt­
ed to constitutively express ICA M -l. Since ICAM- 
l expression on keratinocytes facilitates leukocyte- 
keratinocyte adhesion and transmigration (30, 31) 
this adaption may help to explain the special ability 
o f junctional epithelium to permit leukocyte traffic 
into the gingival crevice. Unlike endothelial cells, 
keratinocytes do not normally express ICAM -l; 
however, keratinocyte ICAM -l expression can be 
induced both in vivo and in vitro by the action of 
tumor-necrosis factor or interferon-y, but not by 
interleukin-1 or LPS (14, 32, 33).
The importance of these mechanisms in protect­
ing against periodontal disease is highlighted by the 
rapid and severe periodontitis that characterizes 
leukocyte adhesion deficiency (34-36). It is import­
ant that the kinetics of adhesion molecule ex­
pression and the dynamics of leukocyte trafficking 
are studied in greater detail in order to ascertain if 
defects in adhesion molecule expression play a part 
in determining an individuals susceptibility to 
periodontal disease.
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SUMMARY : The changes in Langerhans ceil numbers within the gingiva during a 21 day experimental gingivitis episode were 
investigated Immunohistochemicaily. Monoclonal antibodies to COla (specific for langerhans cells and thymocytes) and 
HLA-OR (class II major histocompatibility antigens * (MHC)) were used to identify Langerhans ceils within gingival biopsies 
taken on days 0, 7, 14 and 21. HLA-QR antibody stained dendritic ceils within the oral epithelium which were morphologically 
identical to the COla* Langerhans ceils. Class II MHC LC numbers rase and plateaued between day 7 and 14 then decreased 
to baseline by day 21. As plaque accumulated and initial inflammation developed there was an increase in the number of 
COla* Langerhans cells which peaked at day 7 and stayed high (day 14). As inflammation developed there was a statistically 
significant decrease in the number of COla* Langerhans cells by day 21 (p a 0.028). The initial increase, followed by a decrea­
se  in COla* Langerhans cells as inflammation developed, suggests that migration of Langerhans cells occurs within the gin­
gival epithelium and this may represent an important early event in the gingival immune response to plaque.
KEY WORDS : Experimental gingivitis • Langerhans ceils • HLA-OR • Inflammation - Orai epithelium
RESUME : Lea modifications du nombre de cellules de Langerhans au niveau de la gencive ont ete etudlies par Immunohisto- 
chimie pendant une periods de 21 jours de gingivite experimentale. Las anticorps monodonaux CDla (speciflques dee cel­
lules de Langerhans (LC) el das thymocytes) et HLA-OR (antigenes principaux d'histocompatibiiite de clasae II (MHC) ont etd 
utilises pour identifier las cellules de Langerhans dans les biopsies gingivales prelevees aux jours 0, 7, 14 et 21. L’anticorps 
HLA-OR a colore des cellules dendritiques dans i’epitheiium buccal qui sont identiques du point de vue morphoiogique aux 
cellules de Langerhans C01a». La nombre des cellules de Langerhans MHC c lasse  II augments et attaint un plateau enlre le 
7Eme et le I44me jour, puis revient aux valours de depart au jour 21. Au cours de ('accumulation de plaque et du dEveloppe- 
ment initial de ('Inflammation, on observe une augmentation du nombre des cellules de Langerhans C01A* qui attaint un pie 
au jour 7, puis rests eleve au jour 14. Aveo le deveioppement de I'lnflammation, on note une diminution statistiquemant signi­
ficative du nombre des LC C01a* au jour 21 (p * 0.028). L'augmentation initials suivie d'une diminution des LC COla* au 
cours du deveioppement de I’lnflammation suggerent qu'une migration des LC a lieu dans I’Epithelium gingival et represents 
un evenement prococe important de la reponse immunitaire gingivale a la plaque dentaire.
MOTS CLES : Gingivite experimentale - Cellules de Langerhans - HLA-OR • Inflammation - Epithelium buccal
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INTRODUCTION
Langerhans calls (LC) are dendritic, suorabasal calls 
found in most stratified squam ous epithalia including eoi- 
thalia of the oral m ucosa (Daniels. 1984.). They are of 
bone marrow origirT(Katz et al., 1979) and share  many 
c h a r a c te r i s t ic s  in co m m o n  w ith th e  m a c r o p n a g e  
(Thoroecke et al., 1980). In addition. LCs express Fc IgG 
receotors and C3 receptors (Stingl et al.. 1977) a s  well 
as COla and C lass II maior histocompatibility (MHC) anti­
gens (Klareskog at ai., 1977 ; Rowden et ai.. 19771 and 
are  capaole of antigen presentation (Silberoerg-SinaKin 
9t al.. 1980 ; Walsh et al., 1988 : Cruchley et al.. 1989).
Hitzig et al„ (1989) reported a cross-secttonal study 
w here gingival tissue w as ca tegonsed  according to clini­
ca l in d ices . T h e se  a u th o rs  s u g g e s te d  LC n u m b e rs  
in c re a se d  during  early  s ta g e s  of in flam m ation  an d  
decreased  in severe inflammation. T hese cross-sectional 
findings on chronic gingivitis, are  in contrast to longitudi­
nal experim ental gingivitis s tu d ies w here LC num bers 
w ere reported to increase steadily with gingival inflamma­
tion (N ew com b et al., 1982 ; O iFranco et al.. 1985 ; 
Newcomb and Powell, 1986a, 1986b).
T he aim  of th e  p r e s e n t  s tu d y  w a s  to e x a m in e  
ch an g es in LC num bers within hum an gingival tissu es  
during experimentally induced gingivitis. The monoclonal 
antibody to CD 1 a  (cluster of differentiation (CD) antigen 1 a) 
(Fithian et al.. 1981 : Harnst et al., 1983 : OiFranco et 
al., 1985) w as used in the immunohistochemicai analysis 
of LC num bers in the biopsy material. Langerhans ceils 
h av e  b een  show n to be  HLA-OR* (K lareskog  et al..
1977) and related to this, are capab le  of antigen p resen ­
tation (Stingl et al„ 1978), therefore HLA-OR positivity of 
LCs w as also a ssessed .
METHODS
Biopsy materia! was obtained using the expenmental gingivi­
tis model of LPe. Theilade and Jensen (1965). Ethical approval 
was granted by the local ethical committee. Five dental students 
(4 male. 1 female) who consented to participate in the study, 
received oral hygiene instructions and frequent prophylaxis unol 
maximal clinical gingival health was obtained. All subjects were 
then instructed to cease all oral hygiene measures and plaque 
was allowed to accumulate undisturbed for a penod or 21 days. 
The clinical indices were recorded (every 7 days) at each biopsy 
site, using the Plaque Index (PI) of Silness and Loe (1964) and 
the Modified Gingival Index (MGI) of Lobene et al. (1986). The 
MGI is a modification of the Lde and Silness (1963) Gingival 
index, it omits the bleeding-upon-probing component of the 
index and permits a non-mvasive evaluation of the early visible 
changes in the extent and seventy of gingivitis. One examiner 
was used throughout the experiment to record the clinical 
indices (E.A.).
Gingival biopsies (2mm x 2mm) were obtained surgically on 
day 0 of the experimental gingivitis phase, from the mid-buccal 
aspect of the lower right first permanent molar. The remaining 
first permanent molars were then biopsied in rotation (day 7. 14 
and 21). In total four biopsies, one at each time point, were 
taken from each individual. All tissue biopsies were embedded 
in Tissue Tek and snap frozen, 8um thick sections were cut and 
stained using the ABC method of Hsu. Raine and Fanger 
(1981). Frozen cryostat sections of the specimen were air dned 
and fixed in cold acetone. Following fixation, the sections were
blocked with horse serum before the addition of the pnmary 
monoclonal antibodies. The sections were reacted for 1 hour at 
room temperature (RT) with a i : 50 dilution ot the mouse mono­
clonal antibodies OKT6 (anti-COla) (Ortho Diagnostics, 
Buckinghamshire, UK) or OKIat (anti-HLA-OR) (Ortho 
Diagnostics, Buckinghamshire. UK). The pnmary monoclonal 
antibooies were then labelled with biotmylated anti-mouse 
immunoglobulin. Before the addition of avidin-biotinylated pe­
roxidase comolex (Vector Laboratones. Peterborough. U.K.) the 
sections were deoeroxidised (0.03 % hydrogen peroxide in 
methanol) to remove endogenous peroxidase. Between each 
mcubanon the slides were wasned with phospnate buffered sali­
ne (pH 7.4). The reaction was developed using the substrate 
diammobenzidine tetranydrochlonde and to enhance staining, 
the sections were then incubated in 0.5 % copper sulphate solu­
tion. The slides were finally counterstained with haematoxylin, 
dehydrated and mounted. One section from each biopsy was 
also stained with haematoxylin and eosin. Monoclonal annbooy 
specificmes were confirmed using human tonsil and human skin 
as control tissue and approonate negative control sections trea­
ted with non-specific pnmary mouse monoclonal antibodies 
(CD21 and CD22. both IgGl).
Only sections with intact gingival oral epithelium (OE) were 
used for LC quantification. LCs were identified as dendritic 
nucleated, COla* or HLA-OR* cells, within the full thickness of 
the gingival OE. Ten randomly chosen high power fields from 
biopsies (minimum » 3 sections) from each individual at each 
lime point were studied and LCs were counted "blind* at x 400 
magmficaaon. The area of sectioned gingival OE was measured 
from eacn section using computer assisted image analysis 
(Video Vector Oynamics. Glasgow. U.K.) and the mean number 
of positive ceils per biopsy calculated and expressed as LCs per 
high power field (0.018 mm2). Serial sections from day 0 and 
day 7 bioosies were prepared to permit calculation of the per­
centage of HLA-OR* COla* LCs.
Repeated measures analysis of variance (SPSS PC) were 
used to determine if 'day' effects were significant for both CD 1a* 
and HLA-OR* expression on LCs during the expenmental gingi­
vitis exoeriment. Paired t-tests were then used to oompare bet­
ween days, and a multiple comparison correction employed. 
Lack of a biopsy for subject A on day 0 necessitated omitting 
this subject from the repeated measures analysis.
RESULTS
Following the withdrawal of oral hygiene procedures 
the clinical indices of the biopsy sites ro se  and peaked  by 
day 21, with the rise in PI just preceding the rise in the 
MGI (Table I). At day 0 in healthy gingiva, CD1 a*  LCs 
w ere seen  within the oral and sulcular epithelia. Generally 
they w ere dendritic and  w ere found within the stratum spi- 
nosum  of the gingival OE. with only a  few cells p resen t 
within the sulcular epithelium. Junctional epithelium w as 
often incomplete and variable and th e  term sulcular epi­
thelium w as used  to include both junctional and oral sul­
cular epithelium. As-piaque accum ulated there w as a  shift 
of LCs from the stratum  spinosum  to the stratum granulo- 
sum  (day 0 to day 7) and by day 14 the  CO 1a* LCs w ere 
m ore basaily positioned (Fig. 1). HLA-OR* dendritic calls 
were found within the  gingival OE and w ere morphologi­
cally identical to the CD 1a* LCs (Fig. 2) and this evidence 
together with the  serial section d a ta , strongly su g g e sts  
th a t th e  two m onoclonal an tib o d ies a re  de tec tin g  th e  
sam e ceil type within the  gingival OE. HLA-OR antigens 
w ere detected on 52.5 %  (day 0) and 32.1 %  (day 7) of
2
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C 0 1 a *  L C s  ( c a l c u l a t e d  from  s e r i a l  s e c t i o n s ) .  
K era tinocy tas onty faintly s ta in ed  for HLA-OR an d  com oi- 
ned with their diffusa ex p ress io n  perm itted  c le a r  d istinc­
tion from LCs to be  m aoe.
A s th e  c lin ic a l m d ic a s  in c r e a s e d ,  th e  d e n s i ty  of 
CD l a ” LCs within the  gingival O E in c re a sed  during the 
first s e v e n  d ay s  of oral hy g ien e  aosten tion . Following this 
initial in c r e a s e ,  C D la *  1C  n u m o e rs  d e c r e a s e d  only 
slightly with further o iaq u e  a ccu m u la tio n  and  d e v eio o - 
m e n t of g in g iv a l  in f la m m a tio n  (d a y  7 to  d a y  14). 
However, a s  inflam m ation oev eio o ed  (dav 14 to day  21), 
the n u m o e rs  of C D la*  LCs d e te c ted  within th e  gingival 
OE d e c re a s e d  bacx to b ase lin e  levels by day 21 (T able I). 
The n u m o e r of HLA-OR* LC s h o w ev er in c re a s e d  and  
p la teau e d  b e tw een  day 7 an d  day 14, then  d e c r e a s e d  to 
o ase im e  levels  by day 21 (T able  I).
R e o e a te d  m e a su re s  an a ly sis  of v a rian ce  (MANOVA) 
d e m o n s t r a te d  s ig n ific a n t c h a n g e s  in th e  n u m o e rs  of 
CD 1a* LC s with time and  further analysis  (pa ired  t-tests) 
d e m o n s tra te d  th a t the  d e c r e a s e  in C D la *  L C s w m cn 
occurred  b e tw een  day 7 and  21 and  b e tw een  day 14 and
21 w ere  statistically  significant (p -  0 .0 0 3  an d  o  -  0 .023 
resoec tive iy ). H ow ever, no  s tatistica lly  s ig n ifican ce  w as 
d e m o n stra ted  w nen MANOVA w a s  u s e d  to a n a ly se  HLA- 
DR* LCs c n a n g e s . The s ta tis tic a l leve ls  tor th e s e  a n a ­
lyses m ust b e  re d u c ed  a s  thev  w e re  oart of multiDie com ­
p ariso n s  (n =• 6) a n d  a  th e re fo re  a  statistically  significant 
th resno id  of 0 .0 2  snou id  b e  u s e d .
DISCUSSION
Conflicting d a ta  ex ists  on  the  d y n am ics  of LC num ­
b e rs  during  g ingival in flam m ation . M any w o rk e rs  h av e  
s u g g e s te d  th a t a s  in flam m atio n  d e v e io o s  th e r e  is an 
in c re a se  in th e  n u m b e r of LC s p r e s e n t  within gingival 
oral eo ithelium  (N ew com o et al.. 1982 ; Q iF ranco  et ai.. 
1985 ; N ew com o and  Pow ell, 1986a, 1986b). H ow ever, a 
re c a n t c r o s s - s e c t io n a l  s tu d y  by H itz ig  e t a l . .  (1 9 8 9 ) 
w h e re  t i s s u e  w a s  c a t e g o r i s e d  a c c o rd in g  to  c lin ic a l 
indices, s u g g e s te d  th a t d u n n g  initial inflam m ation  there  
w as an in c re a se  in LC n u m o ers . an d  in s e v e re  inflam m a­
tion this d e c re a s e d , con trad ic ting  p rev io u s  s tu d ie s . This
Table I. Clinical param eters and L anqem ans call num bers 
(COtA* and HLA-OR*) during the 21 days of experim ental 
gingivitis. M eans with s tan d ard  dev iations in p a ren th e sis  
are show n for CD1A and HLA-OR positive L angernans ceils 
in 10 high pow er fields (0.018 mm2)
DAY S U 8JE C T  PI MGI
21
CD1A*LCS HLA-OR* LCs 
per0.018 mm2 per 0.018 mm2
A 0 0 Not done Not done
3 1 0 42(1 .3 ) 0.8 (0.6)
C 0 0 8.2 (1.3) 2 3  (1.1)
0 0 0 3.7(1.1) 0.3 (0.5)
E 0 0 4 9  (1.9) 0.5(0.7)
mean 4.8(1.1) 1.0 (0.8)
A 1 0 5.8 (1.1) 2 3 (0 .7 )
3 1 1 7.0 (2.3) 1.3 (0.9)
C 2 1 5.3 (2.0) 1.4 (0.7)
0 2: 1 5.8 (1.3) 2 0 (1 .1 )
E 2 2 4.8(1.1) 3.4 (0.8)
mean 5.9 (0.8) 21 (0.8)
A. 2 2 5.2 (1.5) 2.9 (1.0)
3 2 2 5.1 (1.3) 0.8 (1.0)
C 2 2 5.3 (1.3) 0.8 (0.6)
O 2 2 5.3 (1.2) 3.3 (1.8)
c 2 2 5.3 (1.2) 2 2 (1 .5 )
mean 5.3 (0.3) 1.9 (1.8)
A 2 2 5.1 (1.8) 0.0 (0.0)
3 3 3 4 0  (1.9) 1.1(0.7)
C 2 2 4 3 (1 .1 ) 1.0 (0.8)
0 2 2 2 3  (1.8) 18  (0.8)
E 2 2 1.8 (1.3) 19(1 .0 )
mean 3.6 (1.3) 1.2 (0.8)
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Fig. 1. Day 14 biopsy with COla” langerhans cells within the 
oral epithelium (solid arrows) (Immunoperoxidaae) (x 73.75).
0.02 mm
Fig. 2. Day 7 biopsy : A HLA-OR” Langerhans cells within the 
oral epithelium (solid arrow) (Immunoperoxidase) (X 500).
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work providas an insight into the ch an g es in LC num bers 
within the gingival OE at different s ta g es of inflammation. 
Results from the present study support the view of Hitztg 
et al.. (1989) that there is initially an increase in LC num­
bers followed by a  d ec rease  a s  inflammation oevelops.
OiFranco et al.. (1985), how ever com pared  treated  
and un treated  lesions within the sa m e individual using 
OKTS, S -1 0 0  and HLA-OR m ark e rs . T h e se  w orkers 
found that the num oers of LCs presen t in the inflamed 
tissu e  w ere significantly in c rease d , and that the  b est 
marker for LCs w as GKT6 wnich gave a  maximum num­
ber of LCs in the gingival epithelium of 9.8 LC/mm^. This 
is extremely low wnen com pared  to both the maximum 
n u m b er of LC s re p o rte d  in th e  p r e s e n t  s tu o y  (389  
LC/mm*) an d to the study  of Hitzig et a l.(1989) (11? 
LC/mm*). suggesting that the absolute num bers of LCs 
found w ithin th e s e  d is e a s e d  s u b |e c ts  w a s  se v e re ly  
depressed . Interestingly, Hitzig et al.. (1989) used  thinner 
sections 6p.m. than the 8iim of the  p resen t study, and this 
plus a  more restrictive criteria for LC determ ination may 
account for the  lower n um bers se en . N ew com b et al., 
(1982) employed Adenosine T riphosphatase to com pare 
LC num bers in gingival tissue  obtained after 0. 3 and 21 
days of p laque accumulation in 4 volunteers. T hese  wor­
kers found a  statistically significant increase in the num­
ber of LCs present as plaque accumulated (day 0 to day 3). 
However, with the developm ent of gingival inflammation 
(day 3 to day 21), there w as no difference in the num ber 
of LCs present. The p resen t study repons a  peak  in the 
number of LCs present after 7 days of p laque accum ula­
tion. and a  statistically significant d e c rease  in 0 0 1 3 '  LCs 
seen  betw een days 7 and 21 and days 14 and day 21 
(Table I) (p * 0.003 and p * 0.028 respectively) (MANO­
VA). Newcomb and Powell (1986b) have m ore recently 
dem onstra ted  that ad en o s in e  trip h o sp h a tase  is not a s  
specific for LCs a s  the CD1 a  monoclonal antibody.
The above studies exam ined LC num bers in different 
individuals : d iseased  com pared with healthy individuals 
or at different time points, sites  within the sa m e  d iseased  
individual. Closer evaluation of the d ata  from th ese  stu ­
dies su g g e sts  that the num bers of LCs d etec ted  within 
these subjects are severely d ecreased  in com parison to 
the p resen t study.
The num ber of C lass II MHC positive (HLA-OR'*’) LCs 
plateaued betw een day 7 and 14 and returned to baseli­
ne levels by day 21. As th e  num ber of C O la*  LCs remai­
ned relatively constant betw een day 7 and day 14. this 
mignt be explained if the CO 1a* LCs p resen t on  day 0 
consisted of som e HLA-OR* calls which becom e c la s s  II* 
ceils a s  inflammation developed (Walsh et al.. 1988). The 
HLA-OR sp ec ific  m onoclonal an tibody  could a lso  be 
detecting m acropnages. Further histochem ical analysis 
however, using the m acrophage specific OKM1 monoclo­
nal antibody (Ortho), suggested  that m acrophages were 
too infrequent within the epithelium to appreciably effect 
the num bers of HLA-OR* calls. The p ercen tage  of C D la*  
LCs whicn also expressed  HLA-OR antigen varied from 
52.5 to 82.1 % (calculated from day 0 and day  7 serial 
sections reoectiveiy). w h e reas  the  C D la  and  HLA-OR 
positive LCs given in Table I. albeit from non-serial sec­
tions indicate a range in this study betw een 0 to 75 %. 
This lower percen tage  and wide variation in the  HLA-OR 
expression of CDla-i- LCs derived from non-serial se c ­
tions ind icates the a d v an tag es  of serial sec tio n s when 
enum erating two antigens on o n e  call type.
The inflammatory reaction produced in experim ental 
gingivitis results in various cells releasing cytokines and 
lymphokines (Charon et al., 1982 ; M ergenhagen 1984 ; 
O'Neill and W oodson. 1986 ; Kinane et al., 1992). The 
oifferential effects of cytokines on LCs su rface  antigen 
expression may modulate the subpopulation of LCs pre­
sent (Walsh et al., 1988 ; Ishii e t al.. 1990). W alsh et aL  
(1990) hav e  dem o n stra ted  that C lass  II MHC positive 
(HLA-OR*) LCs are  required for effective antigen  presen­
tation and that this expression  is im portant for gingival 
LCs to initiate a  T lymphocyte resp o n se  to antigen. It is 
u nclear of w hat significance th e  LC nu m b er c h a n g e s  
reported h ere  are, but a  flux of LCs into and out of the 
gingival epithelium may b e  occurring analo g o u s to the 
changes se e n  in the num ber of LCs p resen t a t th e  reac­
tion s ite  during  co n ta c t h y p e rsen s itiv ity  (S ilb e rb erg - 
Sinakin et al., 1980).
In conclusion, ch anges in LC num bers occurs within 
the first w eeks of gingival inflammation. This m ay reflect 
m ovem ent in and out of gingival epithelium and  sug g ests  
that th e se  cells are  active in antigen presentation  even at 
this early s ta g e  of inflammation. Migration of gingival LCs 
into the lymphoid system  would result in stimulation of 
lymphocytes and initiation of an immune response . This 
flux of LCs m ay rep resen t an  im portant early “immune 
triggering" ev en t in th e  gingival im m une re s p o n s e  to 
plaque.
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Lactoferrin in the gingival crevice  
as a marker of polymorphonuclear 
leucocytes in periodontal 
diseases
Adonogianaki E. Moughal NA and Kinane OF: Lactofernn in the gingival crevice 
as a marker o f polymorphonuclear leucocytes in periodontal diseases.
J Clin Periodontal 1992; 19: 000-000.
Abstract. This study examined lactofernn (LF) levels in gingival crevicular fluid 
(GCF) and set out to test the hypothesis that LF could act as a marker of 
crevicular polymorphonuclear leucocytes (PMN). Therefore. 2 experiments were 
conducted: (a) to quantify total LF (ng/30 s sample) in GCF; (b) to correlate 
LF levels (ng/^1) and PMN numbers (PMNs/uD in gingival crevicular washings 
(GCW). GCF was collected from 71 sites in a total of 22 patients. These sites were 
classified on the basis of clinical indices of gingivitis (GI) and pocket depth (PD) 
into three clinical groups: ‘healthy*, 'gingivitis’ and ‘periodontitis’. GCWswere 
obtained from an additional 63 sites in 21 patients. LF in GCF and GCWs was 
assayed by a sandwich ELISA. Total leucocyte and differential counts were per­
formed on the GCWs. GCF LF (ng/30 s) correlated positively with GI (r*0 .4 l8 . 
p<0.001), PD (r*0.4 l5 , p<0.001) and GCF volume (r*0.624, p<0.00l). Gingi­
vitis (n *  21) and periodontitis sites ( n * 24) demonstrated significantly higher 
(p<0.05) total GCF LF than healthy (n—26) sites. Tn GCWs LF (ng//d) showed 
stronger correlations with clinical indices (GI: r *0.452. PD: r*0.513. p <  0.001) 
than did PMN numbers (PMNs/jd) (GI: r-0 .279 , PD: r-0 .3 8 8 . p<0.05). LF 
correlated strongly with PMNs in GCWs (r*0.531, p *0.001) and provides a 
simple and effective marker of crevicular PMN numbers.
The polymorphonuclear leucocyte 
(PMN) is the predominant leucocyte 
within the gingival crevice in both 
health and disease (Attstrom Sc. Egel- 
berg 1970, Kowashi et al. 1980, Thurre 
et al. 1984). Qualitative and quantitative 
PMN deficiencies result in gross perio­
dontal destruction (Wilton et al. 1988, 
Kinane St Davies. 1990). Although the 
PMN has a  protective role, the interplay 
between microbial plaque components, 
complement, immune complexes and 
PMNs, initiates the release of PMN in­
tracellular contents during inflam­
mation (HensO' 1971a, Henson 1971b, 
Taichman et al. 1977) which may dam­
age the neighbouring tissues (Wilton 
1986). The PMN therefore appears to 
have both a protective and potentially 
destructive role in the pathogenesis of 
periodontal disease. Granulocytes 
dominate periodontal inflammation 
(Gillett et al. 1990) and it has been sug­
gested that PMN numbers in the crevice
could be a useful marker of the inflam­
matory status of specific sites (Fine St 
Mandei 1986). PMN numbers in gin­
gival washings have been shown to in­
crease with the development of experi­
mental gingivitis (Kowashi et al. 1980, 
Thurre et al. 1984) and higher PMN 
numbers have been obtained at perio­
dontitis when compared to gingivitis 
sites (Thurre et al. 1984).
Sampling gingival crevicular fluid 
(GCF) provides a non-invasive means 
of quantifying site specific biochemical 
parameters which could help identify 
the periodontal status of different sites. 
Numerous PMN constituents, mainly 
enzymes, have been studied in GCF but 
most of these are not exclusive to the 
PMN (Fine St Mandei 1986, Curtis et 
al. 1989). Lactoferrin (LF) is an iron 
binding protein present specifically and 
in abundance in PMN secondary gran­
ules (Spitznage! et al. 1974) but not in 
other leucocytes (Bennet St Kokocinsld.
E. Adonogianaki, N. A. Moughal 
and 0. F. Kinane 
?«nodontal Unit. Oeoartmam ol Oral 
Medicine & Pathology, Glasgow Oenial 
Hosoiiat and Scnool. 378 Saucntanail Street. 
Glasgow. G2. 3JZ. UK
K«y words: gingival cravieuiar fluid: gingival 
crevicular waaninga; lactelemn: polymor­
phonuclear leucocytes.
Accepted (or publication 4 December 1991
1978) and only in trace amounts in 
serum (Hetherington et al. 1983). PMN 
secondary granules are more numerous 
than primary granules (Falloon St Gai- 
lin. 1986) and their contents are released 
earlier and more readily during in vitro 
PMN stimulation (Bentwood St Hen­
son, 1980). Moreover. PMN secondary 
granules have been shown to be prefer­
entially released, over primary granules, 
during both adherence in vitro and mi­
gration through epithelium in vivo 
(Wright St Gallin. 1979). Wilton (1986) 
summarised the stimuli for PMN de­
granulation in the crevice and con­
cluded that PMN secondary granule re­
lease is more likely in vivo. It has been 
suggested therefore that LF in GCF 
could perhaps prove a  reliable marker 
of PMN emigration and/or activation 
in the crevice (Fine St Mandei 1986. 
Curtis et ai. 1989).
Crevicular LF may act as an antimi­
crobial agent by creating an iron
2 AiJorwgtunoKi. .Uoughai and Kinane
limiting environment due to its high af­
finity lor iron, although it may also ex­
ert a direct bactericidal effect indepen­
dent of iron deprivation (Arnold et al. 
1982). In addition. LF facilitates phago­
cytosis of plaque bactena by reducing 
their hydrophobicity and preventing 
their adherence (Wilton 1986). LF may 
also be implicated in the inflammatory 
response by enhancing PMN ad­
hesiveness and chemotaxis (Oseas et al. 
1981, Falloon &Gailin 1986), by modu­
lating production of interleukin-1 
(Zucali et al. 1989) and prostaglandins 
(Peius et al. 1979, Banal et al. 1987) and 
by scavenging iron which could catalyse 
free hydroxyl radical formation (Briti- 
gan et al. 1989). Although promising 
as a periodontal disease activity marker 
and/or modulator, LF in GCF has only 
been reponed in one study to date by 
Friedman et al. (1983), who found 
higher LF concentration in pooled GCF 
from gingivitis, periodontitis and local­
ised periodontitis patients when com­
pared to healthy controls.
The present study was undertaken 
firstly, to assess LF levels in discrete 
GCF samples and to determine their 
correlation with the clinical indices of 
the sites sampled, and secondly, to test 
the hypothesis that LF could act as a 
marker of PMN emigration into the 
crevice. In order to address both issues, 
experiments were conducted: (a) to 
quantify LF in GCF; (b) to compare 
LF levels and PMN numbers in gingival 
crevicular washings (GCW).
Material and Methods 
Ctlnleal criteria
43 individuals attending the Glasgow 
Dental Hospital were selected to partici­
pate in this study. These individuals 
were all Caucasian, had no history of 
systemic disease and had not received 
any antibiotics for the past 3 months. 
32 of these individuals (APD category) 
suffered from advanced periodontal dis­
ease as determined by clinical and radi­
ographic examination. The additional 
ten subjects (H category) could be 
classified as periodontally healthy (no 
attachment loss, pocket depths £3  mm 
and no significant gingival inflam­
mation).
GCF samples were collected from 22 
of the above individuals (age range 22 
to 51 years: 10 male. 12 female; 16 APD, 
6 H) and GCWs from the remaining 
twenty one individuals (age range 20 to 
52 years; 7 male, 14 female; 16 APD, 5
H). A maximum of 4 sites were sampled 
per subject. The evaluation of gingival 
inflammation of the sues sampled were 
performed by the modified gingival 
index (GI) (Lobene et al. 1986) and the 
pocket depth (PD) was assessed (after 
GCF or GCW sampling) to the nearest 
mm using a Williams periodontal probe. 
Diseased s ite s (G Ii2 . PD>3 mm) were 
obtained from the periodontitis patients 
whereas healthy sites (G I^ l ,  P D ^2  
mm) were obtained mainly from the 
periodontally healthy subjects and in 
some cases from the periodontitis pa­
tients.
PMN numbers were assessed only in 
GCWs whereas LF levels were quan­
tified in both GCF and GOV samples. 
For the establishment of the range of LF 
levels in GCF according to the clinical 
presentation of the sites sampled, the 
latter were allocated into three clinical 
groups: 'healthy', 'gingivitis’ and ‘perio- 
donnas'. Sites with gingival scoring of 
0 or I and pocket depth not exceeding 
2 mm were categorised as ‘healthy’. GI 
between 2 and 4. and pocket depth less 
than or equal to 3 mm were the criteria 
for the ‘gingivitis' sites, whereas sites 
with pocket depth exceeding 3 mm were 
designated 'periodontitis’ sites.
Gingival cravteular fluid sampling and 
preceasing
Whatman grade 4 paper strips (2x13 
mm) were used for GCF collection 
(Griffiths et aL, 1988). The individual 
crevicular site was gently air-dried and 
any visible supragingivai plaque was re­
moved. The area was carefully isolated 
with cotton roils and saliva ejector to 
avoid saliva contamination o f ' the 
samples. The paper strip was introduced 
into the crevice until mild resistance was 
felt and left for 30 s. Care was taken in 
order to avoid mechanical injury of the 
tissues. After GCF collection, the paper 
strip was transferred to the chainide- 
locatcd Periotron (Periotron 6000, Har- 
co Electronics. Winnipeg, Canada) for 
the assessment o f fluid volume. The 
jaws of the Periotron were wiped with 
pure methanol between sequential read­
ings. The strips were then placed in indi­
vidual sterile microcentrifuge tubes and 
stored at — 30*C until further pro­
cessing. Subsequently, the strips were 
eluted into I mi o f phosphate buffered 
saline containing 0.05% Tween 20 
(PBST) and 0.1 % bovine serum albumin 
(BSA) for I h using a rotating mixer. 
The strips were then discarded and the
eluaie aliquoted and stored at — "0’C 
until used for the quantitation of lacto- 
femn. Prior to assaying the sample was 
diluted further in the same buffer.
Gingival cravteular waatilngs
GCWs were obtained using a modifi­
cation of the Skapski & Lehner method 
(1976). The teeth were isolated with sal­
iva ejector and cotton rolls and any vis­
ible supragingivai plaque was removed. 
Aliquots of 20 pi of Phosphate Buffered 
Saline (PBS) were ejected and reaspir­
ated in the crevice 3 x using a 20 pi 
micropipette, fitted with a flat ended 
pipette tip (Labsystems, UK), resting 
interdentally on the surface of the tooth. 
The gingival washings were then stored 
in individual microcentrifuge tubes at 
4°C. I pi aliquot of the washing, ob­
tained using a Hamilton Microsyringe, 
was eluted in I mi of PBST (0.1% BSA) 
and the eluate was stored separately at 
— 70SC for subsequent quantitation of 
GCW LF.
Total and dlfforamlal whit* call count*
Within 30 min of GCW collection a 
total cell count was performed on 5 pi 
o f the sample. A differential count of 
200-300 ceils into polymorphonuclear 
and mononuclear cells was carried out 
after cytocentrifuging the rest of the 
sample at 70 g (Shandon Scientific 
Limited. UK) and staining the cells by 
the Leishman method. The number of 
PM N//d GCW was finally calculated 
using the formula: total cell count x % 
PM Ns/100.
LF quantification
LF quantitation was performed on the 
eluate of GCWs and GCF. A modifi­
cation of the technique described by He- 
therington et al. (1983) was applied. 
Goat anti-LF (Nordic) was coated on 
the polystyrene microplate (Immuion 
IV, Dynatech laboratories). The eluate 
was added and any LF present was cap­
tured by the immobilized antibody. In­
cubation with the second anti-LF (rab­
bit) (Nordic) was followed by addition 
of peroxidase conjugated anti-rabbit 
IgG (goat) (ICN). Each plate included 
positive and negative controls and serial 
dilutions o f purified LF (Calbiochem) 
to permit construction of a  standard 
curve from which sample LF quantities 
could be estimated. Visualisation was 
achieved by incubation with the sub-
iMCtof'errm and P M N s  m the crevice
Table I. Spearman rank correlation coef­
ficients (r| between clinical indices anti GCF 
LF levels ol ft—<1 sues sampled; prooabilitv 
levels I/O are snown in parenthesis
Parameter LF (ng/30 s sample)
GI r-0.418 <p<0.00l)
PO r-0.415 <p<0.00l)
GCF ful) r-0.624 l/»<0.00l)
stnue (o-pncnylcncdiamincl and stop* 
ping the reaction with H,SO». The plate 
was read at 490 nm.
LF levels in GCF samples were ex­
pressed as absolute amounts in ng per 
30 s sample lng/30 s sample). In GCWs 
LF levels were expressed as ng/ pi GCW.
Statistical analysis
LF levels in GCF samples were skewed 
and were transformed to the base 10 
(logic) in order to normalise their distri­
bution and to obtain representative 
means of LF levels in the three clinical 
groups, healthy', ‘gingivitis’ and ‘perio­
dontitis’. For the same reason the 95% 
confidence intervals were preferred 
rather than the standard error (SE) or 
standard deviation (SD). Significant dif­
ferences of GCF LF mean levels among 
the clinical groups were determined by 
two sample r-test on the log)0 transform­
ed data.
Associations between LF levels (GCF 
and GCWs) or PMN numbers (GCWs) 
and the clinical indices (GI, PD and 
GCF volume) were determined using 
the non-parametric Spearman rank cor­
relation coefficient. The association be­
tween LF levels (ng//il GCW) and PMN 
numbers (PMNs//d GCW) in GCWs 
was determined by the Pearson corre­
lation coefficient on the logi0 transform­
ed data. Data were analyzed using the 
‘Minitab’ statistical package on the 
IBM PC computer.
Results
Gingival erevteuiar fluid
Seventy one sites were sampled in total 
for GCF. Associations between LF 
levels in GCF (ng/30 s sample) and the 
clinical indices were determined, and the 
Spearman rank correlation coefficients 
and their significance levels are shown 
in Table I. Absolute amounts of GCF 
LF demonstrated positive and signifi­
cant correlations with GI. PD and GCF 
volume:
Table 2 shows the sites allocated to 
the three clinical groups, ‘healthy’ (/t—
26). ‘gingivitis' (/» —21) and perio­
dontitis' (ft — 24). Higher GCF LF levels 
(ng/30 s sample) from gingivitis (p —
0.012) and periodontitis (p—0.0023) 
sites were obtained when compared to 
healthy sites (Table 2). No significant 
difference in LF levels between gingi­
vitis and periodontitis sites was demon­
strated (p>0.05) (Table 2).
Gingival cravteular washings
A total of 63 sites were sampled for 
GCWs. The mean GI and PD of the 
sites sampled were 1.87 (SD: 1.23) and 
3.19 mm (SD:2.2) respectively. 3oth LF 
levels (ng/'pl GCW) and PMN numbers 
(PMNs/pi GCW) were determined in 
each sample. The relationship between 
GCW LF levels and PMN numbers was 
examined, the Pearson correlation coef­
ficient was determined ( r —0.531, 
p <  0.001, n —63) and the least squares 
method was used in order to plot the 
best fitting line (Fig. I). The association 
between both GCW LF levels and 
GCW PMN numbers and the clinical 
indices was also assessed (Table 3). 
GCW LF levels and PMN numbers cor­
related positively and significantly with 
both GI and PD. but LF demonstrated 
consistently higher correlation coef­
ficients than PMNs with both clinical 
indices (Table 3).
Discussion
Recently, a method has been described 
for the approximate determination of 
PMN numbers in discrete GCF
samples, collected with paper strips (Ci- 
masoni & Giannopoufou 1988). This 
technique would appear to permit as­
sessment of LF levels and PMN num­
bers from the same GCF sample. How­
ever. in a pilot .study performed in our 
clinics and laboratories on a limited 
number of GCF samples, no PMNs 
could be recovered from the strips, 
either when vortexing (Cimasoni & Gi- 
annopoulou 1988) or centrifuging the 
sample (Ebersole et al. 1984) (data not 
shown). Thus, we resorted to the semi- 
quantitative method of GCWs for the 
determination of PMNs in the crevice 
and obtaining their relationship with 
GCW LF. Moreover, each site was 
sampled only once, either for GCF or 
GCW, as it was felt disruption by either 
sampling method would have alTected 
the results obtained by the subsequent 
sampling technique. Therefore. 2 differ­
ent experiments, on GCF and GCWs 
from discrete sites, were conducted so 
as to address the two central issues: (a) 
what levels of LF are present in GCF 
and how do they relate to the clinical 
condition of the sites sampled? and (b) 
can crevicular LF be used as a  marker 
for PMNs in the area?
We chose to report GCF LF levels as 
absolute amounts in ng/30 s sample. 
The rationale for expressing PMN con­
stituents in G C F as absolute amounts 
with a standardised collection time has 
been discussed in detail by several inves­
tigators (Lamster e t al. 1986, Smith & 
Geegan 1991). In contrast. LF levels 
and PMNs in GCWs were expressed as 
concentrations (ng/pi GCW, PMNs/pi
Table 2. Clinical indices and LF levels at healthy gingivitis and periodontitis sites; the mean 
(±SE) clinical indices and GCF volume are shown: the mean LF levels, expressed as ng/30 
s sample, are given; figures in parenthesis indicate the 93% confidence intervals
Parameter
Site
Healthy
(/•—26)
Gingivitis
(ft—21)
Periodontitis 
(ft-24)
GI OJ8±0.10 2_57t0.11 2.46+0.17
PD 1.54+0.10 2.71tO.10 5.04+0.29
GCF 04) 0.09+0.02 0.3210.06 0.3510.06
LF (ng/30 s) sample 95 (68-I3Z) 181 (123-266)* 217(144-328T
* Significantly dilTereni from healthy sites p < 0.02. 
“ Significantly different from healthy sites p< 0.003.
Table J. Spearman rank correlation coeiTidents (r) between dinical indices and GCW LF 
levels and PMN numbers of ft—63 GCWs obtained; probability levels (p) are shown in 
parenthesis __________________________________________
Parameter LF (ng/ Ail GCW) PMNs (PMNs/pi GCW)
GI r—0.452 O»<0.00l) r—0.279 (p< 0.030)
PO r—0.513 0»<0.00l) r—0.388 (p<0.003)
•i . I diirw^tcinaKi. Mmn’imi and Kinane
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Fig. I. PMN*/ pi GCW as function of GCW LF levels (ng//il GCW> in nm 63 GCWs. 3o(h 
variables are transformed to log,*, The Pearson correlation coefficient (r«0.531, /»<0.00l) 
was determined and the best fitting line plotted by the least squares method (regression 
analysis).
GCW respectively). However, as GCW 
is a semiquantitative technique. GCW 
LF and PMN concentrations are di­
rectly proportional to their absolute 
amounts present within the crevice.
Our data demonstrate that GCF LF 
(ng/30 s sample) correlates positively 
with the degree of gingival inflam­
mation (r»  0.418, p <  0.001, /t»71) and 
poclcet depth (r—0.415, p <0.001. e *  
71) (Table I). LF is contained within the 
PMN secondary granules (Spitznagei et 
al. 1974) which also contain lysozyme 
and collagenase (Baggiolini et al. 1978). 
The latter are potent enzymes which are 
released in the crevice at the same time 
as LF during PMN degranulation and 
could contribute to the development of 
inflammation and cause surrounding 
tissue damage (Cimasoni 1983). The ac­
tivity of such enzymes in the crevice is 
modulated by inhibitors like zl-anti- 
trypsin (MWT:55 kO) and x2-macro- 
globulin (MWT:720 kO) present in the 
area (Adonogianaid et al. 1992). These 
inhibitors would be less effective if the 
PMN was closely adherent to its sub­
strate (bacteria or epithelial cells) as the 
interface (PMN-substrate) would ex­
clude proteins with a molecular weight 
greater than 50 kD (Wilton 1986). LF. 
which enhances PMN adhesiveness 
(Oseas et aL 1981), may thus have a 
synergistic effect on PMN enzymes and 
indirectly contribute to surrounding 
tissue damage. Moreover. LF could di­
rectly cause damage to host ceils due 
to its strongly cationic charge. There­
fore, although LF has properties ben­
eficial to the host (antimicrobial), it 
also has potentially harmful features. 
LF is present in only trace amounts 
in serum (Hetherington et al. 1983). 
The positive correlation of GCF LF 
(ng/30 s) with GCF volume ( r»
0.624. p<  0.001, n*71) (Table 1) sug­
gests that a proportion of LF may be 
released by the PMN infiltrate pres­
ent within the connective tissue 
underlying the junctional epithelium 
area and may be passively transferred 
into the crevice by GCF flow.
When the sites sampled for GCF were 
allocated into the three clinical groups 
(Table 2), gingivitis (p»0.012) and 
periodontitis (p—0.002) sites demon­
strated elevated LF levels (ng/30 s) 
when compared to healthy sites. No sig­
nificant difference however, could be 
observed between gingivitis and perio­
dontitis sites although the latter did 
demonstrate a tendency for increasing 
LF levels. In this cross-sectional study, 
PO was used as the differentiating fac­
tor between gingivitis and periodontitis 
sites. PD. reflects the history, rather 
than the activity, of periodontal disease 
a t a  specific site and this may have a 
bearing on the inability of LF levels 
(ng/30 s) to differentiate periodontitis 
from gingivitis sites.
LF has been quantified previously in 
pooled GCF, and higher LF levels were 
obtained a t gingivitis, periodontitis and 
localised periodontitis patients when 
compared to healthy controls (Fried­
man et al. 1983). However, as the meth­
odologies applied in this and our study
differ substantially comparison between 
the results is difficult.
Is LF a useful marker of crevicular 
PMNs? When the association between 
PMN numbers and LF levels in GCWs 
from discrete sites was examined a posi­
tive (r^O.531. 3) and significant
(pcO.OOl) association was obtained 
(Fig. 1). The moderately strong re­
lationship between GCW LF and crev- 
icuiar PMNs could be due to the LF 
contribution of degranulating PMNs 
within the gingival connective tissue. Al­
ternatively, LF might reflect better the 
activated rather than the total PMNs 
present in the crevice.
When associations between the clini­
cal indices and LF concentration or 
PMN numbers in GCWs were examined 
positive correlations were obtained 
(Table 3). Interestingly, LF in GCWs 
demonstrated stronger correlations with 
both GI and PD than did PMN num­
bers (Table 3). This suggests that PMN 
activation/degranulation may be a 
better test of periodontal disease status 
at a specific site rather than simply 
PMN numbers present in the crevice.
In conclusion, our data support the 
view that LF is a useful marker of PMN 
emigration and/or activation in the 
crevice. LF determination in GCF is 
more accurate and simpler to perform 
than the enumeration of PMNs using 
GCWs or styroflex strips. LF correlates 
well with the clinical indices of the sites 
sampled but further investigation of a 
longitudinal nature is required in order 
to assess its potential as a marker of 
periodontal disease activity.
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Zusammenfassung
Lataofemn int gwgiraien Sudan als Marker 
fur polymorphkemige Leukozyten bei para• 
dontaien Krankheiten
Urn die Hypoihese zu prufen, daQ Laktofer- 
rin als Marker fur krevikulare. polymorph- 
kemige Leukozyten (PMN) infrags kommen 
kann. warden in dieser Studie die Laktoferrin 
(LF) Niveau* im krevikuiaren Sekret der 
Gingiva (GCF) untenucht und dargestellL 2 
Experimenie wurden vorgenomnten: a) tar 
Quantifiziening der gesamten LF (ng/30 s 
Probe) im GCF (krevikuiaren Gingivasekret) 
und: b) zur (Correlation der LF-Niveaus (ng/ 
>il) und der PMN-Zahl (PMN/jiI) bei krevi-
Lactofcrn  i and PM Ns fit the crevice JT
kulSran GlngivaspOlungen (OCW). Bei im 
gwuxn 22 patlenten warden no 7t Steilen 
GCF enltiommeit. Voii klinischcn Indizes bei 
der Gingivitis (OI) und der Tbichcntlefe (PD) 
nuigeliend, wurden dies* Steilen in (lie drei 
kllniiciien Oruppen: ‘gesund*, ‘Gingivitis* 
und Tarodontiti*' eingetetlt. Danach wurden 
bei 21 Patlenien nn weiteren 63 Stellen 
GCWs (krevikulfire UingivuspOtungen) vor- 
ganummen. Dec Vorkommen von LF In der 
OCW wurde durch eino Sandwich ELISA 
gcpiilft. In den OFW‘» wurden Gewiml- und 
(lirTerenztcrie Lcukozytenausrilhlungen vor* 
genommen. Die LF-Niveaus im GCF (ng/30 
j) korrellorten poslilv mlt der Ot (r«0.418. 
y»-i0.00l), der PD (rwO.415, /r<0.00l) und 
Jem OCF Volumen (r«0.624. /*<0.00l). Es 
zeigl* rich. dnO in Oingivitis- (n»21), und 
Pnruduntilieilellen (n ■* 24) signiflkant hfihe- 
re (p < 0.05) OCF LP Gcsamtwerte vorka- 
men via in gesunden (a—26). Bei den LF* 
Wei ten In OCW's (ng/jil) waren itlrkere 
Korrelalionen ni klinischcn Indizes vorhlin­
den (GL r—0.432. PD: r-0.J13, /?<0.00l) 
al* bei den PMN-Zahlenwerten (PMNs//il) 
(GI: r-0.279, PD: r-0.388, p<0.03). LF- 
Werl* kunelierten itark mil den PMNs In 
den OCW* (r-0.531, p<0.001) und bieten 
alio einen einfachen und eiTekliven Marker 
kievikulaier PMN-Znhtan an.
RCeumd
La lactoferrtne du sllton gingival cn lam tpte 
martfueur tics leucocytes polynttclialres dans 
la tnaladle partnlontuie
Celt* ttude a examine ai lea laua de lactoferri- 
ite (LF) du ftuido criviculairo gingival (GCF) 
pou valent scrvlr de marqueur des leucocytes 
polymicleaire* (PMN) du lillon gingival. La 
premiiro experience a 4(4 de caiuuler la t|uan- 
tlt4 de LF presents dans le OCF en ng pour 
un cvhantillonage de 30 s. La seconde consis- 
tail 4 mettre en relation (aux de LF (ng/ 
pi) et nomhre d* PMN (PMNs//»l) dans des 
lavages crlvlcttlalrei (GCW). Le OCF a et* 
preleve au niveau de 71 sites chcz 22 patients. 
Ces sites ont 4t6 ripartls en «*aln», «g(ngivt- 
tee et eparodontitcn suivant I’lndlce d’lnflam- 
inallon gingivale (GI) et 1u prolondeur do 
povlie au sondaga (PD). Les GCWs ont tga- 
lenient et4 pr4vel4s au niveau de 63 sites chcz 
21 patients. Les teneurs en LF duns le GCF 
et les GCWs ont kti metur4es par 12LISA 
sandwich. Le nombre total de leucocytes et 
les vomptage* diflerenllels uni 4l4 effoctuea 
sur les OCWs. La LF pr4sonto dan* le GCF 
it ait en relation positive avec le Ot (r *0.418: 
/»<0.00l). la PD (r-0.4IJ; p-cO.001) et le 
volume de OCF (r—0.624; /K0.00I). Les 21 
tiles avec gingivite et les 24 avec parodontilo 
avaient davantage (p<0.03) de LF totalo 
dans le GCF que les 26 sains, Dans les GCWs 
la LF moiitiait plus de vuMclnliuu avec tea 
indices cllniqucs (GI: r-*0.452; PD: r« 0.313 
et p< 0.001) que ne te fklsalt le nombre d* 
PMNs (Ot: r-0.279; PD: r«0.38S et 
p<0.05). La LF ctail Toil en correlation avec 
les PMN* des GCWs (r-0.331 et /»<0.001)
et represente done un marqueur simple et
efTlcace du nombre de PMNs crtviculaires.
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Introduction
During the initiation of inflammation, vascular en­
dothelium is activated by a variety of molecules 
which increase the permeability of vessels and regu­
late che passage of leukocytes from the blood­
stream into the inflamed tissues. Of the molecules 
capable of acting on the endothelial cells, interleu­
kin-1 (IL-l). an inflammatory cytokine, has been 
detected in inflamed gingiva (I). IL-l upregulates 
expression of endothelial leucocyte adhesion mol- 
ecules-l (ELAM -l) and intercellular adhesion mol­
ecule-1 (ICAM -l). which are ligands for adhesion 
molecules on leukocytes (integrins). and thus influ­
ence gingival leukocyte infiltration.
x2-macroglobulin (o2-M) and x 1 -antitrypsin 
(a I-AT) together comprise 90% of the serum pro- 
tease inhibitors (2) and have been identified in 
gingival crevicular fluid (GCF) from diseased sites 
at about 75% of their serum leveis (3). Transferrin 
(TF) is a serum-derived iron-binding glvcorprotein 
(4) which in G CF might function as an antibac­
terial agent by producing an iron-limiting environ­
ment (5). TF has been reported in G C F at levels 
similar to those of x2-M and xl-AT (3). Recent 
evidence suggests that, in addition to their classical 
roles, these proteins can modulate the imm une re­
sponses via several pathways: x2-M binds import­
ant effector molecules such as cytokines and ceil 
receptors which inhibit immunological reactions 
(6): xl-AT has been implicated in the inhibition of 
lymphocyte responses, complement activation and 
neutrophil migration (7): and TF is involved in T-
cell transformation and macrophage activation (8).
The dynamics of these acute-phase proteins, and 
the cytokine IL-l in GCF. were compared with 
leukocyte infiltration and expression of the endo­
thelial ceil adhesion molecules ICAM-l and 
ELAM -l. dunng 21-day experimental gingivitis 
episode (9).
Material and Methods
Twelve healthy students stopped toothbrushing for 
21 d. A t baseline (d 0). and after 4. 7. II. 14. 17 
and 21 d of undisturbed plaque accumulation and 
following the remstitution of oral hygiene pro­
cedures (d 28 and 3 5). clinical changes were re­
corded using a Plaque Index (10) and a modified 
Gingival Index (11). and G CF was sampled using 
Whatman grade-4 paper strips (2x13  mm) (12) for 
30 seconds. Quantification of GCF volume was 
performed using the Periotron 6000 (Harco). The 
strips were eiuted into 1 mi of phosphate-buffered 
saline and 200 ul aliquots were analyzed for the 
x2-M. xl-AT and TF. For the IL-l bioassay. GCF 
was eiuted from the paper strips by incubation for 
30 minutes at 4'-C in 150 fd o f RPMI 1640 medium 
with supplements. Indirect competitive immunoas­
says were developed for the quantification o f z2- 
M and TF. zl-AT was assayed using a double- 
antibody sandwich assay. For each individuaL a 
mean values was obtained for each sampling inci­
dence for x2-M. xl-AT and T F  levels (in ng per 
30-s sample).
IL-l activity was determined by bioassay using
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che (L-1 -sensitive cetl line DlO(N4)M (13) except 
chat ceil proliferation was determined by a colorim­
etric method ( U). The potency of the stimulatory 
activity in the eluate was determined from dose- 
resoonse curves obtained with a recombinant hu­
man DNA-denved IL-l beta (rhlL-ltf) standard, 
using che computer program ALLFIT (15). G in­
gival biopsies (2;<2 mmi were caken from the first 
moiar buccal gingiva on d 0. 7. 14. and 21 and 
emoedded in Tissue Tek. snap frozen in liquid ni­
trogen after which senal 8 um thick sections were 
cut. Frozen sections were immunooeroxidase- 
stained using a panei of monoclonal antibodies for 
Langerhans cells. T-helper. T-suppressor. primed 
T iCD45RO). pan-T and 3 cells, monocyte;macro­
phages. neutrophils. HLA-DR. ICAM-l and 
ELa M-L Leukocytes in the sections were counted 
ac x 400 magnification in defined areas. Lang­
erhans ceils and other infiltrating cells within the 
epithelium were counted and the area of sectioned 
oral epithelium (AO E) determined, using com puter 
assisted image analysis. Three adjacent areas 
within each section were counted and the mean 
number of positive ceils per biopsy was calculated 
and expressed as either ceils per t). I mm* of connec­
tive tissue or of AOE. HLA-DR. (CAM-1 and 
ELAM-l were scored using a grading system for 
specified areas of the section.
Results
Following withdrawal of oral hygiene procedures 
the plaque index rose rapidly and was followed by 
the gingival inflammatory index. GCF EL-1 peaked 
within 7 d of the inflammatory episode (p < 0.05'). 
x2-M. xl-AT. T F  and G CF volume increases 
matched the gingival inflammation index. x2-M 
levels throughout the study were markedly higher 
than the levels o f xl-AT fp <  0.05').
The term sulcular epithelium (SE) was used to 
include boch the JE and oral sulcular epithelium. 
Langerhans cell (LC) numbers increased from 
baseline and peaked at d 14 (p =*0.03: Mann-W hit­
ney). HLA-DR staining increased from baseiine 
and peaked a t d 7. after which the H LA-DR" 
cellular infiltrate started to t'alL reaching baseline 
levels by d 21. Pan-T ceils and PMN also peaked 
a t d 7 in the SE. then reduced as inflammation 
progressed. Expression of vascular [CAM-1 and 
ELAM-l increased at or before d 7. which co­
incided with the peak in CL-1 levels and T-cell 
infiltration. [CAM-1 expression in junctional epi­
thelial keratinocytes peaked a t d 7 and exhibited a 
gradient effect in the density o f [CAM-1 from the 
crevicuiar towards the basal region of the epithe- 
'  iium.
Discussion
Dunng the initiation of gingival inflammation 
many immune and inflammatory events take place 
at different time points. EL-1 appears to peak at d 
7. as does upregulation of ELAM -l. (CAM-1. 
HLA-DR and leukocyte infiltration. The changes 
in acute-phase proteins appear to follow changes 
in the inflammatory index and probably reflect 
the changes in vascular permeability. x2-M levels 
throughout the study were markedly higher than 
the levels of xl-AT and may reflect the fact that 
z2-M can be locally produced by resident ceils or 
infiltrating macrophages (16).
Sulcular neutrophil numbers decreased as gingi­
vitis progressed and only recovered to baseline 
levels at d 21. suggesting PMN movement into the 
gingival crevice, presumably by chemocaxis. The 
spatial and temporal changes in PMN numbers 
illustrate the difficulty in interpretation using 
sequential biopsies. The flux of ceils into the crev­
ice. o r back into the connective tissue, o r arriving 
from the blood vessels, cannot easily be determined 
without time-lapse video analysis. However, immu- 
aocvtochemistry and G C F ELISA techniques are 
valuable tools in the investigation of immune and 
inflammatory processes in experimental gingivitis 
and may elucidate the role of specific cells and 
soluble factors in the initiation and pathogenesis 
of periodontal disease.
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BIOASSAY OF INTERLEUKIN 1 (IL-l) IN HUMAN 
GINGIVAL CREVICULAR FLUID DURING 
EXPERIMENTAL GINGIVITIS
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Summary—The cytokine IL-l was demonstrated in crevicular fluid during a 14- and 21-day experimental 
gingivitis in healthy human volunteers. A sensitive and specific bioassay allowed detection of biologically 
active IL-l at levels ranging from 0.18 ng/jil at baseline to 1.70 ng/ul in inflamed gingiva. Levels of IL-l 
increased rapidly with plaque accumulation and in advance of the subsequent gingival inflammation, 
peaking within 7 days of the start of gingivitis. As changes in IL-l were detected before clinically 
recognizable gingival changes, IL-l may have potential'as an early marker of gingival inflammatory 
changes.
Key words: interleukin 1. experimental gingivitis.
IL-l is a cytokine found in two forms. IL-lat and 
IL-lfl, which have been shown to be intimately 
involved in the initiation and regulation of the inflam­
matory response (Dinarello, 1984). Although struc­
turally these molecules differ, the potency and activity 
of both are virtually identical and they bind to the 
same receptor with equal affinity (March et al., 198S; 
Sims et al., 1988).
Oppenheim, Charon and Luger (1982) and Charon 
et al. (1982) have reported significant increases 
in IL-l from inflamed sites in periodontitis. These 
findings, however, were based on the detection of 
IL-l in a thymocyte proliferation assay that is not 
specific as it may also respond to other cytokines such 
as IL-2, -6 and tumour necrosis factor-a (Lotz et al., 
1988; Ranges et al., 1988). In addition, thymocyte 
proliferation assays are relatively insensitive to IL-l. 
More recently, immunoassays have been used to 
demonstrate IL-10 in gingival tissues from patients 
with chronic periodontitis (Honig et al., 1989) and 
both IL-lcc and IL-l/J in GCF from periodontally 
diseased sites (Masada et al., 1990). Although im­
munoassays can be very sensitive and specific for 
detecting molecules that bear particular epitopes, 
the molecule’s biological function is uncertain, i.e. 
it could be bound to an inhibitor or in an other 
inactive form. We have now examined the changes in 
IL-l concentration in GCF, using a specific and 
sensitive bioassay for both IL-la and IL-10, and the 
experimental gingivitis model of Loe, Theilade and 
Jensen (1963) which is ideally suited to investigations 
of the composition of GCF during inflammatory 
episodes.
Abbreviations: GCF, gingival crevicular fluid; IL, interleukin.
Two groups of six dental students aged between 
20 and 21 yr (8 male, 4 female), with no evidence 
of periodontal disease and unremarkable medical 
histories, volunteered for the study. All had more 
than 26 teeth, a high standard of oral hygiene and 
healthy gingiva. For 2 months before the experiments 
the subjects were regularly examined and their oral 
hygiene monitored to achieve maximal gingival 
health. After baseline values had been measured the 
volunteers were instructed to stop ail oral hygiene 
procedures. One group of six stopped for 14 days and 
the other for 21 days, after which they were given a 
thorough professional prophylaxis, told to start their 
normal oral hygiene procedures again and checked 1 
and 2 weeks later. Clinical measurements and GCF 
samples were taken at baseline and then at 4-day 
intervals for the 14-day group and at 7-day intervals 
for the 21-day group, from the same two sites in each 
patient—the lower right lateral incisor, distobuccal 
aspect and the lower right central incisor, distobuccal 
aspect. Plaque accumulation was assessed by the 
Plaque Index of Silness and Loe (1964) and the 
Loboie er al. (1986) modified Gingival Index was 
used for non-invasive evaluation of the early visible 
changes in severity and extent of gingivitis. One 
examiner recorded the clinical indices throughout the 
experiment. GCF was collected with 2 x 13-mm 
strips of Whatman grade 4 paper after the crevice had 
been gently air-dried and supragingivai plaque re­
moved. The paper strip was inserted into the crevice 
until mild resistance was felt, and left for 30 s. Care 
was taken to avoid mechanical injury. After collec­
tion the paper strip was transferred at the chairside 
to a Periotron 6000 (Harco, Winnipeg, Canada), for 
quantification of the volume collected. The strips 
were then stored at — 30°C until further processing.
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Table I. Plaque Index (PI), modified Gingival Index (MGI). GCF and IL-l for the six subjects during the 14-day
experimental gingivius study
Indices
Days
0 (SE) 4 (SE) 7 (SE) II (SE) 14 (SE) 21 (SE) 28 (SE)
PI 0.17 0.11 1.58 0.25 1.58 0.14 1.9 0.19 2.7 0.14 0.5 0.22 0.5 0.22
MGI 0.17 0.11 0.17 0.11 1.33 0.25 2.17 0.23 18 0.13 2.5 0.22 0.33 0.14
GCFOtl) 0.21 0.02 0.23 0.03 0.36 0.06 0.41 0.03 0.54 0.04 0.43 0.05 0.36 0.06
IL-l (ng//il) 0.19 0.05 1.30 0.36 1.57 0.48 0.78 0.16 0.95 0.23 0.19 0.05 0.20 0.07
Means and SE are shown.
GCF was eluted from the paper strips by incu­
bation for 30min at 4°C in 150^1 of RPMI 1640 
medium supplemented with 5% fetal calf serum. 
30 ftg/ml gentamicin and 2.2 /tg/ml amphotericin B. 
After elution, the paper strip was removed and 
the eluate was centrifuged for 2 min in a microfuge 
to remove any particulate matter. The supernatant 
was stored frozen at — 20°C for later assay. IL-l 
activity was bioassayed using the IL-l sensitive cell 
line D10(N4)M (Heile, Boeile and Aarden. 1988; 
Hopkins and Humphries, 1989) with the modification 
that cell proliferation was determined by a colori­
metric method with 3-[4,5-dimethylthiazol-2-yl]-2.5i 
diphenyltetrazolium bromide (Mossman. 1983). The 
potency of the stimulatory activity in the eluate was 
determined from dose-response curves obtained with 
a recombinant human DNA-derived IL-l/? {rhil-1/?) 
standard using the computer program ALLFIT (De 
Lean, Munson and Rodbard. 1978). Adding enough 
anti-IL-l/? serum (a sheep polyclonal serum (S77/?); 
gift of Dr A. Shaw, Glaxo. Geneva] to 20^1 of 
selected eiuates, to neutralize completely the activity 
of 100 pg of rhil-lf}, inhibited at least 70% of the 
stimulatory activity. This bioassay is particularly 
sensitive and specific for IL-l and thus the remaining 
activity was presumed to be associated with IL-loe.
The mean Gingival Indices, Plaque Indices. GCF 
volume and IL-1 levels for the six subjects during the 
14-day experimental gingivitis are given in Table I. 
After abstaining from oral hygiene, dental plaque 
accumulated rapidly. This was followed by an in­
crease in local gingival inflammation that lagged., 
behind the detectable increase in plaque. The IL-l 
concentration increased rapidly with plaque accumu­
lation and in advance of the subsequent gingival 
inflammation. At day 14, when regular oral hygiene 
procedures were resumed, the Plaque Index rapidly 
returned to baseline. The modified Gingival Index 
(inflammation index) followed the rise and fall in the 
plaque accumulation index, but lagged behind it by 
a few days. The average IL-l level for this group of 
subjects had started to drop well before normal oral 
hygiene was started again, and returned to baseline
levels ahead of the inflammation index. A similar 
series of changes was found with the 21-day gingivitis 
(Table 2). Regression analysis was done with the IL-l 
levels. Plaque Index and modified Gingival Index for 
each subject summed over the seven sampling inter­
vals for the 14-day gingivitis and the four sampling 
intervals for the 21-day experiment (Table 3) 
(Matthews et al., 1990). Plaque and IL-l levels were 
both positively correlated with the modified Gingival 
Index, although the relationship between Plaque 
Index and IL-l was less strong.
Although IL-l was originally considered to be a 
product of mononuclear phagocytes, recent evidence 
suggests that keratinoctes and gingival fibroblasts 
can also produce IL-l in response to stimulation by 
bacterial components (Walsh. Seymour and Powell. 
1982; Hanazawa et al., 1982, 1988; Takada et al., 
1991). The accumulation of dental plaque might 
provide the appropriate trigger for gingival cells or 
monocyte/macrophages to produce IL-l, which 
would then propagate an inflammatory response. In 
this experimental gingivitis the increase in IL-l con­
centration in the crevicular fluid was found before 
there was observable inflammation of the gingiva, but 
closely followed the Plaque (accumulation) Index. 
Whereas the plaque and inflammation indices con­
tinued to increase whilst oral hygiene remained with­
drawn, the concentration of IL-l began to decline 
after day 7. This early decline may be a normal 
regulation of IL-l production, or due to inhibition or 
degradation by host or bacterial factors. Non-specific 
inhibition of IL-l bioactivity might result from pro­
teolytic digestion by phagocyte and microbial en­
zymes present in the crevice fluid (Sandholm, 1986). 
In the gingival sulcus IL-l might also be affected by 
an inhibitor produced by human gingival epithelial 
cells (Walsh et al., 1987). The early rise of IL-l 
concentration suggests its involvement in the in­
itiation and propagation of the gingivitis.
Although there was minimal intra-individual vari­
ation in our clinical and biochemical data (not 
shown), we found a wide intersubject variation in the 
quantity of crevicular IL-l. Whereas most of the
Table 2. Plaque Index (PI), modified Gingival Index (MGI), GCF and IL-l for the six subjects during 
the 21-day experimental gingivitis study______________________
Indices
Days
0 (SE) 7 (SE) 14 (SE) 21 (SE)
PI 0.25 0.5 1.6 0.5 10 0.1 2.2 0.4
MGI 0.0 0.0 1.0 0.7 10 0.1 2.2 0.4
GCF0*1) 0.23 0.08 0.2 0.05 0.15 0.02 0.26 0.06
IL-Kng/iti) 0.47 0.19 1.74 0.69 1.05 0.14 0.54 0.11
Means and SE are shown.
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Table 3. Regression analysis of experimental indices
Comparison r P
PI versus IL-l 0.59 0.045
PI versus MGI 0.72 <0.01
IL-l versus MGI 0.76 0.017
PI. Plaque Index; MCI. modified Gingival Index.
subjects developed a substantial rise in crevicular IL-1 
activity, which peaked within 7 days of withdrawing 
oral hygiene, two subjects within the 14 day study 
showed only slight crevicular IL-l activity throughout 
the study. The heterogeneous IL-l responses of these 
subjects might reflect individual variation in plaque 
accumulation or variation in subsequent inflam­
mation due to plaque. Alternatively, it might be a 
result of an inherent variation in the ability to produce 
IL-l at this site. The lack of correlation between the 
Plaque Index and IL-l in these subjects suggests that 
plaque accumulation per se is not the major deter­
mining factor in gingival IL-l production. The posi­
tive correlation between the Plaque Index and the 
modified Gingival Index (Table 3) is consistent with 
previous studies based on the experimental gingivi­
tis model (Loe et al., 1965). The overall corre­
lation between IL-l and the inflammatory index 
supports the proposed implication of IL -1 in gingival 
inflammation.
IL-la and -/? have recently been detected in larger 
amounts than normal from sites manifesting active 
periodontitis (Masada et al.. 1990). In the light of this, 
our findings of a peak and then a drop to baseline 
levels in the first few weeks of a developing inflamma­
tory episode require further discussion. The exper­
imental gingivitis model allows examination of early 
changes dunng the development of periodontal dis­
ease. A gradual increase in basal levels of IL-1 may 
take place during the long time course of developing 
chronic gingivitis and periodontitis. The early peak 
in IL-l levels reported here is consistent with the 
‘burst hypothesis’ of periodontal disease progression, 
and if this dramatic change in IL-l levels occurs in 
periodontitis sites it could be an indicator of incipient 
breakdown at those sites. IL-l is one of the factors 
known to stimulate bone resorption and collagenase 
production by fibroblasts, both of which are features 
of periodontal destruction (Gowen et al.. 1983; Heath 
et al., 1985; Postlethwaite et al., 1983). In addition, 
as changes in IL-1 levels were detected well in advance 
of clinically recognizable gingival changes. IL-l 
may have a role as an early marker of gingival 
inflammatory changes.
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Endothelial leukocyte adhesion molecule 1 (ELAM-l) and 
Intercellular adhesion molecule 1 (ICAM-L) are adhesion molecules 
which regulate cellular traffic into inflamed areas and botch are 
present in clinically 'healthy' gingiva ( 1 , 2 ) .  It has recently 
been reported that the cutaneous lymphocyte-associated antigen, 
for which the monoclonal antibody SECA 452 is specific, is 
constitutively expressed in a subset of skin-homing memory T 
cells which predominate in normal and chronically inflamed skin 
(3 ) . These skin-homing T cells bind to ELAM-l which is expressed 
in skin (4) and gingiva (1,2) - The marked lymphocytic infiltrate 
noted even in clinically healthy gingiva is intriguing, par­
ticularly the characteristic location of suppressor T cells and 
the possibility they have a role in gingival immune surveillance 
(2). To investigate whether there is selective cutaneous 
localisation of corresponding skin-homing T cell clones we have 
compared T cell receptor (TCR) gene rearrangement profiles in
samples or normal human skin, in normal gingival mucosa and in 
peripheral blood from the 3ame 3ubject3. T cell clones can be 
distinguished from each other by the antigen-binding domains of 
the TCH3 (5) and by TCH gene rearrangements which include clone- 
specific hypervariable junctional regions (6). TC3y genes are 
understood to be rearranged in all T cell3 including those which 
express a(3 TCte (T) and can act as clonal markers in small tissue 
samples (8) . We have applied the polymerase chain reaction (PCH) 
to amplify the V-J junctions of TCRy gene rearrangements and have 
separated the amplification products by high resolution electro­
phoresis to detect clone-related size differences. These 
differences result from variation in rearrangement breakpoints 
in the Vy and Jy genes and from insertion of uncoded W region 
nucleotides where the Vy and Jy genes join (6,8,9). Each of the 
four primer combinations used in the present 3tudy may give rise 
to 20 or more nucleotide bands which can be resolved by electro­
phoresis, thus permitting at least 30 different y gene clonotypes 
(3et3 of rearrangements forming a single band) to be distin­
guished. We have also compared major T cell 3ubset3 in, normal 
3kin and normal gingival mucosa to attempt to rationalise T 
lymphocyte clonotype findings.
Four healthy adults (3M; IF) provided samples of DNA from 
peripheral blood mononuclear cells (PBMC) and 6mm diameter punch 
biopsies of skin. Two of the subjects also supplied additional 
4mm2 biopsies of clinically healthy gingival mucosa. To 
establish whether specific clonotypes were associated with 
particular anatomical sites, 8 of the skin samples were obtained 
from symmetrical locations (e.g. right and left forearms, right 
and left chest) and the gingival specimens were taken from 
contralateral buccal midpoints of the upper right and upper left 
first molars. To permit comparison of CD3, CD4, CD8 and HECA
2
positive T Lymphocyte 3ub3et3 within normal 3icin and gingiva, 
frozen sections from tixe gingival and normal 3kin biopsies were 
obtained. DNA wa3 isolated from the samples and then the 
products of 35 PCR cycles with a primer for Jyl,2 paired with 
primers for Vy2, Vy4, Vy8 and VylQ were electrophoresed on 
denaturing 6% polyacrylamide gel3 and autoradiography performed 
(8) . Autoradiographic band patterns, as in Fig. 1, were scanned 
by laser densitometer (LKB, Sweden) and the absorbance values of 
the samples were then clustered by the method of unweighted pair 
group average linkage, to estimate similarities (10,11). Sum 
serial cryostat sections of snap frozen tissue biopsies were 
immunohistochemically stained using mouse monoclonal antibodies 
specific for CD3, CD8, CD4 (SAPU, Scotland) and HECA 452 (a gift 
from CJLM Meijer, Amsterdam). Epithelial and connective tissue 
infiltrates were analysed as previously described (12,2).
With, each primer combination studied, multiple clonotypes 
which vary from individual to individual were found in blood, 
skin and gingival mucosa. The similarities between tissues from 
contralateral sites within the 3ame individual are illustrated 
by the VylO gene rearrangements in Fig. 1. Band patterns 
differed between blood, 3kin and gingiva but tended to be 
qualitatively and quantitatively similar in multiple skin 
biopsies or in paired gingival samples from the same subject 
(Fig. 1). Findings similar to those seen in normal skin have 
been obtained in Lesions of the T cell-associated cutaneous 
disorders psoriasis (13) and vitiligo (14) . Immunohistochemi3try 
shows consistently greater numbers of CD3, CD4, CD8 and HECA 452 
positive T cells in the epithelium and connective tissue of the 
gingival mucosa than in epidermis and dermis.
Recent reports of a subset of circulating skin-homing memory 
T lymphocytes, which constitutively express the skin associated
T call antigen defined by the monoclonal antibody HECA 452 and 
bind selectively to the endothelial adhesion molecule ELAM-L, 
suggest the existence of a corresponding subset of 3kin-homing 
T cell clones. We have thus investigated thi3 possibility using 
highly sensitive ?CRs which permit detection of clonal TCRy gene 
rearrangements in L-5 percent of a few hundred lymphocytes (8) .
T cell receptor 7 (gamma) gene rearrangements were used as clonal 
markers of T call3 in blood, skin and gingival mucosa from 
healthy human subjects. In each tissue there was marked clonal 
heterogeneity, as evidenced by the presence of multiple gene 
rearrangements (junctional diversity) of all four Vy genes
investigated. The striking similarity in the rearrangement
s
profiles when skin was compared to skin or gingiva to gingiva 
indicate selective localisation of different subsets of T cell 
clones in 3kin and gingiva. These findings are consistent with, 
the existence of local immune 3y3tems composed of 3kin-homing and 
gingiva-homing memory T cells. However the alternative pos­
sibility exists that specific T cells proliferate locally within 
certain tissues giving ri3e to characteristic T cell clones for 
these regions. In addition to clonal differences there are 
markedly more CD3, CD4, CD8 and HECA. positive T lymphocytes in 
clinically 'healthy' gingiva, which may be related to the fact 
that ELAM-L is strongly expressed in vascular endothelium of 
normal gingival mucosa (1) - Other factors which might influence 
the localisation of dominant T cell clones in the gingival mucosa 
include expansion of specific T cell clones in response to local 
antigenic stimulation and upregulation of general adhesion 
molecules such as ICAM-L (L) which may attract T cell, subsets 
other them, those which home to normal skin. Despite it3 
importance, much remains to be learned about the structure and 
function of the skin immune system in health and disease (L2) .
' 4
Thi3 3tudy 3hows that high resolution electrophoretic analysis 
of 9GH products from Vy and Jy primers can provide new infor­
mation about che anatomical distribution of T cell clonotypes and 
specifically that T cells localised to 'healthy' gingiva are 
remarkably similar between contralateral 3ites but differ from 
T cell3 of 3kin and peripheral blood- Continuing work may 
elucidate T cell clonotypes specific for patients with particular 
forms of periodontal disease.
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Figure 1. C o m p a r is o n  o f  T c e i l  c l o n e s  w ith . 7 vio - Jyl,2 T c e l l  
r e c e p t o r  g e n e  r e a r r a n g e m e n t s  i n  b l o o d ,  3 k in  a n d  g i n g i v a l  m u c o sa  
o f  h e a l t h y  s u b j e c t s .  Subject C ( m a le  34y): l a n e  1, PBMC? l a n e  
2; r i g h t  arm? l a n e s  3 a n d  4, r i g h t  an d  l e f t  g i n g i v a .  S u b j e c t  □ 
( f e m a l e  30y) : l a n e  5, PBMC; l a n e  5, r i g h t  arm ; l a n e s  7 a n d  3, 
r i g h t  an d  l e f t  g i n g i v a .  R e l a t i v e  m o l e c u l a r  m a ss  c a l i b r a t i o n  ( i n  
n u c l e o t i d e s )  c a l c u l a t e d  fr o m  DNA m o le c u l a r  w e i g h t  m a r k e r  7 .  T h e  
r a n g e  o f  m o l e c u l a r  3 i z e s  i 3  d u e  t o  v a r i a t i o n  i n  r e a r r a n g e m e n t  
b r e a k p o i n t s  a n d  num ber o f  N - r e g i o n  n u c l e o t i d e s  i n  d i f f e r e n t  
c l o n e s .
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